Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Conclusions 52
References 54
Annexes 57
Dr Margaret Chan
Director-General
World Health Organization
Michael Lynch, John Painter and Nelli Westercamp (United States Centers for
Disease Control and Prevention) and Cristin Fergus (London School of Economics,
University of London) provided data analysis and interpretation for sections
on chemoprevention, diagnostic testing and treatment. Adam Bennett (Global
Health Group), Donal Bisanzio and Peter Gething (MAP) and Thom Eisele (Tulane
University) produced analysis of malaria treatment from household surveys. Li Liu
(Johns Hopkins Bloomberg School of Public Health), Dan Hogan and Colin Mathers
(WHO Department of Health Statistics and Information Systems) prepared estimates
of malaria mortality in children aged under 5 years, on behalf of the Child Health
Epidemiology Reference Group, and undertook calculations on life expectancy.
The maps for country and regional profiles were produced by MAPs ROAD-
MAPII team; led by Mike Thorn, the team comprised Harry Gibson, Naomi Gray,
Joe Harris, Andy Henry, Annie Kingsbury, Daniel Pfeffer and Jen Rozier. MAP is
supported by the Bill & Melinda Gates Foundation and the Medical Research
Council (United Kingdom).
We are also grateful to:
Melanie Renshaw (African Leaders Malaria Alliance [ALMA]), Trenton Ruebush
(independent consultant) and Larry Slutsker (Program for Appropriate
Technology in Health [PATH]), who graciously reviewed all sections and
provided substantial comments for their improvement;
Claudia Nannini (WHO) for legal review;
Carlota Gui (WHO consultant) and Laurent Bergeron (WHO Global Malaria
Programme) for the translation into Spanish and French, respectively, of the
foreword and key points;
Claude Cardot and the Designisgood team for the design and layout of the
report;
Paprika (Annecy, France) for generating Annex 4;
Alex Williamson for the report cover; and
Hilary Cadman and the Cadman Editing Services team for technical editing of
the report.
The production of the World Malaria Report 2016 was coordinated by Richard
Cibulskis (WHO Global Malaria Programme). Laurent Bergeron (WHO Global
Malaria Programme) provided programmatic support for overall management of
the project. The World Malaria Report 2016 was produced by John Aponte (WHO
consultant), Maru Aregawi, Laurent Bergeron, Richard Cibulskis, Jane Cunningham,
Tessa Knox, Edith Patouillard, Pascal Ringwald, Silvia Schwarte, Saira Stewart and
Ryan Williams, on behalf of the WHO Global Malaria Programme. We are grateful
to our colleagues in the Global Malaria Programme who reviewed sections of the
report and provided helpful comments: Pedro Alonso, Amy Barrette, Andrea Bosman,
Gawrie Loku Galappaththy, Abdisalan Noor, Peter Olumese, Leonard Ortega, Camille
Pillon, Charlotte Rasmussen, Vasee Sathiyamoorthy and David Schellenberg. We also
thank Hiwot Taffese Negash and Simone Colairo-Valerio for administrative support.
Funding for the production of this report was gratefully received from the Bill
& Melinda Gates Foundation; Luxembourgs Ministry of Foreign and European
Affairs Directorate for Development Cooperation and Humanitarian Affairs; the
Spanish Agency for International Development Cooperation; the Swiss Agency for
Development and Cooperation through a grant to the Swiss Tropical and Public
Health Institute; and the United States Agency for International Development.
3. Preventing malaria
Vector control
The proportion of the population at risk in sub-Saharan Africa sleeping under
an insecticide-treated mosquito net (ITN) or protected by indoor residual
spraying (IRS) is estimated to have risen from 37% in 2010 (uncertainty interval
[UI]: 2548%) to 57% in 2015 (UI: 4470%).
In sub-Saharan Africa, 53% of the population at risk slept under an ITN in 2015
(95% confidence interval [CI]: 5057%), increasing from 30% in 2010 (95% CI:
2832%),
The rise in the proportion of people at risk sleeping under an ITN has been
driven by an increase in the proportion of the population with access to an ITN
(60% in 2015, 95% CI: 5764%; 34% in 2010, 95% CI: 3235%).
The proportion of households with at least one ITN increased to 79% in 2015
(95% CI: 7683); thus, a fifth of households where ITNs are the main method of
vector control do not have access to a net.
The proportion of households with sufficient ITNs for all household members
was 42% (95% CI: 3945%).
IRS is generally used by NMCPs only in particular areas. The proportion of the
population at risk protected by IRS declined from a peak of 5.7% globally in 2010
to 3.1% in 2015, and from 10.5% to 5.7% in sub-Saharan Africa.
Reductions in IRS coverage may be attributed to cessation of spraying with
pyrethroids, particularly in the WHO African Region.
Of 73 malaria endemic countries that provided monitoring data for 2010
onwards, 60 reported resistance to at least one insecticide, and 50 reported
resistance to two or more insecticide classes.
Resistance to pyrethroids the only class currently used in ITNs is the most
commonly reported. A WHO-coordinated five-country evaluation showed that
ITNs still remained effective but there is still a need for new vector control tools.
Intermittent preventive therapy in pregnancy
In 2015, 31% of eligible pregnant women received three or more doses of
intermittent preventive treatment in pregnancy (IPTp) among 20 countries with
sufficient data, a major increase from 6% in 2010.
6. Impact
Parasite prevalence
The proportion of the population at risk in sub-Saharan Africa who are infected
with malaria parasites is estimated to have declined from 17% in 2010 to 13% in
2015 (UI: 1115%).
The number of people infected with malaria parasites in sub-Saharan Africa
is estimated to have decreased from 131 million in 2010 (UI: 126136 million) to
114 million in 2015 (UI: 99130 million).
Infection rates are higher in children aged 210 years, but most infected people
are in other age groups.
Case incidence
In 2015, an estimated 212 million cases of malaria occurred worldwide (UI:
148304 million).
Most of the cases in 2015 were in the WHO African Region (90%), followed by
the WHO South-East Asia Region (7%) and the WHO Eastern Mediterranean
Region (2%).
About 4% of estimated cases globally are due to P. vivax, but outside the African
continent the proportion of P. vivax infections is 41%.
The incidence rate of malaria is estimated to have decreased by 41% globally
between 2000 and 2015, and by 21% between 2010 and 2015.
Malaria has not been re-established in any of the countries that eliminated
malaria between 2000 and 2015.
Reduced malaria mortality, increased life expectancy and economic valuation
Between 2001 and 2015, it is estimated that a cumulative 6.8 million fewer
malaria deaths have occurred globally than would have occurred had incidence
and mortality rates remained unchanged since 2000.
The highest proportion of deaths was averted in the WHO African Region (94%).
Of the estimated 6.8 million fewer malaria deaths between 2001 and 2015,
about 6.6 million (97%) were for children aged under 5 years.
Not all of the deaths averted can be attributed to malaria control efforts. Some
progress is probably related to increased urbanization and overall economic
development, which has led to improved housing and nutrition.
As a consequence of reduced malaria mortality rates, particularly among
children aged under 5 years, it is estimated that life expectancy at birth has
increased by 1.2 years in the WHO African Region. This increase represents 12%
of the total increase in life expectancy of 9.4 years seen in sub-Saharan Africa,
from 50.6 years in 2000 to 60 years in 2015.
Globally, reductions in malaria mortality have led to an increase in life
expectancy of 0.26 years in malaria endemic countries, representing 5% of the
overall gain of 5.1 years.
Current methodologies suggest that the increased life-expectancy resulting
from malaria mortality reductions observed between 2000 and 2015 can be
valued at US$ 1810 billion in the WHO African Region (UI: US$13302480billion),
which is equivalent to 44% of the gross domestic product (GDP) of the affected
countries in 2015.
Globally, the malaria mortality reductions are valued at US$ 2040 billion (UI:
US$ 15602700 billion), which is 3.6% of the total GDP of malaria affected
countries.
The economic value of longer life is expressed as a percentage of GDP to provide
a convenient and well-known comparison, but is not meant to suggest that the
value of longevity is itself a component of domestic output, or that the value
of these gains enter directly into the national income accounts. Nonetheless,
the comparison suggests that the value of the gains in life expectancy due to
reductions in malaria mortality are substantial.
Dr Margaret Chan
Directeur gnral
de lOrganisation mondiale de la Sant
(OMS)
Le Rapport sur le paludisme dans le monde, publi chaque anne par lOMS,
fournit une analyse dtaille des progrs et des tendances de la lutte contre le
paludisme au niveau mondial, rgional et national. Il sagit l du produit dun
effort collaboratif entre les ministres de la Sant des pays endmiques et de
nombreuses organisations partenaires dans le monde.
Notre rapport 2016 met en lumire plusieurs tendances positives, notamment
en Afrique subsaharienne o la maladie svit le plus. Il indique que laccs aux
interventions prventives et thrapeutiques augmente rapidement parmi les
populations qui en ont le plus besoin et ce, dans nombre de pays.
Les enfants sont particulirement vulnrables; ils reprsentent plus des deux
tiers des dcs dus au paludisme dans le monde. Des enqutes ralises dans
22 pays africains montrent que le pourcentage denfants ayant t soumis
un test de diagnostic du paludisme au sein dtablissements de soins publics a
augment de 77 % ces cinq dernires annes. Ce test permet aux prestataires de
sant de rapidement diffrencier les fivres palustres des autres, ce qui garantit
ladministration dun traitement appropri.
Le paludisme pendant la grossesse peut avoir des consquences dramatiques:
mortalit maternelle, anmie et enfants prsentant un poids insuffisant la
naissance, une cause principale de mortalit nonatale. LOMS recommande le
traitement prventif intermittent pendant la grossesse (TPIp) toutes les femmes
enceintes dAfrique subsaharienne vivant dans des zones de transmission modre
leve. Au cours des cinq dernires annes, le taux dadministration dau moins
trois doses de TPIp a t multipli par cinq dans 20 pays africains au total.
Les moustiquaires imprgnes dinsecticide longue dure sont essentielles la
prvention du paludisme et lOMS en recommande lutilisation lensemble de la
population risque. En Afrique subsaharienne, le pourcentage de la population
dormant sous moustiquaire a quasiment doubl ces cinq dernires annes.
3. Prvention du paludisme
Lutte antivectorielle
En Afrique subsaharienne, le pourcentage de la population risque dormant
sous moustiquaire imprgne dinsecticide (MII) ou ayant bnfici de la
pulvrisation intradomiciliaire dinsecticides effet rmanent (PID) aurait
augment de 37% en 2010 (incertitude comprise entre 25% et 48%) 57% en
2015 (incertitude: 44%-70%).
En Afrique subsaharienne, 53% de la population risque dort sous moustiquaire
en 2015 (intervalle de confiance [IC] de 95%: 50%-57%), contre 30% en 2010
(IC de 95%: 28%-32%).
Laugmentation du pourcentage de la population risque dormant sous MII est
due un accs accru aux moustiquaires (60% en 2015, IC de 95%: 57%-64%;
34% en 2010, IC de 95%: 32%-35%).
Le pourcentage des mnages possdant au moins une MII a augment,
pour atteindre 79% en 2015 (IC de 95%: 76%-83%); en dautres termes, un
cinquime des mnages pour lesquels les MII sont le principal moyen de lutte
antivectorielle nont pas accs une moustiquaire.
Le pourcentage des mnages avec un nombre de MII suffisant pour couvrir
tous les membres du foyer slve 42% (IC de 95%: 39%-45%).
La PID est gnralement utilise par les PNLP dans des zones spcifiques
uniquement. Le pourcentage de la population risque protge par PID a
baiss, passant dun pic de 5,7% au niveau mondial en 2010 3,1% en 2015, et
de 10,5% 5,7% en Afrique subsaharienne.
La baisse de la couverture en PID peut tre attribue larrt de la pulvrisation
base de pyrthodes, en particulier dans la rgion Afrique de lOMS.
Sur 73 pays endmiques ayant communiqu des donnes de suivi partir de
2010, 60 ont signal une rsistance au moins une classe dinsecticides, et 50
deux classes au moins.
La rsistance aux pyrthodes, la seule classe dinsecticides actuellement
utilise pour les MII, est la plus frquente. Quand bien mme une valuation
coordonne par lOMS dans cinq pays a montr que les moustiquaires taient
toujours efficaces, de nouveaux outils de lutte antivectorielle sont ncessaires.
4. Diagnostic et traitement
Accs aux soins
Sur 23 enqutes reprsentatives au niveau national et ralises en Afrique
subsaharienne entre2013 et2015 (reprsentant 61% de la population risque),
une mdiane de 54% des enfants de moins de 5 ans ayant eu de la fivre (cart
interquartile [I]: 41%-59%) ont t orients vers un prestataire de sant form.
Le pourcentage des enfants fivreux ayant sollicit des soins dans le secteur
public est plus important que dans le secteur priv, savoir une mdiane de
42% (I: 31%-50%) contre 20% (I: 12%-28%).
Le pourcentage denfants fivreux nayant pas sollicit de soins est important
(mdiane de 36%, I: 26%-42%).
Diagnostic
Le pourcentage denfants fivreux ayant t soumis un test de diagnostic est
plus important dans le secteur public (mdiane de 51%, I: 35%-60%) que
dans le secteur priv formel (mdiane de 40%, I: 28%-57%) ou le secteur
priv informel (mdiane de 9%, I: 4%-12%). Le pourcentage denfants ayant
t soumis un test dans le secteur public est en augmentation, car il tait de
29% en 2010 (I: 19%-46%).
Les donnes rapportes par les PNLP indiquent que le pourcentage de cas
suspects de paludisme soumis un test parasitologique dans le secteur
public a augment de 40% dans la rgion Afrique de lOMS 76% en 2015.
Cette hausse est principalement due une plus grande utilisation des tests de
diagnostic rapide (TDR) qui reprsentent 74% des moyens de dpistage parmi
les cas suspects de paludisme en 2015.
La suppression de la HRP2, permettant aux parasites du paludisme dchapper
la dtection par les tests de diagnostic rapide habituels, a t rapporte dans
plus de 10 pays.
Traitement
Sur 11 enqutes nationales ralises auprs des mnages entre2013 et2015
en Afrique subsaharienne, le pourcentage mdian des enfants de moins de
5 ans prsentant, ou ayant rcemment prsent une infection Plasmodium
(P.) falciparum avec des antcdents de fivre et ayant reu un mdicament
antipaludique slve 30% (I: 20%-51%). Le pourcentage mdian ayant
reu une combinaison thrapeutique base dartmisinine (ACT) est de
14% (I: 5%-45%). Ces rsultats ne permettent nanmoins de tirer aucune
conclusion prcise; en effet, les plages associes aux valeurs mdianes sont
larges, indiquant des carts importants entre pays. Par ailleurs, ces enqutes
ralises auprs des mnages ne couvrent quun tiers de la population risque
en Afrique subsaharienne.
Des financements plus importants sont ncessaires pour mieux suivre laccs
au traitement antipaludique au niveau des tablissements de soins (par le biais
des systmes de reporting de routine et des enqutes auprs des tablissements
de soins) et au niveau communautaire et ce, dans le but de mieux mesurer
lampleur des obstacles.
Le pourcentage dACT parmi les traitements antipaludiques administrs
aux enfants ayant eu de la fivre dans les 2 semaines prcdant lenqute
et eu un rsultat positif au TDR au moment de lenqute a augment dune
valeur mdiane de 29% en 2010-2012 (I: 17%-55%) 80% en 2013-2015 (I:
29%-95%).
Le traitement antipaludique tait plus susceptible dtre par ACT si les enfants
sollicitaient des soins dtablissements de soins publics ou dagents de sant
communautaires que sils sorientaient vers le secteur priv.
La rsistance du parasite Plasmodium falciparum lartmisinine a t dtecte
dans cinq pays de la sous-rgion du Grand Mkong. Au Cambodge, des taux
dchec au traitement ont t observs pour quatre types dACT.
6. Impact
Prvalence parasitaire
Le pourcentage dinfections palustres parmi la population risque en Afrique
subsaharienne est estime en baisse, passant de 17% en 2010 13% en 2015
(incertitude: 11%-15%).
limination
Entre2000 et2015, 17 pays ont limin le paludisme (cest--dire rduit zro
le nombre de cas indignes pendant au moins trois ans) et 6 dentre eux ont
t certifis exempts de paludisme par lOMS.
Sur la voie de llimination du paludisme, ces 17 pays ont rapport une mdiane
de 184 cas indignes cinq ans avant davoir rduit le nombre de cas zro (I:
78-728) et une mdiane de 1748 cases dix ans auparavant (I: 423-5731).
En 2015, 10 pays et territoires ont rapport moins de 150 cas indignes, et 9 autres
pays en ont recens entre 150 et 1000. Il sagit l de rsultats encourageants
vers latteinte de lobjectif intermdiaire de 2020, savoir liminer le paludisme
dans au moins 10 pays.
La transmission du paludisme nest rapparue dans aucun des pays ayant
limin cette maladie entre2000 et2015.
Baisse de la mortalit lie au paludisme, augmentation de lesprance de vie et
valorisation conomique
Au total, 6,8millions de dcs dus au paludisme ont t vits au niveau mondial
entre2001 et2015, par rapport aux chiffres que nous aurions enregistrs si les
taux dincidence et de mortalit taient rests inchangs depuis 2000.
La plupart des dcs (94%) ont t vits dans la rgion Afrique de lOMS. Sur
les 6,8millions de dcs dus au paludisme vits entre2001 et2015, environ
6,6millions (97%) lont t parmi les enfants de moins de 5 ans.
Tous les dcs vits ne sont pas lis aux efforts de lutte contre le paludisme;
une partie dentre eux sexpliquent vraisemblablement par une urbanisation
accrue et la croissance conomique en gnral, lorigine de lamlioration
des conditions de logements et dune meilleure nutrition.
Consquence de la baisse de la mortalit due au paludisme, en particulier chez
les enfants de moins de 5 ans, lesprance de vie la naissance aurait augment
de 1,2 an dans la rgion Afrique de lOMS. Cette hausse reprsente 12% de
laugmentation de 9,4 ans de lesprance de vie en Afrique subsaharienne,
passe de 50,6 ans en 2000 60 ans en 2015.
Au niveau mondial, la baisse du risque de mortalit due au paludisme aurait
contribu une augmentation de lesprance de vie de 0,26 an dans les pays
endmiques, soit 5% des 5,1 ans gagns au total.
La baisse du risque de mortalit due au paludisme entre2000 et2015 et donc, les
gains en termes desprance de vie, peuvent tre valoriss US$ 1810milliards
dans la rgion Afrique de lOMS (incertitude: US$ 1330-2480milliards), soit
44% du produit intrieur brut (PIB) des pays affects en 2015.
Au niveau mondial, la baisse du risque de mortalit due au paludisme est
valorise US$ 2040milliards (incertitude: US$ 1 560-2 700 milliards), soit
3,6% du total du PIB des pays affects.
Ces valeurs de bien-tre conomique sont exprimes en termes de pourcentage
du PIB titre comparatif; elles ne sauraient laisser entendre que la valeur de
la longvit est une composante de la richesse nationale produite, ni que la
valeur de ces gains est directement intgre dans le revenu national. Cette
comparaison suggre seulement que la valeur conomique attache la baisse
de la mortalit due au paludisme est consquente.
Tratamiento
Entre las 11 encuestas representativas a nivel nacional que fueron llevadas a
cabo entre 2013 y 2015 en el frica subsahariana, la proporcin mediana de
nios por debajo de los 5 aos con evidencia de una infeccin de P. falciparum
reciente o presente e historia de fiebre que recibieron algn medicamento
antipaldico se elev a 30% (RI: 20%51%). De mediana, el 14% (RI: 5%45%)
recibi una terapia combinada con artemisinina (TCA). Sin embargo, no pudo
extraerse ninguna conclusin clara de estos resultados puesto que los rangos
asociados a las medianas eran muy amplios, indicando una gran variedad
entre los pases, a lo que hay que aadir que las encuestas solo representaban
un tercio de la poblacin en riesgo en el frica subsahariana.
Son necesarias mayores inversiones para poder mejorar el seguimiento de
los tratamientos en los centros de salud (a travs de los sistemas rutinarios de
reporte y de las encuestas a los centros de salud) y a nivel comunitario, para
poder entender hasta qu punto existen barreras que impiden el acceso a un
tratamiento contra el paludismo.
El porcentaje de tratamientos antipaldicos con TCA proporcionados a nios
con fiebre en las ltimas dos semanas y con un RDT positivo en el momento
de la encuesta, aument de una mediana inicial de 29% entre 2010-2012 (RI:
17%55%) al 80% en 2013-2015 (RI: 29%95%).
Los tratamientos antipaldicos fueron ms probables de ser TCA si los nios
buscaban tratamiento en centros de salud pblica o a travs de trabajadores
de salud de las comunidades, que si se dirigan al sector privado.
Se ha detectado resistencia de P. falciparum a la artemisinina en cinco pases
de la subregin del Gran Mekong. En Camboya, altos ndices de fracaso
despus de las TCA han sido detectados en cuatro diferentes.
6. Impacto
Prevalencia del parsito que provoca el paludismo
El porcentaje de las poblaciones en riesgo en el frica subsahariana con
infecciones por el parsito del paludismo ha descendido de un 17% calculado
en 2010 a un 13% en 2015 (II: 11%15%).
En el frica subsahariana, el nmero de personas infectadas por el parsito
del paludismo ha descendido de 131 millones en 2010 (II: 126 136 millones) a
114 millones en 2015 (II: 99 130 millones.
La tasa de infeccin es ms alta en nios entre 2 y 10 aos, aunque la mayor
parte de las personas afectadas se encuentran en rangos de edades superiores.
Casos de incidencia
A nivel mundial, se calcularon 212 millones de casos de paludismo en 2015 (II:
148 304 millones).
En 2015, la mayora de los casos fueron registrados en la regin de frica de
la OMS (90%), seguida de la regin de Asia sudoriental (7%) y la regin del
Mediterrneo oriental (2%).
Las infecciones por P. vivax son responsables de un 4% de los casos mundiales
de paludismo, sin embargo fuera del continente africano el porcentaje de
infecciones por P. vivax es de 41%.
A nivel mundial, la tasa de incidencia de casos del paludismo ha disminuido
un 41% entre 2000 y 2015, y un 21% entre 2010 y 2015.
De los 91 pases y territorios con transmisin de paludismo en 2015, se estima
que 40 han alcanzado una reduccin en las tasas de incidencia de 40% o ms
entre 2010 y 2015, y se puede considerar que estn en el camino de alcanzar
la meta del GTS de una reduccin adicional del 40% para el 2020.
Si se quiere alcanzar la meta del GTS en reducir de 40% la tasa de incidencia
de casos para el ao 2020, se debera acelerar la disminucin de la tasa de
incidencia de casos en pases con un alto nmero de casos reportados.
Mortalidad
En 2015, se estimaron 429 000 muertes por paludismo en todo el mundo (II:
235 000 639 000).
En 2015, se estim que la mayora de las muertes ocurrieron en la regin de
frica de la OMS (92%), seguida de la regin de Asia sudoriental de la OMS
(6%) y la regin del Mediterrneo oriental de la OMS (2%).
Since 2000, substantial progress has been made in fighting malaria. According
to the latest estimates, between 2000 and 2015, malaria case incidence was
reduced by 41% and malaria mortality rates by 62% (see Section 6 of this report).
At the beginning of 2016, malaria was considered to be endemic in 91 countries
and territories, down from 108 in 2000 (Figure 1.1). Much of the change can be
attributed to the wide-scale deployment of malaria control interventions(1).
Despite this remarkable progress, malaria continues to have a devastating impact
on peoples health and livelihoods. Updated estimates indicate that 212million
cases occurred globally in 2015, leading to 429000 deaths, most of which were
in children aged under 5 years in Africa.
Recognizing the need to hasten progress in reducing the burden of malaria, WHO
developed the Global Technical Strategy for Malaria 20162030 (GTS) (2), which
sets out a vision for accelerating progress towards malaria elimination. The WHO
strategy is complemented by the Roll Back Malaria advocacy plan, Action and
investment to defeat malaria 20162030 (AIM) (3). Together, these documents
emphasize the need for universal access to interventions for malaria prevention,
diagnosis and treatment; that all countries1 should accelerate efforts towards
malaria elimination; and that malaria surveillance should be a core intervention.
The GTS and AIM also recognize the importance of innovation and research and
a strong enabling environment, and share the same global targets for 2030 and
the same milestones for 2020 and 2025, as shown in Table 1.1. The time frame
of the GTS and AIM is aligned with that of the Sustainable Development Goals
(SDGs) (4). For malaria, Target 3.3 of the SDGs to end the epidemics of AIDS,
tuberculosis, malaria and neglected tropical diseases and combat hepatitis,
waterborne diseases, and other communicable diseases by 2030 is interpreted
as the attainment of the GTS and AIM targets. The indicator used to track progress
of Target 3.3 is malaria case incidence.
1. In order to facilitate reading throughout the report, countries is used as a generic term referring to
countries and areas or territories. The term area or territory is used only when mentioning one or more
areas/territories in lists of specific countries.
Countries endemic for malaria, 2016 Countries endemic in 2000, no longer endemic in 2016
Countries not endemic for malaria, 2000 Not applicable
Table 1.1 Global targets for 2030 and milestones for 2020 and 2025. Source: (2)
Milestones Targets
Goals
2020 2025 2030
The GTS highlights a minimal set of 14 outcome and impact indicators against
which progress in malaria control and elimination should be monitored, of which 12
are relevant at global level. The World Malaria Report 2016 aims to report on these
global indicators, and a selection of other indicators as shown in Table 1.2. It also
reports on the supply of key commodities to endemic countries (which influences
the progress of malaria control and elimination programmes) (Section 2.4); the
evolution of resistance to interventions by vectors and parasites (Sections 3.6 and
4.6, respectively). This year, the report also considers the gain in life expectancy
that the reductions in malaria mortality have brought about, and the economic
value society places on such changes (Section 6.7). The main text is followed by
methods, regional profiles, country trends in selected indicators and data tables.
Country profiles and methods are available online at http://www.who.int/malaria/
publications/world-malaria-report-2016/en/.
The World Malaria Report is produced by the WHO Global Malaria Programme,
with the help of WHO regional and country offices, ministries of health in endemic
countries, and a broad range of other partners. The primary sources of information
are reports from national malaria control programmes (NMCPs) in the 91 endemic
countries. This information is supplemented by data from nationally representative
household surveys (demographic and health surveys, malaria indicator surveys
and multiple indicator cluster surveys) and databases held by other organizations:
the Alliance for Malaria Prevention; the Global Fund to Fight AIDS, Tuberculosis
and Malaria (Global Fund), the Organisation for Economic Co-operation and
Development; Policy Cures; United Nations Childrens Fund (UNICEF); the
USPresidents Malaria Initiative; and WHO. Adescription of data sources and
methods is provided in Annex 1.
Table 1.2 Indicators reviewed in World Malaria Report 2016. Indicators among minimal set of 14 recommended
indicators in GTS are highlighted in light grey.
Applicability of indicator
by transmission setting
Indicator Elimination or
High Low prevention of
re-establishment
Inputs
1.1 Total malaria funding and expenditure per capita
Financing
for malaria control and elimination
1.2 Funding for malaria relevant research
Outcome
Vector control 2.1 Proportion of population at risk that slept under an
ITN the previous night
2.2 Proportion of population with access to an ITN
within their household
2.3 Proportion of households with at least one ITN for
every two people
2.4 Proportion of households with at least one ITN
2.5 Proportion of available ITNs used the previous night
Progress in reducing malaria incidence and mortality between 2000 and 2015
was made possible by large increases in the financing of malaria control and
elimination programmes. Further progress in reducing malaria depends on
increased investments in malaria programmes. The GTS estimated that annual
investments in malaria control and elimination need to increase to US$ 6.4 billion
per year by 2020 to meet the first milestone under that strategy of a 40% reduction
in malaria incidence and mortality rates.
The GTS also recognized that innovations in tools and approaches are needed
to achieve its targets, and estimated that an additional US$ 674 million (range:
US$ 530 million832 million) would be required annually for malaria research
and development.
This section of the report examines recent trends in the financing of malaria
programmes and of malaria research and development. It considers the indicators
listed in Box 2.1.
This section also considers the quantities of commodities delivered, because this
provides insight into malaria expenditures, and because the availability of supplies
is a key determinant of programme coverage.
Figure 2.1 Investments in malaria control activities by funding source, 20052015. Annual values have
been converted to constant 2015 US$ using the gross domestic product implicit price deflator from the USA in order to measure
funding trends in real terms. Sources: ForeignAssistance.gov, Global Fund to Fight AIDS, Tuberculosis and Malaria, national
malaria control programme reports, Organisation for Economic Cooperation and Development (OECD) creditor reporting
system, the World Bank Data Bank, WHO estimates of malaria cases and treatment seeking at public facilities, and WHO
CHOICE unit cost estimates of outpatient visit and inpatient admission
Governments of endemic countries Global Fund USA UK World Bank Others
4
3
US$ (billion)
0
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015
Global Fund, Global Fund to Fight AIDS, Tuberculosis and Malaria; UK, United Kingdom of Great Britain and Northern Ireland;
USA, United States of America
Government of
endemic countries
$944 m, 32%
Africa
$ 2083 m, 70%
Americas
$ 230 m, 8%
UK $465 m, 16% Global Fund $911 m
Eastern
Mediterranean
$122 m, 4%
Europe
$27 m, 1%
France $94 m, 3% South
Germany $72 m, 2% East Asia
$207 m, 7%
Japan $68 m, 2%
Canada $51 m, 2% Western Pacific
BMGF $36 m, 1% $102 m, 3%
EU institutions Unspecified
$33 m, 1% World Bank $74 m recipients
Others $154 m, 5% $186 m, 6%
EU institutions, WHO, UNICEF $13 m
BMGF, Bill & Melinda Gates Foundation; EU, European Union; Global Fund, Global Fund to Fight AIDS, Tuberculosis and
Malaria; UK, United Kingdom of Great Britain and Northern Ireland; UNICEF, United Nations Childrens Fund; USA, United States
of America
Figure 2.3 Malaria financing, 20132015, by type of expenditure. Health-system spending includes planning,
monitoring and evaluation, communications and advocacy, supply management, training and human resources (apart
from those used for the delivery of services). Prevention includes procurement and delivery of insecticide-treated mosquito
nets, support of indoor residual spraying and delivery of intermittent preventive therapy in pregnancy. Treatment includes
commodities and resources for service delivery such as human resources, infrastructure and equipment. Sources: Global
Fund Enhanced Financial Reporting (EFR), USAID PMI malaria operational plans for 2013-2015 available at https://www.
pmi.gov/resource-library/mops/fy-2016, national malaria control programme reports, WHO estimates of malaria cases and
treatment seeking at public facilities, and WHO CHOICE unit cost estimates of outpatient visit and inpatient admission
Health systems Prevention Treatment
6%
6%
17%
24%
15%
88% 32%
Global Fund
53%
USAID PMI
Global Fund, Global Fund to Fight AIDS, Tuberculosis and Malaria; PMI, Presidents Malaria Initiative; USAID, United States
Agency for International Development
Figure 2.4 Funding for malaria-related research Figure 2.5 Source of funding for malaria-
and development, 20102014. Source: Gfinder Public related research and development, 2014.
Search Tool. Policy Cures. https://gfinder.policycures.org/Public Source: Gfinder Public Search Tool. Policy Cures.
SearchTool/ https://gfinder.policycures.org/PublicSearchTool/
Unspecified
GTS annual target: US$ 674 million
0%
400
200
0 Philanthropic
2010 2011 2012 2013 2014 28%
Figure 2.6 Malaria financing per person at risk, 20132015, by estimated number of malaria cases,
2015. The solid bar shows the interquartile range among countries endemic for malaria in 2015, and the white line shows the
median. The 10th and 90th percentiles are shown as black cross-bars. Sources: ForeignAssistance.gov, Global Fund to Fight
AIDS, Tuberculosis and Malaria, national malaria control programme reports, Organisation for Economic Co-operation and
Development creditor (OECD) reporting system and the Data Bank of the World Bank
International Domestic Total 2020 global milestone
10
8
US$ per person at risk
0
> 1 000 000 cases (33 countries) 10 0001 000 000 cases (32 countries) <10 000 cases (26 countries)
1. Based on the assumption that every household received the exact number of nets required for 100%
access within households and that nets are retained for at least 3 years. In practice, ITNs are lost or
replaced before 3 years, so the number of ITNs required to achieve universal access is greater.
Figure 2.7 Number of ITNs delivered by manufacturers and delivered by NMCPs 20092016. Data
from NMCPs for 2016 and 2017 not yet available. Sources: Milliner Global Associates and NMCP reports
200
Number of ITNs (million)
150
100
50
0
2009 2010 2010 2011 2011 2012 2012 2013 2013 2014 2014 2015 2015 2016 2016 2017
ITN, insecticide-treated mosquito net; NMCP, national malaria control programme
Figure 2.8 Number of RDTs sold by manufacturers and distributed by NMCPs, 20102015. Sources:
NMCP reports and data from manufacturers eligible for the WHO Foundation for Innovative New Diagnostics/US Centers for
Disease Control and Prevention Malaria Rapid Diagnostic Test Product Testing Program
250
Combination tests
NMCP deliveries
200
Sub-Saharan Africa
Outside Africa
150
100
50
0
2010 2011 2012 2013 2014 2015
Figure 2.9 Number of ACT treatment courses Figure 2.10 Ratio of ACT treatment courses
delivered by manufacturers and distributed by distributed to diagnostic tests performed
NMCPs, 20102015. AMFm/GF indicates AMFm operated (RDTs or microscopy), WHO African Region
from 2010 to 2013, and GF co-payment mechanism from 2014. 2010-2015. Source: National malaria control
Sources: Companies eligible for procurement by WHO/United programme reports, WHO African Region, 20102015
Nations Childrens Fund and NMCP reports
400 2.00
300 1.50
200 1.00
0 0
2010 2011 2012 2013 2014 2015 2010 2011 2012 2013 2014 2015
ACT, artemisinin-based combination therapy; AMFm,Affordable ACT, artemisinin-based combination therapy; RDT,
Medicines Facilitymalaria; GF, Global Fund to Fight AIDS, rapid diagnostic test
Tuberculosis and Malaria; NMCP, national malaria control
programme
Chemoprevention
In sub-Saharan Africa, intermittent preventive treatment of malaria in pregnancy
(IPTp) with sulfadoxine-pyrimethamine (SP) has been shown to reduce maternal
anaemia (7), low birth weight (1) and perinatal mortality (8). Intermittent preventive
treatment in infants (IPTi) with SP provides protection against clinical malaria and
anaemia (9); however, as of 2015, no countries have reported implementation of
an IPTi policy. Seasonal malaria chemoprevention (SMC) with amodiaquine (AQ)
plus SP (AQ+SP) for children aged 359 months reduces the incidence of clinical
attacks and severe malaria by about 80% (10,11) and could avert millions of cases
and thousands of deaths in children living in areas of highly seasonal malaria
transmission in the Sahel subregion (12). As of 2015, 10 countries had adopted the
policy (Burkina Faso, Chad, Gambia, Guinea, Guinea Bissau, Mali, Niger, Nigeria,
Senegal and Togo).
Vaccines
A number of malaria vaccine research projects are underway (13). The only
vaccine to have completed Phase 3 testing is RTS,S/AS01, which reduced clinical
incidence by 39% and severe malaria by 31.5% among children aged 517months
who completed four doses. Following the positive scientific opinion of the European
Medicines Authority under Article 58 (14), WHO recommended that RTS,S
be implemented on a pilot scale in parts of three to five sub-Saharan African
countries(15). The aim is to provide information on feasibility, safety and mortality
impact, to guide recommendations on the potential wider scale use of this vaccine
in 35 years time. The first phase of vaccination is expected to commence in 2018.
RTS,S is being considered as a complementary malaria control tool in Africa that
could potentially be added to, rather than replace, the core package of proven
malaria preventive, diagnostic and treatment interventions.
Indicators
Ensuring universal access of populations at risk to preventive interventions is
central to achieving the goals and milestones of the GTS. Accordingly, this section
reviews the indicators listed in Box 3.1 to assess the extent to which universal access
to interventions has been achieved. Use of ITNs is reported only for sub-Saharan
Africa, where malaria vectors are most amenable to control with this intervention.
Similarly, the analysis of IPTp is confined to sub-Saharan Africa, the region where
it is applicable. The coverage of IPTi, SMC and vaccines is not reported given their
current limited adoption.
clinics, 4%
Population with access to an ITN in household
80% Antenatal care
Household with enough ITNs for all occupants
clinics, 10%
Population sleeping under an ITN
60%
40%
20%
0
2005 2010 2015
Figure 3.3 Proportion of the population at risk Figure 3.4 Insecticide class used for indoor
protected by IRS by WHO region, 20102015. residual spraying 20102015. Source: National
Source: National malaria control programme reports malaria control programme reports
SEAR
Proportion of population at risk
EMR 30
8% WPR
20
6% 10
0
2010 2011 2012 2013 2014 2015
4% WHO African Region
50
2% 40
Number of countries
30
0
2010 2011 2012 2013 2014 2015 20
80%
Proportion of population at risk
60%
40%
20%
0
2010 2011 2012 2013 2014 2015
Figure 3.6 Insecticide resistance and monitoring status for malaria endemic countries (2015), by
insecticide class and WHO region, 20102015. Source: National malaria control programme reports, African
Network for Vector Resistance, Malaria Atlas Project, Presidents Malaria Initiative (United States), scientific publications
Resistance reported Resistance not reported Not monitored
50
40
Number of countries
30
20
10
0
AFR AMR EMR EUR SEAR WPR AFR AMR EMR EUR SEAR WPR AFR AMR EMR EUR SEAR WPR AFR AMR EMR EUR SEAR WPR
Pyrethroids Organochlorine (DDT) Carbamates Organophosphates
AFR, WHO African Region; AMR, WHO Region of the Americas; DDT, dichloro-diphenyl-trichloroethane; EMR, WHO Eastern
Mediterranean Region; EUR, WHO European Region; SEAR, WHO South-East Asia Region; WPR, WHO Western Pacific Region
80%
Proportion of pregnant women
60%
Receiving at least
1 dose of IPTp
40%
Receiving at least
2 doses of IPTp
20% Receiving at least
3 doses of IPTp
0
2010 2011 2012 2013 2014 2015
Prompt diagnosis and treatment of malaria can cure a patient, preventing the
development of severe malaria and subsequent death. It also reduces the length
of time that patients carry malaria parasites in their blood, which in turn reduces
the risk of onward transmission.
Diagnostic testing
WHO recommends that every suspected malaria case be confirmed by microscopy
or an RDT before treatment (20). Accurate diagnosis improves the management
of febrile illnesses and ensures that antimalarial medicines are only used when
necessary. Only in areas where parasite-based diagnostic testing is not possible
should malaria treatment be initiated solely on clinical suspicion.
Treatment
Prompt and appropriate treatment of uncomplicated malaria is critical in
preventing progression to severe disease and death. WHO recommends ACTs
for the treatment of uncomplicated Plasmodium falciparum malaria. ACTs have
been estimated to reduce malaria mortality in children aged 123 months by 99%
(range: 94100%), and in children aged 2459 months by 97% (range: 8699%) (21).
Indicators
The ability of health systems to diagnose and treat cases is influenced by the extent
to which patients with suspected malaria seek treatment, and by the proportion
of patients who receive a diagnostic test and appropriate treatment after seeking
health care. This section of the report discusses indicators covering care seeking,
diagnostic testing and treatment, as listed in Box 4.1. It also considers the parasites
evolutionary responses to interventions; namely, the potential for selection of
parasites that can evade diagnostic tests and the evolution of drug resistance.
4.1 Children aged under 5 years with fever for whom advice or
treatment was sought from a trained provider
Evidence on the extent to which patients with suspected malaria seek treatment
is derived mainly from household surveys that measure the proportion of children
with fever for whom advice or treatment is sought. A disadvantage of this indicator
is that it considers fever rather than confirmed malaria. Nonetheless, malaria
should be suspected in febrile children who live in malaria endemic areas, and
such children should be taken to a trained provider to obtain a diagnostic test and
treatment, if appropriate. Although the indicators measurement is largely confined
to sub-Saharan Africa and children aged under 5 years, sub-Saharan Africa
accounts for more than 90% of global malaria cases, with most cases occurring
in children aged under 5 years.
Among 23 nationally representative surveys completed in sub-Saharan Africa
between 2013 and 2015 (representing 61% of the population at risk), a higher
proportion of febrile children sought care in the public sector (median: 42%,
interquartile range [IQR]: 3150%) than in the private sector (median: 20%,
IQR:1228%), as shown in Figure 4.1. Most visits to the private sector were to the
informal sector (median: 11%, IQR: 721%), which comprises pharmacies, kiosks
and traditional healers, rather than to the formal private sector (median: 5%,
IQR:721%), which comprises private hospitals and clinics. Overall, a median of
54% (IQR: 4159%) of febrile children were taken to a trained provider (i.e. to public
sector health facilities, formal private sector facilities or community health workers).
A large proportion of febrile children are not brought for care (median: 36%,
IQR:2642%); possible reasons for this are poor access to health-care providers
or a lack of awareness among caregivers about necessary care for febrile children.
Figure 4.1 Proportion of febrile children seeking care, by health sector, sub-Saharan Africa,
20132015. Sources: Nationally representative household survey data from demographic and health surveys, and malaria
indicator surveys
100%
80%
Proportion of children <5 years
with fever in previous 2 weeks
60%
40%
20%
0
Public sector Formal Informal Community No treatment
private sector private sector health worker sought
Figure 4.2 Proportion of febrile children receiving a blood test, by health sector, sub-Saharan
Africa, 20132015. Proportions shown are among those that sought care. Sources: Nationally representative household
survey data from demographic and health surveys, and malaria indicator surveys
100%
that sought care at treatment outlet
80%
Proportion of febrile children
60%
40%
20%
0
Public sector Formal Informal Community
private sector private sector health worker
Figure 4.3 Proportion of suspected malaria Figure 4.4 Proportion of febrile children
cases attending public health facilities who attending public sector health facilities who
receive a diagnostic test, by WHO region, 2010 receive a blood test, sub-Saharan Africa,
2015. Source: National malaria control programme reports 20102015. Sources: Nationally representative household
survey data from demographic and health surveys, and
100% malaria indicator surveys
100%
Proportion of suspected malaria cases
80%
80%
Proportion of children <5 years
with fever in previous 2 weeks
60%
60%
40%
AMR
SEAR 40%
20% WPR
EMR
AFR 20%
0
2010 2011 2012 2013 2014 2015
0
AFR, WHO African Region; AMR, WHO Region of the 20102012 20112013 20122014 20132015
Americas; EMR, WHO Eastern Mediterranean Region;
SEAR, WHO South-East Asia Region; WPR, WHO Western
Pacific Region
80%
60%
40%
20%
0
20102012 20112013 20122014 20132015
Figure 4.6 Proportion of antimalarial treatments Figure 4.7 Proportion of antimalarial treatments
that are ACTs received by febrile children that that are ACTs received by febrile children, by
are RDT positive at the time of survey, sub- health sector, sub-Saharan Africa, 20132015.
Saharan Africa, 20052015. Sources: Nationally Sources: Nationally representative household survey data
representative household survey data from demographic from demographic and health surveys, and malaria
and health surveys, and malaria indicator surveys indicator surveys
100% 100%
Proportion of antimalarial treatments
Proportion of antimalarial treatments
80% 80%
60% 60%
40% 40%
20% 20%
0
0 Public sector Formal Informal Community
20102012 20112013 20122014 20132015 private sector private sector health worker
ACT, artemisinin-based combination therapy; RDT, rapid ACT, artemisinin-based combination therapy
diagnostic test
1 ACT
2 ACTs
4 ACTs
Figure 5.1 Health facility reporting rates by WHO region, 2015. Source: National malaria control programme
reports
80%
Proportion of countries
60%
40%
20%
0
AFR AMR EMR SEAR WPR World
AFR, WHO African Region; AMR, WHO Region of the Americas; EMR, WHO Eastern Mediterranean Region; SEAR, WHO South-
East Asia Region; WPR, WHO Western Pacific Region
Figure 5.2 Bottlenecks in case detection 2015, by WHO region. Sources: Nationally representative household
survey data and national malaria control programme reports
Seeking treatment Seeking treatment at facility covered by surveillance system Receiving diagnostic test Case reported
100%
80%
Proportion of all malaria cases
60%
40%
20%
0
AFR AMR EMR SEAR WPR World
AFR, WHO African Region; AMR, WHO Region of the Americas; EMR, WHO Eastern Mediterranean Region; SEAR, WHO South-
East Asia Region; WPR, WHO Western Pacific Region
The GTS set ambitious yet achievable targets for 2030; namely, to reduce malaria
incidence and mortality rates globally by at least 90% by 2030, with a milestone
of at least a 40% reduction by 2020 (2). The GTS also set a target to eliminate
malaria from at least 35 countries by 2030 (with a milestone of elimination in at
least 10 countries by 2020), and simultaneously to prevent the re-establishment
of malaria in all countries that were malaria free in 2015.
To assess progress towards the targets and milestones of the GTS, this section of
the report reviews the total number of malaria cases and deaths estimated to
have occurred in 2015, and reviews progress according to the indicators listed in
Box6.1. It also considers the gains in life expectancy that have occurred owing
to a reduction in malaria mortality rates, and the economic value of such gains.
The prevalence of infections with malarial parasites in people of all ages, including
children, can provide information on the level of malaria transmission in a country.
Parasite prevalence is most relevant for sub-Saharan Africa, where it is measured
through nationally representative household surveys. Such surveys can be brought
together in a geospatial model to facilitate the mapping of parasite prevalence
and the analysis of trends over time (see Annex 1). This form of analysis is restricted
to sub-Saharan Africa.
Malaria case incidence and mortality rates are relevant in all settings. Surveillance
systems do not capture all malaria cases and deaths that occur; hence, it is
necessary to use estimates of the number of cases or deaths in a country to make
inferences about global trends in malaria case incidence and mortality rates (as
described in Annex 1). The methods for producing estimates either adjust the
number of reported cases to account for the estimated proportion of cases that are
not captured by a surveillance system, or model the relationship between parasite
prevalence and case incidence or mortality. The latter method is used for countries
in sub-Saharan Africa for which surveillance data are lacking. The estimates aim
to fill gaps in reported data; however, because they rely on relationships between
variables that are uncertain, and draw on data that may be imprecisely measured,
the estimates have a considerable degree of uncertainty.
Table 6.1 Estimated malaria cases, 20002015. Estimated cases are shown with 95% upper and lower uncertainty
intervals. Source: WHO estimates
Number of cases (000s) % change
2000 2005 2010 2011 2012 2013 2014 2015 20102015
Lower 202 000 202 000 192 000 183 000 171 000 158 000 152 000 148 000
Estimated total 271 000 266 000 245 000 235 000 224 000 217 000 212 000 212 000 -14%
Upper 314 000 313 000 287 000 276 000 272 000 271 000 306 000 304 000
Lower 18 000 18 700 13 700 13 100 11 200 9 200 8 000 6 600
Estimated P. vivax 28 900 25 700 17 500 16 600 14 200 11 300 9 100 8 500 -51%
Upper 37 400 32 300 22 100 21 000 17 400 14 300 12 200 10 800
% cases P. vivax 8% 10% 7% 7% 6% 5% 4% 4%
Table 6.2. Estimated malaria cases by WHO region, 2015. Estimated cases are shown with 95% upper and
lower uncertainty intervals. Source: WHO estimates
Number of cases (000s)
Outside
AFR AMR EMR EUR SEAR WPR World
sub-Saharan Africa
Lower 131000 500 2400 0 13300 1000 148000 16300
Estimated total 191000 800 3800 0 14400 1200 212000 18100
Upper 258000 1200 7500 0 35200 2200 304000 40300
Lower 300 400 1100 0 3400 500 6600 5800
Estimated P. vivax 1000 500 1400 0 4900 700 8500 7400
Upper 2100 800 1700 0 6800 900 10800 9300
% cases P. vivax 1% 69% 35% 34% 58% 4% 41%
AFR, WHO African Region; AMR, WHO Region of the Americas; EMR, WHO Eastern Mediterranean Region; SEAR, WHO South-
East Asia Region; WPR, WHO Western Pacific Region
P. falciparum P. vivax
AFR, WHO African Region; AMR, WHO Region of the Americas; EMR, WHO Eastern Mediterranean Region; SEAR, WHO South-
East Asia Region; WPR, WHO Western Pacific Region
Figure 6.2 Estimated country share of (a) total malaria cases and (b) P. vivax malaria cases, 2015.
Source: WHO estimates
Others, 24%
Nigeria, 29%
Niger, 2% (a)
United Republic of Tanzania, 2%
Cameroon, 3%
Kenya, 3% Democratic Republic of the Congo, 9%
Burkina Faso, 3%
Ghana, 3%
Mali, 4% India, 6%
Uganda, 4% India, 49%
Cte dIvoire, 4% Others, 22%
Mozambique, 4%
Indonesia, 7% (b)
Pakistan, 10%
Ethiopia, 12%
Table 6.3 Estimated malaria deaths 20002015. Estimated deaths are shown with 95% upper and lower
uncertainty intervals. Source: WHO estimates
Number of deaths % change
2000 2005 2010 2011 2012 2013 2014 2015 20102015
Lower 655 000 525 000 370 000 334 000 303 000 287 000 248 000 235 000
Estimated deaths 864 000 741 000 554 000 511 000 474 000 452 000 435 000 429 000 -22%
Upper 1 087 000 955 000 740 000 687 000 635 000 610 000 656 000 639 000
Lower 4 600 4 600 3 300 3 300 2 800 2 400 2 200 1 800
Estimated P. vivax deaths 11 100 9 700 6 400 6 100 5 200 4 100 3 300 3 100 -52%
Upper 15 700 14 300 10 700 9 500 8 200 6 300 5 200 4 900
Lower 571 000 437 000 286 000 253 000 224 000 210 000 180 000 165 000
Estimated deaths <5 years 753 000 616 000 428 000 387 000 351 000 330 000 315 000 303 000 -29%
Upper 947 000 794 000 573 000 520 000 470 000 446 000 476 000 450 000
% deaths P. vivax 1.3% 1.3% 1.2% 1.2% 1.1% 0.9% 0.8% 0.7%
% deaths <5 years 87% 83% 77% 76% 74% 73% 73% 70%
Figure 6.3 Estimated malaria deaths (thousands) by WHO region, 2015. The area of the circles is
proportional to the estimated number of cases in each region. Source: WHO estimates
P. falciparum P. vivax
AFR, WHO African Region; AMR, WHO Region of the Americas; EMR, WHO Eastern Mediterranean Region; SEAR, WHO South-
East Asia Region; WPR, WHO Western Pacific Region
Figure 6.4 Estimated country share of (a) total malaria deaths and (b) P. vivax malaria deaths,
2015. Source: WHO estimates
(a)
Niger, 2%
Kenya, 3%
Democratic Republic of the Congo, 10%
Uganda, 3%
Ghana, 3%
Cte dIvoire, 3%
Angola, 3% India, 6%
Burkina Faso, 3%
Mali, 5%
Mozambique, 4%
United Republic of Tanzania, 4%
Others, 19%
India, 51%
Indonesia, 7%
(b)
Pakistan, 11%
Ethiopia*, 12%
* There were zero reported P. vivax malaria deaths in Ethiopia;
the proportion shown here refers to WHO estimates
Figure 6.5 Estimated (a) parasite prevalence and (b) number of people
infected, sub-Saharan Africa, 20052015. Source: Malaria Atlas Project
(http://www.map.ox.ac.uk/) (1)
(a) 40% 95% confidence interval
Proportion of population infected
20%
All ages
10%
0
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015
(b) 160
Number of people infected (million)
80
40
Figure 6.6 Reduction in malaria case incidence Figure 6.7 Country-level changes in malaria
rate by WHO region, 20102015. No indigenous case incidence rate 20102015, by number of
cases were recorded in the WHO European Region in 2015. cases in 2010. Source: WHO estimates
Source: WHO estimates
30
Western Pacific 30%
20
African 21%
10
Eastern Mediterranean 11%
0
World 21% Decrease >40% Decrease 2040% Change <20% Increase >20%
Change in malaria incidence 20102015
Figure 6.8 Reduction in malaria mortality Figure 6.9 Country-level changes in malaria
rate, by WHO region, 20102015. No deaths from mortality rate 20102015, by number of deaths
indigenous malaria were recorded in the WHO European in 2010. Source: WHO estimates
Region from 2010 to 2015. Source: WHO estimates
Americas 37%
30
African 31% 20
Eastern Mediterranean 6% 10
0
World 29% Decrease >40% Decrease 2040% Change <20% Increase >20%
Change in malaria mortality rate 20102015
Figure 6.10 Countries attaining zero indigenous malaria cases since 2000. Countries are shown by the
year that they attained 3 consecutive years of zero indigenous cases. Countries that have been certified as free of malaria are
shown in green, with the year of certification in brackets. Source: Country reports
1. Excludes Tajikistan, which reported zero indigenous cases in 2015 but has not yet attained 3years of
zero indigenous cases.
Figure 6.11 Indigenous malaria cases in the Figure 6.12 Number of indigenous malaria cases
years before attaining zero indigenous cases for countries endemic for malaria in 2015, by
for the 17 countries that eliminated malaria, WHO region. Source: WHO estimates
20002015. Median number of cases is shown as a blue
line. Interquartile range is shaded in light blue. Source: AFR AMR EMR SEAR WPR
Country reports
<150 10
100 000
1501000 9
Estimated cases in 2015
10 000
Number of malaria cases
100010 000 11
1000
10 000 29
1 000 000
100
6.7 Malaria cases and deaths averted since 2000 and change in
life expectancy
It is estimated that a cumulative 1.3 billion fewer malaria cases and 6.8 million
fewer malaria deaths occurred globally between 2001 and 2015 than would have
occurred had incidence and mortality rates remained unchanged since 2000. The
highest proportion of cases and deaths were averted in the WHO African Region
(94%). Of the estimated 6.8 million fewer malaria deaths between 2001 and 2015,
about 6.6 million (97%) were for children aged under 5 years.
Not all of the cases and deaths averted can be attributed to malaria control efforts.
Some progress is probably related to increased urbanization and overall economic
development, which has led to improved housing and nutrition. However, it has
previously been estimated that 70% of the cases averted between 2001 and 2015
were due to malaria interventions (1).
In the WHO African Region, reduced malaria mortality rates, particularly among
children aged under 5 years, have led to a rise in life expectancy at birth of
1.2years, accounting for 12% of the total increase in life expectancy of 9.4 years
from 50.6 years in 2000 to 60 years in 2015. Across all malaria endemic countries,
the contribution of malaria mortality reduction was 0.26 years or 5% of the total
increase in life expectancy between 2000 and 2015, from 66.4 years to 71.4 years
(Table 6.5, Figure 6.13).
Figure 6.13. Gains in life expectancy in malaria endemic countries, 20002015. Source: WHO estimates
Life expectancy at birth in 2000 Gain in life expectancy due to malaria mortality reduction
Gain in life expectancy due to reduction in deaths from other causes
80
70
Life expectancy (years)
60
50
40
AFR AMR EMR EUR SEAR WPR World
AFR, WHO African Region; AMR, WHO Region of the Americas; EMR, WHO Eastern Mediterranean Region; EUR, WHO
European Region; SEAR, WHO South-East Asia Region; WPR, WHO Western Pacific Region
Table 6.5. Gains in life expectancy in malaria endemic countries, 20002015. Source: WHO estimates
Gain in life expectancy due to
Life expectancy at birth % gain due
reductions in mortality from
to malaria
2000 2015 Malaria Other causes
AFR 50.6 60.0 1.159 8.2 12.3%
AMR 73.7 76.9 0.003 3.2 0.1%
EMR 65.4 68.8 0.045 3.4 1.3%
EUR 72.3 76.8 0.000 4.5 0.0%
SEAR 63.5 69.0 0.034 5.4 0.6%
WPR 72.5 76.6 0.018 4.0 0.4%
World 66.4 71.4 0.255 4.8 5.0%
AFR, WHO African Region; AMR, WHO Region of the Americas; EMR, WHO Eastern Mediterranean Region; EUR, WHO
European Region; SEAR, WHO South-East Asia Region; WPR, WHO Western Pacific Region
Table 6.6. Economic value of reduced malaria mortality risk, estimated by full income approach,
20002015. Source: WHO estimates
Value of malaria mortality risk reduction Value of malaria mortality risk reduction
20002015 (US$ 2015, PPP, billions) as % of GDP
Estimate Lower Upper Estimate Lower Upper
AFR 1 810 1 330 2 480 44.4% 32.6% 60.9%
AMR 8 7 9 0.1% 0.1% 0.1%
EMR 64 53 75 1.3% 1.1% 1.5%
EUR
SEAR 131 107 160 1.0% 0.8% 1.3%
WPR 28 24 33 0.1% 0.1% 0.1%
World 2 040 1 560 2 700 3.6% 2.8% 4.8%
AFR, WHO African Region; AMR, WHO Region of the Americas; EMR, WHO Eastern Mediterranean Region; EUR, WHO
European Region; GDP, gross domestic product; PPP, purchasing power parity; SEAR, WHO South-East Asia Region; WPR, WHO
Western Pacific Region
The World Malaria Report 2016 is the first such report to be released during the era
of the GTS 20162030 (2). Because the latest data included in the report are mostly
from 2015, direct reporting on the progress of the GTS is not possible. However, the
World Malaria Report 2016 provides a baseline against which progress since 2015
can be assessed in the future. Also, by looking at trends in indicators since 2010,
the report can give an indication of where programmes are on track to meet the
GTS 2020 milestones and where progress needs to be accelerated.
Although malaria funding increased considerably between 2000 and 2010, it has
remained relatively stable since 2010. It totalled US$ 2.9 billion in 2015, representing
only 46% of the GTS funding milestone for 2020. Governments of malaria endemic
countries provided 32% of total funding in 2015, and the Global Fund accounted for
nearly half of international financing. Pledges to the Global Fund for financing for
20172019 have increased by 8% compared to 20142016 pledges. Total funding must
increase substantially if the GTS 2020 milestone of US$ 6.4 billion is to be achieved.
The coverage of malaria interventions rose between 2010 and 2015. More than half
of the population of sub-Saharan Africa (57%) now benefits from vector-control
interventions (IRS or ITNs), and an increased proportion of pregnant women receive
three doses of IPTp (31% in 2015). More than half of suspected malaria cases attending
public health facilities in the WHO African Region receive a diagnostic test, and the
proportion of malaria cases treated with effective antimalarial drugs is increasing.
Nevertheless, significant gaps in programme coverage remain. Access to vector
control has been greatly extended through mass-distribution campaigns; however,
increasing the coverage of chemoprevention, diagnostic testing and treatment
requires these interventions to be delivered through health systems that are frequently
under-resourced and poorly accessible to those most at risk of malaria. Moreover,
the potential for strengthening health systems in malaria endemic countries is often
constrained by low national incomes and per capita domestic spending on health
and malaria control. The limited ability to strengthen systems in order to deliver
interventions remains a significant challenge for ensuring universal access to malaria
prevention, diagnosis and treatment, as called for in Pillar 1 of the GTS (2).
Pillar 2 of the GTS calls for countries to accelerate efforts towards malaria
elimination and attainment of malaria free status (2). Ten countries eliminated
Figure 1.1 Countries endemic for malaria in 2000 secondary or teaching hospitals. Costs of outpatient
and 2016 visits and inpatient bed-stays were estimated from the
Data on the number of indigenous cases (an indicator perspective of the public health-care provider, using
of whether countries are endemic for malaria) were WHO-CHOICE estimates.1 The estimates were updated
as reported to WHO by national malaria control for 20052015 by rerunning the regression model using
programmes (NMCPs). Countries with 3 consecutive the relevant gross domestic product (GDP) per capita
years of zero indigenous cases are considered to have in each year. When no GDP data were available for a
eliminated malaria. given year, outpatient department and inpatient unit
costs were imputed using the values from the most
Table 1.1 Global targets for 2030 and milestones recent year with available unit-cost data, and were
for 2020 and 2025 adjusted with the GDP deflator. When no unit-cost
Targets and milestones are as described in the Global data were available for the full period, a unit cost
Technical Strategy for Malaria 20162030 (GTS) (1) and was imputed from the median unit cost in that year in
Action and investment to defeat malaria 20162030 countries within the same World Bank income group.
(AIM) (2). Uncertainty around case and cost parameters was
estimated through probabilistic uncertainty analysis;
Table 1.2 Indicators reviewed in World Malaria
that is, by assigning a uniform distribution informed by
Report 2016 lower and upper estimates for each parameter. The
Indicators are as described in Monitoring and evaluation
figure shows the mean total costs of service delivery for
of the Global Technical Strategy for Malaria 20162030
patient care from 1000 estimations.
and Action and investment to defeat malaria 20162030
(3). International financing data were obtained from several
sources. The Global Fund to Fight AIDS, Tuberculosis and
Figure 2.1 Investments in malaria control activities Malaria (Global Fund) provided disbursed amounts by
by funding source, 20052015 year and country for 20052015. Data on funding from
Contributions from governments of endemic countries the government of the United States of America (USA)
are estimated as the sum of NMCP expenditures were sourced from the US Foreign Aid Dashboard, with
reported by NMCPs for the World Malaria Report of the technical assistance of the Kaiser Family Foundation.
the relevant year plus the estimated costs of delivery of Funding data were available for the US Agency for
patient-care services at government health facilities. If International Development (USAID), the US Centers
data on NMCP expenditures were missing for 2015, data for Disease Control (CDC) and the US Department of
from previous years were used after conversion to the Defense. Country-level data were available for USAID
equivalent 2015 US$ value. The number of malaria cases for 20062015. Financing data for other international
attending outpatient services at government facilities funders included annual disbursement flows for 2005
was derived from WHO estimates of malaria cases (see 2014, obtained from the Organisation for Economic
methods notes for Table 6.1) multiplied by the proportion Co-operation and Development (OECD) creditor
of estimated cases seeking care at government facilities. reporting system (CRS) database on aid activity. For
Between 1% and 3% of uncomplicated cases were each year and each funder, the country-level and
assumed to have moved to the severe stage of disease, regional-level project-type interventions and other
and 5080% of these severe cases were assumed to technical assistance were extracted. The 2014 value for
have been admitted to secondary or tertiary level international annual contributions was used as the 2015
hospitals. Outpatients were assumed to have been value, except for contributions from the United Kingdom
treated at health centres (with or without beds) or at of Great Britain and Northern Ireland; for this value, a
primary level hospitals (e.g. district hospitals). Inpatients linear increase was assumed based on trends from 2012
were assumed to have been admitted to primary,
1. http://www.who.int/choice/en/
2. http://stats.oecd.org/ 3. https://gfinder.policycures.org/PublicSearchTool
risk of malaria was derived from NMCP reports. Funding RDTs) divided by the total number of tests undertaken,
milestones for 2020 were derived from the costing of as reported by countries in the WHO African Region.
the GTS (1).
Figure 3.1 Proportion of population at risk with
Figure 2.7 Number of ITNs delivered by access to an ITN and sleeping under an ITN, and
manufacturers and distributed by NMCPs, proportion of households with at least one ITN
20092016 and enough ITNs for all occupants, sub-Saharan
Data on the number of insecticide-treated mosquito Africa, 20052015
nets (ITNs) delivered by manufacturers to countries were Estimates of ITN coverage were derived from a
provided to WHO by Milliner Global Associates. Data model developed by the Malaria Atlas Project,4 using
from NMCP reports were used for the number of ITNs a two-stage process. First, we defined a mechanism
distributed within countries. for estimating net crop (i.e. the total number of ITNs
in households in a country at a given point in time),
Figure 2.8 Number of RDTs sold by manufacturers taking into account inputs to the system (e.g. deliveries
and distributed by NMCPs, 20102015 of ITNs to a country) and outputs (e.g. loss of ITNs
The numbers of rapid diagnostic tests (RDTs) distributed from households). We then used empirical modelling
by WHO region are the annual totals reported as having to translate estimated net crops into resulting levels of
been distributed by NMCPs. Numbers of RDT sales were coverage (e.g.access within households, use in all ages
reported by 41 manufacturers that participated in RDT and use among children aged under 5 years).
product testing by WHO, the Foundation for Innovative The model incorporates data from three sources:
New Diagnostics, the CDC and the Special Programme
the number of ITNs delivered by manufacturers to
for Research and Training in Tropical Diseases. The
countries, as provided to WHO by Milliner Global
number of RDTs reported by manufacturers represents
Associates;
total sales to the public and private sectors worldwide.
the number of ITNs distributed within countries, as
Figure 2.9 Number of ACT treatment courses reported to WHO by NMCPs; and
delivered by manufacturers and distributed by data from nationally representative household
NMCPs, 20102015 surveys from 39 countries in sub-Saharan Africa,
Data on artemisinin-based combination therapy (ACT) from 2001 to 2015.
sales were provided by eight manufacturers eligible for
procurement by WHO or the United Nations Childrens Countries and populations at risk
Fund (UNICEF). ACT sales were categorized as being The main analysis covered 40 of the 47 malaria endemic
to either the public sector or the private sector. Data countries or areas of sub-Saharan Africa. The islands of
on ACTs distributed within countries through the public Mayotte (for which no ITN delivery or distribution data
sector were taken from NMCP reports to WHO. were available) and Cabo Verde (which does not distribute
ITNs) were excluded, as were the low-transmission
Figure 2.10 Ratio of ACT treatment courses countries of Namibia, Sao Tome and Principe, South
distributed to diagnostic tests performed (RDTs Africa and Swaziland, for which ITNs comprise a small
or microscopy), WHO African Region 20102015 proportion of vector control. Analyses were limited to
The ratio was calculated using the number of ACTs populations categorized by NMCPs as being at risk.
distributed, the number of microscopic examinations
of blood slides, and the number of RDTs performed Estimating national net crops through time
in the WHO African Region, as reported by NMCPs to As described by Flaxman et al. (5), national ITN systems
WHO. The test positivity rate was calculated as the were represented using a discrete-time stock-and-flow
total number of positive tests (i.e. slide examinations or
4. http://www.map.ox.ac.uk/
Many recent national surveys report the number of Figure 3.4 Insecticide class used for indoor
ITNs observed in each household surveyed. Hence, it residual spraying, 20102015
is possible to not only estimate net crop, but also to Data on the type of insecticide used for IRS were
generate a histogram that summarizes the household reported to WHO by NMCPs. Insecticides were
classified into pyrethroids or other classes (carbamates, Figure 3.7 Proportion of pregnant women
organochlorines or organophosphates). If data were not receiving IPTp, by dose, sub-Saharan Africa,
reported for a particular year, data from the most recent 20102015
year were used. For the period 20102015 this method The total number of pregnant women eligible for
of imputation was used for an average of 19 countries intermittent preventive treatment in pregnancy (IPTp)
each year. was calculated by adding total live births calculated
from the United Nations (UN) population data and
Figure 3.5 Proportion of the population at risk
spontaneous pregnancy loss (specifically, miscarriages
protected by IRS or sleeping under an ITN in and stillbirths) after the first trimester. Spontaneous
sub-Saharan Africa, 20102015 pregnancy loss has previously been calculated by
The proportion of the population at risk sleeping under Dellicour et al. (6). Country-specific estimates of IPTp
an ITN was derived as described for Figure 3.1, and coverage were calculated as the ratio of pregnant
the proportion benefiting from IRS was derived as women receiving IPTp at antenatal care (ANC) clinics
for Figure 3.4. In combining these proportions, the to the estimated number of IPTp-eligible pregnant
extent to which populations benefit from one or both women in a given year. ANC attendance rates were
of these interventions must be estimated. Analysis of derived in the same way, using the number of initial
household survey data indicates that about half of the ANC visits reported through routine information systems.
people in IRS-sprayed households are also protected Local linear interpolation was used to compute missing
by ITNs, but the extent of overlap between intervention values. Annual aggregate estimates exclude countries
coverage can vary from 0% to 100% (if the proportions for which a report or interpolation was not available
sum to <1). To reflect this uncertainty, we assumed the for the specific year. Among 34 countries with IPTp
combined coverage to have a rectangular distribution policy, IPTp1 dose coverage could be calculated for
with the range of maximum (0%, ITNcoverage + IRScoverage 34 countries, IPTp2 for 33 countries, and IPTp3 for 20
100%) to minimum (ITN coverage, IRScoverage). Palisades countries. Aggregate estimates of IPTp1 and IPTp2
@Risk software (version 6.0)5 was used to sample from coverage for 20 countries with IPTp3 estimates were
the distributions for each country, and a continental similar to estimates of IPT1 and IPTp2 coverage using
estimate of vector-control coverage was obtained by data from all countries.
summing the combined ITN and IRS coverage of all
countries. Figure 4.1 Proportion of febrile children seeking
care, by health sector, sub-Saharan Africa, 2013
Figure 3.6 Insecticide resistance and monitoring
2015
status for malaria endemic countries (2015), by Estimates were derived from 23 nationally representative
insecticide class and WHO region, 20102015 household surveys (demographic health surveys and
Insecticide resistance monitoring results were collected malaria indicator surveys) conducted between 2013 and
from NMCP reports to WHO, the African Network for 2015. The surveys asked caregivers whether their child
Vector Resistance, the Malaria Atlas Project, PMI and had had a fever in the 2 weeks preceding the survey,
the published literature. In these studies, confirmed whether care was sought for the fever and, if so, where
resistance was defined as mosquito mortality <90% in care was sought.
bioassay tests with standard insecticide doses. Where
multiple insecticide classes or types, mosquito species Figure 4.2 Proportion of febrile children receiving
or time points were tested, the highest resistance status a blood test, by health sector, sub-Saharan
was considered. Africa, 20132015
Estimates were derived from 22 nationally representative
household surveys (demographic health surveys and
malaria indicator surveys) conducted between 2013 and
5. https://www.palisade.com/risk/
Figure 4.4 Proportion of febrile children attending Figure 4.8 Distribution of multidrug resistance,
public health facilities who receive a blood test, 2016
sub-Saharan Africa, 20102015 Information was derived from WHOs database on
Estimates were derived from 41 nationally representative antimalarial treatment efficacy.6
household surveys (demographic health surveys and
Figure 5.1 Health facility reporting rates by WHO
malaria indicator surveys) conducted between 2010 and
region, 2015
2015. The surveys asked caregivers whether their child
Using data provided by NMCPs, reporting rates of
had had a fever in the 2 weeks preceding the survey;
health facilities were calculated as follows: (the number
whether care was sought for the fever and, if so, where
of health facility reports received in 2015) (number of
care was sought; and whether the child had received a
finger or heel stick as part of the care (indicating that a
malaria diagnostic test was performed). Median values 6. http://www.who.int/malaria/areas/drug_resistance/drug_effica-
cy_database/en/
health facilities providing treatment for uncomplicated and 80%. Countries that were approaching elimination
malaria reporting frequency). were assigned a value of more than 80%.
Figure 5.2 Bottlenecks in case detection 2015, by Table 6.1 Estimated malaria cases, 20002015
WHO region The number of malaria cases was estimated by one of
The procedure for estimating the proportion of cases two methods. The first method was used for countries
detected by surveillance systems follows the method outside Africa and for low-transmission countries in
by which WHO estimates the number of malaria cases Africa. Estimates were made by adjusting the number
in a country using data reported by NMCPs(7,8). The of reported malaria cases for completeness of reporting,
procedure considers four proportions: the proportion the likelihood that cases were parasite positive, and
of cases that seek treatment, the proportion of cases the extent of health-service use. The procedure, which
that seek treatment in health facilities covered by a is described in the World Malaria Report 2008 (7,8),
countrys malaria surveillance system, the proportion combines data reported by NMCPs (reported cases,
of cases in these facilities that receive a diagnostic test reporting completeness and likelihood that cases are
and the proportion of cases in these facilities that are parasite positive) with data obtained from nationally
reported through the system. The proportion of malaria representative household surveys on health-service use.
cases seeking treatment was estimated using the latest The number of malaria cases caused by Plasmodium
nationally representative household survey for a country. vivax in each country was estimated by multiplying the
If no household survey was available, the proportion was countrys reported proportion of P. vivax cases by the
derived by sampling at random from results for other total number of estimated cases for the country. The
countries and areas in the region that had a household second method was used for high-transmission countries
survey: Bolivia (Plurinational State of), Botswana, in Africa in which the quality of surveillance data did not
Cabo Verde, French Guiana, Guatemala, South Sudan, permit a robust estimate from the number of reported
Suriname, Thailand and Venezuela (Bolivarian Republic cases. Estimates of the number of malaria cases were
of). For 13 countries approaching malaria elimination derived from information on parasite prevalence
(Algeria, Belize, Bhutan, China, Democratic Peoples obtained from household surveys. First, data on parasite
Republic of Korea, Ecuador, El Salvador, Iran [Islamic prevalence from 27 573 georeferenced population
Republic of], Malaysia, Mexico, Panama, Republic of clusters between 1995 and 2014 were assembled within
Korea and Saudi Arabia), it was assumed that 99% of a spatiotemporal Bayesian geostatistical model, along
cases sought treatment. The proportion of cases seeking with environmental and sociodemographic covariates,
treatment at a facility covered by a countrys surveillance and data on both the use of ITNs and access to ACTs.
system was derived in a similar way; the types of facility The geospatial model enabled predictions of P.
covered by a countrys surveillance system were provided falciparum prevalence in children aged 210 years, at
through NMCP reports. Reporting rates of health facilities a resolution of 5 5 km2, throughout all malaria endemic
were calculated according to the methods notes for African countries for each year from 2000 to 2015.
Figure 5.1. The reporting rates were assigned to three Second, an ensemble model was developed to predict
ranges (<50%, 5080% and >80%) to reflect uncertainty malaria incidence as a function of parasite prevalence.
about the number of cases represented in facility reports. The model was then applied to the estimated parasite
The rates were assigned a triangular distribution in the prevalence in order to obtain estimates of the malaria
outer ranges and a uniform distribution in mid-range, case incidence at 5 5 km2 resolution for each year from
with expected values in the low, mid and high ranges 2000 to 2015. Data for each 5 5 km2 area were then
of 33%, 65% and 87%, respectively. If the reporting aggregated within country and regional boundaries to
completeness was not available for 2015, the value from obtain both national and regional estimates of malaria
the most recent year reported was used. If this value was cases (9).
missing for all years, it was assumed to lie between 50%
risk of malaria within each country. The total population the peak number of cases were excluded. Thus, if
of each country was taken from the 2015 revision of the a country had experienced zero cases and malaria
World population prospects (4), and the proportion at risk returned, cases were only included from the year in
of malaria was derived from NMCP reports. which they peaked. This inclusion criterion generates a
slope that is steeper than if cases from all years were
Figure 6.7 Country-level changes in malaria case
included (because some increases are excluded). In
incidence rate, 20102015, by number of cases
some earlier years where data on indigenous case were
in 2010
not available, the total number of reported cases was
See methods notes for Figure 6.6 for estimates of case
used (i.e. for country years with larger numbers of cases,
incidence. See methods notes for Table 6.1 for estimates
in which the proportion of imported cases is expected
of number of cases.
to be low).
Figure 6.8 Reduction in malaria mortality rate by
Figure 6.12 Number of indigenous malaria cases
WHO region, 20102015
for countries endemic for malaria in 2015, by
See methods notes for Table 6.3 for estimation of number
WHO region
of deaths. Malaria death rates were derived by dividing
See methods notes for Table 6.1 for the estimation
annual malaria deaths by the midyear population at
of number of cases. For 18 countries (Algeria, Belize,
risk of malaria within each country. The total population
Bhutan, Cabo Verde, China, Democratic Peoples
of each country was taken from the 2015 revision of the
Republic of Korea, Dominican Republic, Ecuador, El
World population prospects (4), and the proportion at
Salvador, Iran [Islamic Republic of], Malaysia, Mexico,
risk of malaria was derived from NMCP reports. Where
Panama, Republic of Korea, Saudi Arabia, Suriname,
death rates were quoted for children aged under 5 years,
Swaziland and Tajikistan), estimates were based on
the number of deaths estimated in children aged under
indigenous cases only; these values were very close to
5 years was divided by the estimated number of children
the reported numbers of cases. For other countries in
aged under 5 years at risk of malaria.
which the numbers of locally transmitted and imported
Figure 6.9 Country-level changes in malaria cases were not individually available, estimates
mortality rate 20102015, by number of deaths included imported cases; however, imported cases
in 2010 were expected to comprise only a small proportion of
See methods notes for Figure 6.8 for estimates of the large total number of cases in these countries.
mortality rates. See methods notes for Table 6.3 for
Figure 6.13 and Table 6.5 Gains in life expectancy
estimates of number of deaths.
in malaria endemic countries, 20002015
Figure 6.10 Countries attaining zero indigenous The relative contribution of the decline in malaria
malaria cases since 2000 mortality risk to total life expectancy gain between
Countries are shown by the year in which they attained 2000 and 2015 was estimated using WHO annual
zero indigenous cases for 3 consecutive years, according life tables for 20002015 for countries with malaria
to reports submitted by NMCPs. transmission in 2000, and WHO estimates of malaria
age-specific death rates (17). A cause-decomposition
Figure 6.11 Indigenous malaria cases in the years of life expectancy gain approach was followed, with the
before attaining zero indigenous cases, for the analysis conducted at WHO regional level (18).
17 countries that eliminated malaria, 20002015
For the 17 countries that attained zero indigenous cases Table 6.6 Economic value of reduced malaria
for 3 consecutive years between 2000 and 2015, the mortality risk, estimated by full income approach,
number of NMCP-reported indigenous cases was 20002015
tabulated according to the number of years preceding Malaria mortality risk reductions between 2000 and
the attainment of zero cases. Data from years before 2015 were valued using a full income approach. The
Changes in malaria mortality risk were valued as the Changes in malaria mortality risks were valued as the
payment that individuals would need to receive to sum of WTA of all individuals assumed to experience
accept an increase in mortality risk (19). This approach, these changes; 2015 life tables were used, and the
referred to as value of a statistical life (VSL), is a common calculations were as described in Jamison et al. (19).
method for valuing mortality risks in public policy studies VSL conversions used the OECD consumer price index
in high-income settings. It involves asking individuals data. 7 Calculations were conducted in 2015 US$, at
about their willingness to accept (WTA) compensation PPP with GDP data sourced from the World Bank. 8
for an increase in mortality risk, in stated-preference Probabilistic uncertainty analysis through 1000 Monte
surveys (20). These surveys have placed a value of Carlo simulations was used to determine the mean
US$380 (range: US$ 189569) on a 1 in 10 000 increase and 95% uncertainty range for the value of change
in mortality risk for a given year for individuals aged in mortality risk across malaria endemic countries in
50 years with an average life expectancy of 33 years, 20002015. The reference VSL was assigned a uniform
living in OECD countries that had an average GDP per distribution (range: US$ 189569), as were elasticity
capita of US$ 37 787 (in 2015 purchasing power parity values (range: 11.4).
[PPP] adjusted US$) (20,21). For this reference VSL to
be applied to other settings, it is necessary to take into
account differences in life expectancy and the GDP per
capita using the following formula:
ec50 GDPpc
VSL
c (
=VSLr
33 GDPr )
Where:
References
1. WHO. Global Technical Strategy for Malaria 2016 7. Cibulskis RE, Aregawi M, Williams R, Otten M, Dye C.
2030. Geneva: World Health Organization (WHO); Worldwide incidence of malaria in 2009: estimates,
2015 (http://www.who.int/malaria/areas/global_ time trends, and a critique of methods. PLoS Med.
technical_strategy/en, accessed 16 November 2016). 2011;8(12):e1001142.
2. Roll Back Malaria Partnership. Action and investment 8. WHO. World Malaria Report. Geneva: World Health
to defeat malaria 20162030. For a Malaria free Organization; 2008 (http://www.who.int/malaria/
World. Geneva: World Health Organization (WHO); publications/atoz/9789241563697/en, accessed 15
2015 (http://www.rollbackmalaria.org/files/files/ October 2013).
aim/RBM_AIM_Report_A4_EN-Sept2015.pdf,
9. Bhatt S, Weiss DJ, Cameron E, Bisanzio D, Mappin B,
accessed 16 November 2016).
Dalrymple U et al. The effect of malaria control on
3. Malaria Policy Advisory Committee. Monitoring Plasmodium falciparum in Africa between 2000 and
and evaluation of the Global Technical Strategy 2015. Nature. 2015;526(7572):207211.
for Malaria 20162030 and Action and investment
10. WHO. World Malaria Report. Geneva: World Health
to defeat malaria 20162030. Background
Organization; 2015 (http://www.who.int/malaria/
document for Session 8, Malaria Policy Advisory
publications/world-malaria-report-2015/report/
Committee Meeting, 1416 September 2016, Geneva,
en/, accessed 15 October 2013).
Switzerland: World Health Organization; 2016 (http://
www.who.int/malaria/mpac/mpac-sept2016-SME- 11. Alles HK, Mendis KN, Carter R. Malaria mortality
recommendations-session8.pdf?ua=1l, accessed 17 rates in South Asia and in Africa: implications for
November 2016). malaria control. Parasitol Today. 1998;14(9):369375.
4. UN. Revision of world population prospects [website]. 12. Luxemburger C, Ricci F, Nosten F, Raimond D, Bathet
United Nations; 2015 (http://esa.un.org/unpd/wpp, S, White NJ. The epidemiology of severe malaria in
accessed 1 August 2015). an area of low transmission in Thailand. Trans R Soc
Trop Med Hyg. 1997;91(3):256262.
5. Flaxman AD, Fullman N, Otten MW, Menon M,
Cibulskis RE, Ng M et al. Rapid scaling up of 13. Meek SR. Epidemiology of malaria in displaced
insecticide-treated bed net coverage in Africa Khmers on the Thai-Kampuchean border. Southeast
and its relationship with development assistance Asian J Trop Med Public Health. 1988;19(2):243252.
for health: a systematic synthesis of supply,
14. Douglas NM, Pontororing GJ, Lampah DA, Yeo TW,
distribution, and household survey data. PLoS Med.
Kenangalem E, Poespoprodjo JR et al. Mortality
2010;7(8):e1000328.
attributable to Plasmodium vivax malaria: a
6. Dellicour S, Tatem AJ, Guerra CA, Snow RW, ter Kuile clinical audit from Papua, Indonesia. BMC Med.
FO. Quantifying the number of pregnancies at risk of 2014;12(1):217.
malaria in 2007: a demographic study. PLoS Med.
15. Liu L, Oza S, Hogan D, Perin J, Rudan I, Lawn JE et
2010;7(1):e1000221.
al. Global, regional, and national causes of child
17. WHO. WHO methods and data sources for life tables
19902015. Department of Information, Evidence
and Research, Global Health Estimates Technical
Paper WHO/HIS/IER/GHE/2016.8, Geneva: World
Health Organization (WHO); 2016.
Funding for
malaria increased
from
US$ 233 million
to
US$ 262 million >85
between 2010 0
Not applicable
and 2015
Estimated malaria
case incidence
decreased B. Share of estimated malaria cases, 2015
by 15%
between 2010 Others, 5%
and 2015 Togo, 2%
Benin, 3%
Guinea, 4%
Estimated malaria
Niger, 5%
mortality rate
reduced Bukina Faso, 6%
Nigeria, 55%
by 29%
between 2010 Ghana, 6%
and 2015
Mali, 7%
Zero countries
eliminated Cte dIvoire, 7%
malaria
since 2010
600
Mali
Guinea-Bissau
Nigeria
400 Burkina Faso
Guinea
Cte dIvoire
200 Togo
Niger
Mauritania
Algeria
0
2010 2011 2012 2013 2014 2015 0 4 8 12 16 20
Global Fund, Global Fund to Fight AIDS, Tuberculosis and Malaria; US$
UK, United Kingdom of Great Britain and Northern Ireland; USAID,
United States Agency for International Development * Includes NMCP spending and patient service delivery care costs;
* Includes NMCP spending and patient service delivery care costs; refer to Annex 1 for more information
refer to Annex 1 for more information
A. Parasite
174 million prevalence, 2015
people at risk for
malaria in 2015
161 million
at high risk
Funding for
malaria increased
from
US$ 65 million
to
US$ 116 million
between 2010
and 2015
>85
Estimated malaria
0
Not applicable
case incidence
decreased B. Share of estimated malaria cases, 2015
by 33%
between 2010 Others, 4%
and 2015 Burundi, 4%
Zero countries
eliminated
malaria
since 2010
Equatorial Guinea
400 Angola
Gabon
of the Congo
Burundi
200
Central African
Republic
Chad
100
Cameroon
Congo
0
2010 2011 2012 2013 2014 2015 0 4 8 12 16 20
Global Fund, Global Fund to Fight AIDS, Tuberculosis and Malaria; US$
UK, United Kingdom of Great Britain and Northern Ireland; USAID,
United States Agency for International Development * Includes NMCP spending and patient service delivery care costs;
* Includes NMCP spending and patient service delivery care costs; refer to Annex 1 for more information
refer to Annex 1 for more information
Burundi*
Chad
Democratic Republic*
Democratic Republic of the Congo*
of the Congo
Central African Chad*
Republic
Angola*
Cameroon
Cameroon*
Angola
Sao Tome*
Congo and Principe*
Congo*
Equatorial Guinea
Equatorial Guinea*
Gabon
0% 20% 40% 60% 80% 100% -100% -50% 0% 50% 100%
f Reduction Increase p
IRS, indoor residual spraying; ITN, insecticide-treated mosquito net * Change in admission rate ()
* Administrative ITN coverage
A. Parasite
319 million prevalence,
2015
people at risk for
malaria in 2015
232 million
at high risk
Funding
for malaria
decreased from
US$ 156 million
to
US$ 150 million
between 2010
and 2015
>85
Estimated malaria
0
Not applicable
case incidence
decreased B. Share of estimated malaria cases, 2015
by 22%
between 2010
Others, 7%
and 2015
Madagascar, 5% Uganda, 18%
Estimated malaria Ethiopia, 6%
mortality rate
reduced Zambia, 6%
by 22%
between 2010 Malawi, 7% Mozambique,
18%
and 2015
Rwanda, 8%
Zero countries
eliminated United Republic
of Tanzania, 11% Kenya, 14%
malaria
since 2010
600
Mozambique
United Republic
of Tanzania
South Africa
400 Comoros
Uganda
Kenya
200 Eritrea
Madagascar
Botswana
Ethiopia
0
2010 2011 2012 2013 2014 2015 0 4 8 12 16 20
Global Fund, Global Fund to Fight AIDS, Tuberculosis and Malaria; US$
UK, United Kingdom of Great Britain and Northern Ireland; USAID,
United States Agency for International Development * Includes NMCP spending and patient service delivery care costs;
* Includes NMCP spending and patient service delivery care costs; refer to Annex 1 for more information
refer to Annex 1 for more information
A. Confirmed
132 million malaria
people at risk for cases per
1000
malaria in 2015 population,
21 million 2015
at high risk
Funding for
malaria increased
from
US$ 170 million
to
Confirmed cases
per 1000 population
between 2010
0
00.1
decreased
by 31% B. Share of estimated malaria cases, 2015
between 2010
and 2015 Guyana, 3% Others, 5%
between 2010
and 2015
achieved zero
indigenous cases
Brazil, 24%
for 3 years
since 2010
Nicaragua
Venezuela
(Bolivarian Republic of)
Belize
Dominican Republic
100 Bolivia
(Plurinational State of)
Honduras
Haiti
Guatemala
Ecuador
0 French Guiana
2010 2011 2012 2013 2014 2015 0 4 8 12 16 20
Global Fund, Global Fund to Fight AIDS, Tuberculosis and Malaria; US$
UK, United Kingdom of Great Britain and Northern Ireland; USAID,
United States Agency for International Development * Includes NMCP spending and patient service delivery care costs;
* Includes NMCP spending and patient service delivery care costs; refer to Annex 1 for more information
refer to Annex 1 for more information
E. Proportion of cases due to P.falciparum and F. Change in reported malaria incidence and
P.vivax, 20132015 mortality rates, 20102015
Incidence Mortality
2020 milestone: -40%
P. falciparum P. vivax Other
Nicaragua
Haiti Venezuela
Dominican Republic (Bolivarian Republic of)
Peru
Colombia
Panama
French Guiana
Guatemala
Guyana
Haiti
Suriname Bolivia
Ecuador (Plurinational State of)
Venezuela Guyana
(Bolivarian Republic of) Brazil
Honduras
Mexico
Peru
Colombia
Nicaragua
Ecuador
Brazil
Bolivia French Guiana
(Plurinational State of) Dominican Republic
Guatemala
Honduras
Panama
El Salvador
Belize
El Salvador Belize
Mexico Suriname
decreased from
Insufficient data
0
to 0.11.0
US$ 45 million
1.010
PP
1050 >85
between 2010 50100 0
and 2015 > 100 Not applicable
Estimated malaria
case incidence
decreased
by 11% B. Share of estimated malaria cases, 2015
between 2010
Yemen, 8%
and 2015
Estimated malaria
mortality rate Afghanistan, 11% Sudan, 36%
reduced
by 6%
between 2010
and 2015 Somalia, 18%
One country
achieved zero
indigenous cases
Pakistan, 27%
for 3 years
since 2010
Iran
(Islamic Republic of)
150
Djibouti
Sudan
US$ (million)
100
Somalia
Afghanistan
50
Yemen
Pakistan
0
2010 2011 2012 2013 2014 2015 0 4 8 12 16 20
Global Fund, Global Fund to Fight AIDS, Tuberculosis and Malaria; US$
UK, United Kingdom of Great Britain and Northern Ireland; USAID,
United States Agency for International Development * Includes NMCP spending and patient service delivery care costs;
* Includes NMCP spending and patient service delivery care costs; refer to Annex 1 for more information
refer to Annex 1 for more information
E. Proportion of cases due to P.falciparum and F. Change in reported malaria incidence and
P.vivax, 20132015 mortality rates, 20102015
Incidence Mortality
2020 milestone: -40%
P. falciparum P. vivax Other
Djibouti
Saudi Arabia
Saudi Arabia
Djibouti
Afghanistan
Yemen
Somalia
Somalia
Pakistan
Sudan
Sudan
Pakistan
Iran Yemen
(Islamic Republic of)
Iran
Afghanistan (Islamic Republic of)
US$ 92 million
between 2010
and 2015
Estimated malaria
case incidence
decreased
by 54% B. Share of estimated malaria cases, 2015
between 2010
and 2015 Myanmar, 2% Others, 0%
Indonesia, 9%
Estimated malaria
mortality rate
reduced
India, 89%
by 46%
between 2010
and 2015
One country
achieved zero
indigenous cases
for 3 years
since 2010
Bhutan
300
Myanmar
250
Bangladesh
200
US$ (million)
Thailand
100 Indonesia
50 Nepal
India
0
2010 2011 2012 2013 2014 2015 0 4 8 12 16 20
Global Fund, Global Fund to Fight AIDS, Tuberculosis and Malaria; US$
UK, United Kingdom of Great Britain and Northern Ireland; USAID,
United States Agency for International Development * Includes NMCP spending and patient service delivery care costs;
* Includes NMCP spending and patient service delivery care costs; refer to Annex 1 for more information
refer to Annex 1 for more information
E. Proportion of cases due to P.falciparum and F. Change in reported malaria incidence and
P.vivax, 20132015 mortality rates, 20102015
Incidence Mortality
2020 milestone: -40%
P. falciparum P. vivax Other
India
Bangladesh
Democratic Peoples
Myanmar Republic of Korea
Indonesia
India
Myanmar
Timor-Leste
Indonesia Nepal
Thailand Thailand
Bhutan Bangladesh
Nepal Bhutan
Democratic Peoples
Republic of Korea Timor-Leste
Funding for
1050
50100
malaria increased > 100
US$ 29 million
to
US$ 50 million
between 2010
and 2015
Estimated malaria
case incidence
decreased B. Share of estimated malaria cases, 2015
by 30%
between 2010 Solomon Islands, 3% Others, 3%
and 2015
Lao Peoples Democratic
Republic, 7%
Estimated malaria
mortality rate Cambodia, 10%
reduced
by 58%
between 2010
and 2015
Papua
New Guinea, 77%
Zero countries
eliminated
malaria
since 2010
Vanuatu
Solomon Islands
150
Papua New Guinea
Cambodia
US$ (million)
100
Lao Peoples
Democratic Republic
Philippines
50 Viet Nam
Republic of Korea
China
0
2010 2011 2012 2013 2014 2015 0 4 8 12 16 20
Global Fund, Global Fund to Fight AIDS, Tuberculosis and Malaria; US$
UK, United Kingdom of Great Britain and Northern Ireland; USAID,
United States Agency for International Development * Includes NMCP spending and patient service delivery care costs;
* Includes NMCP spending and patient service delivery care costs; refer to Annex 1 for more information
refer to Annex 1 for more information
E. Proportion of cases due to P.falciparum and F. Change in reported malaria incidence and
P.vivax, 20132015 mortality rates, 20102015
Incidence Mortality
2020 milestone: -40%
P. falciparum P. vivax Other
Lao Peoples
Democratic Republic
Philippines
Cambodia
Papua New Guinea
Solomon Islands
Cambodia
Lao Peoples
Democratic Republic Malaysia
China Philippines
Vanuatu
Papua New Guinea*
Malaysia
Vanuatu
Republic of Korea
China
0% 20% 40% 60% 80% 100% -100% -50% 0% 50% 100%
f Reduction Increase p
* Change in admission rate ()
Countries in bold reported <200 indigenous malaria cases
15
10
15
10
Democratic Republic
Cte dIvoire of the Congo Equatorial Guinea Eritrea Ethiopia Gabon
>20
15
10
15
10
15
10
15
10
15
10
United Republic
of Tanzania Zambia Zimbabwe
>20
15
Domestic
10 Total
African Region
5
0
2005 2010 2015 2005 2010 2015 2005 2010 2015
15
10
15
10
Venezuela
Mexico Nicaragua Panama Peru Suriname (Bolivarian Republic of)
>20
15
10
Iran
Afghanistan Djibouti (Islamic Republic of) Pakistan Saudi Arabia Somalia
>20
15
10
Democratic Peoples
Sudan Yemen Tajikistan Bangladesh Bhutan Republic of Korea
>20
15
10
15
10
Lao Peoples
Cambodia China Democratic Republic Malaysia Papua New Guinea Philippines
>20
15
10
75%
50%
25%
Democratic Republic
Chad Comoros Congo Cte dIvoire of the Congo Equatorial Guinea
100%
75%
50%
25%
75%
50%
25%
75%
50%
25%
75%
50%
25%
United Republic
Sierra Leone South Sudan Togo Uganda of Tanzania Zambia
100%
75%
50%
25%
0
2000 2005 2010 2015 2000 2005 2010 2015 2000 2005 2010 2015 2000 2005 2010 2015 2000 2005 2010 2015
Zimbabwe
100%
75%
50%
25%
Modelled data
0 95% confidence interval
2000 2005 2010 2015
African Region
No model estimates are available for Algeria, Botswana, Cabo Verde, Mayotte, Namibia,
SaoTome and Principe, South Africa and Swaziland, because ITNs are not the primary method
ofvector control in these countries
500
250
<1
500
250
<1
Democratic Republic
Cte dIvoire of the Congo Equatorial Guinea Eritrea Ethiopia Gabon
>750
500
250
<1
500
250
<1
500
250
<1
500
250
<1
500
250
<1
United Republic
of Tanzania Zambia Zimbabwe
>750
500
Point estimate
250
95% confidence interval
African Region
<1
2000 2005 2010 2015 2000 2005 2010 2015 2000 2005 2010 2015
250
<1
250
<1
Venezuela
Mexico Nicaragua Panama Peru Suriname (Bolivarian Republic of)
>500
250
<1
Iran
Afghanistan Djibouti (Islamic Republic of) Pakistan Saudi Arabia Somalia
>500
250
<1
Democratic Peoples
Sudan Yemen Tajikistan Bangladesh Bhutan Republic of Korea
>500
250
<1
250
<1
Lao Peoples
Cambodia China Democratic Republic Malaysia Papua New Guinea Philippines
>500
250
<1
300
200
100
300
200
100
Democratic Republic
Cte dIvoire of the Congo Equatorial Guinea Eritrea Ethiopia Gabon
400
300
200
100
300
200
100
300
200
100
300
200
100
300
200
100
United Republic
of Tanzania Zambia Zimbabwe
400
300
75
50
25
75
50
25
Venezuela
Mexico Nicaragua Panama Peru Suriname (Bolivarian Republic of)
>100
75
50
25
Iran
Afghanistan Djibouti (Islamic Republic of) Pakistan Saudi Arabia Somalia
>100
75
50
25
Democratic Peoples
Sudan Yemen Tajikistan Bangladesh Bhutan Republic of Korea
>100
75
50
25
75
50
25
Lao Peoples
Cambodia China Democratic Republic Malaysia Papua New Guinea Philippines
>100
75
50
25
Decrease Zero
Change Increase indigenous
WHO region Country/area <20% >20% deaths
>40% 2040%
& subregion in 2015
African, West Algeria
African, Central Angola
African, West Benin
African, South-East Botswana
African, West Burkina Faso
African, Central Burundi
African, Central Cameroon
African, West Cabo Verde
African, Central Central African Republic
African, Central Chad
African, South-East Comoros
African, Central Congo
African, West Cte d'Ivoire
African, Central Democratic Republic of the Congo
African, Central Equatorial Guinea
African, South-East Eritrea
African, South-East Ethiopia
African, Central Gabon
African, West Gambia
African, West Ghana
African, West Guinea
African, West Guinea-Bissau
African, South-East Kenya
African, West Liberia
African, South-East Madagascar
African, South-East Malawi
African, West Mali
African, West Mauritania
African Mayotte
African, South-East Mozambique
African, South-East Namibia
African, West Niger
African, West Nigeria
African, South-East Rwanda
African, Central Sao Tome and Principe
African, West Senegal
African, West Sierra Leone
African, South-East South Africa
African, South-East South Sudan
African, South-East Swaziland
African, West Togo
African, South-East Uganda
African, South-East United Republic of Tanzania
African, South-East Zambia
African, South-East Zimbabwe
Change in estimated incidence rate Change in estimated mortality rate
AFRICAN
Algeria - -
Angola
Benin
Botswana -
Burkina Faso
Burundi
Cabo Verde -
Cameroon
Central African Republic
Chad
Comoros
Congo
Cte d'Ivoire
Democratic Republic of the Congo
Equatorial Guinea -
Eritrea
Ethiopia
Gabon
Gambia
Ghana
Guinea
Guinea-Bissau
Kenya
Liberia
Madagascar
Malawi
Mali
Mauritania -
Mayotte - - - -
Mozambique
Namibia
Niger
Nigeria
Rwanda
Sao Tome and Principe
Senegal
Sierra Leone
South Africa
South Sudan2
Swaziland -
Togo
Uganda
United Republic of Tanzania -
Mainland
Zanzibar
Zambia
Zimbabwe
AMERICAS
Belize NA NA
Bolivia (Plurinational State of) NA NA
Brazil NA NA
Colombia NA NA
Costa Rica NA NA
Dominican Republic NA NA
Patients of all Malaria RDTs used at G6PD test is ACT for Pre-referral Single dose of Primaquine Directly
ages should diagnosis is community recommended treatment of treatment with primaquine is used for observed
get diagnostic free of charge level before P. f. quinine or is used as radical treatment
test in the public treatment with artemether IM gametocidal treatment of with
sector primaquine or artesunate medicine for P.vivax cases primaquine is
suppositories P.falciparum1 undertaken
- - NA -
-
-
- -
- - - -
-
-
- -
- - - -
NA
NA -
NA
AMERICAS
Ecuador NA NA
El Salvador NA NA
French Guiana NA NA
Guatemala NA NA
Guyana NA NA
Haiti NA NA
Honduras NA NA
Mexico NA NA
Nicaragua NA NA
Panama NA NA
Peru NA NA
Suriname NA NA
Venezuela (Bolivarian Republic of) NA NA
EASTERN MEDITERRANEAN
Afghanistan NA NA
Djibouti
Iran (Islamic Republic of) NA NA
Pakistan NA NA
Saudi Arabia - NA NA
Somalia
Sudan
Yemen NA NA
EUROPEAN
Tajikistan - NA NA
SOUTH-EAST ASIA
Bangladesh NA NA
Bhutan NA NA
Democratic People's Republic of
NA NA
Korea
India NA NA
Indonesia NA NA
Myanmar NA NA
Nepal NA NA
Thailand NA NA
Timor-Leste NA NA
WESTERN PACIFIC
Cambodia NA NA
China NA NA
Lao People's Democratic Republic NA NA
Malaysia - NA NA
Papua New Guinea NA NA
Philippines NA NA
Republic of Korea - - NA NA
Solomon Islands NA NA
Vanuatu NA NA
Viet Nam NA NA
ACT, artemisinin-based combination therapy; DDT, dichloro-diphenyl-trichloroethane; G6PD, glucose-6-phosphate dehydrogenase; IM, intramuscular; IPTc, intermittent
preventive treatment in children; IPTp, intermittent preventive treatment in pregnancy; IRS, indoor residual spraying; ITN, insecticide-treated mosquito net; LLIN, long-lasting
insecticidal net; KA, not applicable; NMCP, national malaria control programme; RDT, rapid diagnostic test; SMC, seasonal malaria chemoprevention
Patients of all Malaria RDTs used at G6PD test is ACT for Pre-referral Single dose of Primaquine Directly
ages should diagnosis is community recommended treatment of treatment with primaquine is used for observed
get diagnostic free of charge level before P. f. quinine or is used as radical treatment
test in the public treatment with artemether IM gametocidal treatment of with
sector primaquine or artesunate medicine for P.vivax cases primaquine is
suppositories P.falciparum1 undertaken
NA
NA
NA
NA
NA
NA
NA
NA
-
- -
- -
- -
- NA -
-
- -
- NA -
= Actually implemented.
= Not implemented.
(-) = Question not answered or not applicable.
1 Single dose of primaquine (0.75mg base/kg) for countries in the WHO Region of the Americas
2 In May 2013 South Sudan was reassigned to the WHO African Region (WHA resolution 66.21, http://apps.who.int/gb/ebwha/pdf_files/WHA66/A66_R21-en.pdf)
AFRICAN
Algeria - - - - CQ
Angola AL AL AS; QN - -
Benin AL AL AS; QN - -
Botswana AL AL QN - -
Burkina Faso AL; AS+AQ AL; AS+AQ AS; QN SP(IPT) -
Burundi AS+AQ AS+AQ AS; QN - -
Cabo Verde AL AL QN - -
Cameroon AS+AQ AS+AQ AS, AM;QN - -
Central African Republic AL AL AS, AM; QN SP(IPT) -
Chad AL; AS+AQ AL; AS+AQ AS,QN SP(IPT) -
Comoros AL AL QN SP(IPT) -
Congo AS+AQ AS+AQ QN SP(IPT) -
Cte d'Ivoire AS+AQ AS+AQ QN SP(IPT) -
Democratic Republic of the Congo AS+AQ AS+AQ AS, QN - -
Equatorial Guinea AS+AQ AS+AQ AS - -
Eritrea AS+AQ AS+AQ QN - AS+AQ+PQ
Ethiopia AL AL AS; AM; QN - CQ
Gabon AS+AQ AS+AQ AS; AM; QN - -
Gambia AL AL QN SP(IPT) -
Ghana AS+AQ AL; AS+AQ AS; AM; QN SP(IPT) -
Guinea AS+AQ AS+AQ AS SP(IPT) -
Guinea-Bissau AL AL AS;QN - -
Kenya AL AL AS; AM; QN - -
Liberia AS+AQ AS+AQ AS; AM; QN - -
Madagascar AS+AQ AS+AQ QN SP(IPT) -
Malawi AL AL AS; QN SP(IPT) -
Mali AS+AQ AL; AS+AQ QN SP(IPT) -
Mauritania AS+AQ AL; AS+AQ QN - -
QN; AS; QN+AS;
Mayotte - AL - CQ+PQ
AS+D; QN+D
Mozambique AL AL AS, QN - -
Namibia AL AL QN - AL
Niger AL AL AS; QN SP(IPT) -
Nigeria AL; AS+AQ AL; AS+AQ AS; AM; QN SP(IPT) -
Rwanda AL AL AS; QN - -
Sao Tome and Principe AS+AQ AS+AQ QN - -
Senegal AL; AS+AQ; DHA-PPQ AL; AS+AQ; DHA-PPQ AS; QN SP(IPT) -
Sierra Leone AS+AQ AL; AS+AQ AS; AM; QN SP(IPT) -
South Africa - AL; QN+CL; QN+D QN - AL+PQ; CQ+PQ
South Sudan1 AS+AQ AS+AQ AM; AS; QN - AS+AQ+PQ
Swaziland - AL AS - -
Togo AL; AS+AQ AL; AS+AQ AS; AM; QN SP(IPT) -
Uganda AL AL AS, QN - -
United Republic of Tanzania AL; AS+AQ AL; AS+AQ AS, AM; QN - -
Mainland AL AL AS, AM; QN SP(IPT) -
Zanzibar AS+AQ AS+AQ AS; QN SP(IPT) -
Zambia AL AL AS; AM; QN - -
Zimbabwe AL AL QN - -
AMERICAS
Argentina - AL+PQ - - CQ+PQ
Belize - CQ+PQ(1d) AL; QN - CQ+PQ(14d)
Bolivia (Plurinational State of) - AL+PQ - - CQ+PQ(7d)
AL+PQ(1d); AM+CL; AS+CL;
Brazil - - CQ+PQ(7d)
AS+MQ+PQ(1d) QN+CL
Colombia - AL AS+AL - CQ+PQ(14d)
CQ+PQ(7d);
Costa Rica - CQ+PQ(1d) QN -
CQ+PQ(14d)
AMERICAS
Dominican Republic - CQ+PQ(1d) QN+CL - CQ+PQ(14d)
Ecuador - AL+PQ QN - CQ (3d)+PQ(7d)
El Salvador - CQ+PQ(1d) QN - CQ+PQ(14d)
French Guiana - AL AS; AL - CQ+PQ
Guatemala - - QN - CQ+PQ(14d)
Guyana - AL+PQ(1d) AM - CQ+PQ(14d)
Haiti - CQ+PQ(1d) QN - CQ+PQ(14d)
Honduras - CQ+PQ(1d) QN - CQ+PQ(14d)
Mexico - CQ+PQ AL - CQ+PQ
Nicaragua - CQ+PQ(1d) QN - CQ+PQ(7d)
CQ+PQ(7d);
Panama - AL+PQ(1d) QN -
CQ+PQ(14d)
Paraguay - AL+PQ AS - CQ+PQ
Peru - AS+MQ AS+MQ - CQ+PQ
Suriname - AL+PQ(1d) AS - CQ+PQ(14d)
Venezuela (Bolivarian Republic of) - AS+MQ+PQ AM; QN - CQ+PQ(14d)
EASTERN MEDITERRANEAN
Afghanistan CQ AS+SP+PQ AS; AM; QN - CQ+PQ(8w)
Djibouti AL AL+PQ QN - CQ+PQ (14d)
Iran (Islamic Republic of) - AS+SP; AS+SP+PQ AS; QN - CQ+PQ(14d & 8w)
Pakistan CQ AS+SP+PQ AS; QN - CQ+PQ (14d & 8w)
Saudi Arabia - AS+SP+PQ AS; AM; QN - CQ+PQ(14d)
Somalia AL AL+PQ AS; AM; QN SP(IPT) AL+PQ(14d)
Sudan AS+SP; AL AS+SP; AL QN; AM - AL+PQ(14d)
Yemen AS+SP AS+SP QN; AM - CQ+PQ(14d)
SOUTH-EAST ASIA
Bangladesh - AL AS+AL; QN - CQ+PQ(14d)
Bhutan - AL AM; QN - CQ+PQ(14d)
Democratic People's Republic of
- - - - CQ+PQ(14d)
Korea
India CQ AS+SP+PQ AM; AS; QN - CQ+PQ(14d)
Indonesia - DHA-PP+PQ AM; AS; QN - DHA-PP+PQ(14d)
AL; AM; AS+MQ;
Myanmar - AM; AS; QN - CQ+PQ(14d)
DHA-PPQ; PQ
Nepal CQ AL+PQ AS; QN - CQ+PQ(14d)
Sri Lanka - AL+PQ QN - CQ+PQ(14d)
Thailand - DHA-PPQ QN+D - CQ+PQ(14d)
Timor-Leste - AL AM; AS; QN - CQ+PQ(14d)
WESTERN PACIFIC
AS+MQ; DHA-
Cambodia - AM; AS; QN - DHA-PPQ
PPQ+PQ
ART+NQ; ART-PPQ;
China - AM; AS; PYR - CQ+PQ(8d)
AS+AQ; DHA-PPQ
Lao People's Democratic Republic - AL AS+AL - CQ+PQ(14d)
Malaysia - AS+MQ AS+D; QN - CQ+PQ(14d)
Papua New Guinea - AL AM; AS - AL+PQ
Philippines AL AL+PQ QN+T; QN+D; QN+CL SP(IPT) CQ+PQ(14d)
Republic of Korea CQ - - - CQ+PQ(14d)
Solomon Islands AL AL AL; AS - AL+PQ(14d)
Vanuatu - AL AS CQ(weekly) AL+PQ(14d)
Viet Nam DHA-PPQ DHA-PPQ AS; QN - CQ+PQ(14d)
1 In May 2013, South Sudan was reassigned to the WHO African Region (WHA resolution 66.21, http://apps.who.int/gb/ebwha/pdf_files/WHA66/A66_R21-en.pdf)
WORLD MALARIA REPORT 2016 99
Annex 4 C. Funding for malaria control, 20132015
AFRICAN
2013 0 0 0 0
Algeria 2014 0 0 0 0
2015 0 0 0 0
2013 25654554 29044735 0 0
Angola 2014 -249457 29034800 0 0
2015 1319877 28000000 0 0
2013 28126482 16942762 0 0
Benin 2014 13120913 16519800 510289 0
2015 2663084 16500000 510901 0
2013 0 0 0 0
Botswana 2014 0 0 0 0
2015 1651425 0 0 0
2013 9563499 9584925 4360225 308128
Burkina Faso 2014 5970765 9511400 1922457 300665
2015 26642827 12000000 1924764 390300
2013 23148751 9389585 0 0
Burundi 2014 4779972 9511400 702875 0
2015 3431421 12000000 703719 0
2013 908176 0 0 0
Cabo Verde 2014 0 0 0 0
2015 507453 0 0 0
2013 11067992 0 0 0
Cameroon 2014 8623656 0 0 0
2015 44506703 0 0 0
2013 12489645 0 0 0
Central African Republic 2014 1994303 0 0 0
2015 2652313 0 0 0
2013 35277508 0 0 0
Chad 2014 12603052 0 0 0
2015 3685635 0 0 0
2013 3602626 0 0 0
Comoros 2014 1108648 0 0 0
2015 74394 0 0 0
2013 748670 0 0 0
Congo 2014 0 0 0 0
2015 -274505 0 0 0
2013 46135572 0 0 0
Cte d'Ivoire 2014 27529564 0 0 0
2015 15049821 0 0 0
2013 59219677 42597521 11516688 15009416
Democratic Republic of the Congo 2014 78210843 50060000 -34980 18098629
2015 126400000 50000000 -35022 23494261
2013 0 0 0 0
Equatorial Guinea 2014 -138287 0 0 0
2015 -136534 0 0 0
2013 14711707 0 0 0
Eritrea 2014 6805860 0 0 0
2015 7287106 0 0 0
2013 115100000 44534650 0 0
Ethiopia 2014 9902341 45054000 0 0
2015 36385300 44000000 0 0
2013 -120 0 0 0
Gabon 2014 -155013 0 0 0
2015 -297542 0 0 0
Government Global Fund The World Bank PMI/USAID Other WHO UNICEF Other
(NMCP) bilaterals contributions6
0 5
- - - - - - 0
1705134 0 - - - 12000 - 0
1335355 - - - - - - -
64047348 5
19286339 - 27200000 - - 3555239 -
27851717 5378690 - 27000000 - - - -
47356258 5
2675645 - 28000000 - - - -
980000 - - - - - - -
1082000 40580540 - - - - - -
- - - - - - - -
1947775 0 0 0 0 - 0 0
2142552 0 0 0 0 - 0 0
1605618 280899 0 0 0 - 0 0
58920267 40645351 0 8552723 0 37800 521760 942955
3126963 2433376 697173 8571017 70804 19048 136540 379610
576253 42735771 284328 8579441 9454 11800 305704 2533200
1134923 19481377 - 9260000 2602730 65000 453631 1277376
2001113 6027330 - 9229345 0 79050 475936 1324385
464515 4523416 - 9500000 - 32595 47445292 -
397920 555169 - - - 130448 - -
253251 64285 - - - 19638 - -
1520070 5
325273 - - - 19142 - -
5246883 5
15293706 - - 5415537 904218 118341 5415537
43709021 5
147856497 - 1123490 - 460000 14718 669000
12122087 5
54918697 - - - 221000 - -
160000 5342710 0 0 - - 2000000 -
530000 5
2852385 - - - 20500 5596000 -
530000 5
- - - - 100000 - -
7493400 5
- - - - - - -
9122400 5
30125205 - - 239735 54574 2667358 673440
1184508 6141762 - - - 20000 216491 -
137147 499000 0 0 0 40000 5576 0
94797 1074877 0 0 0 104000 51630 58500
114685 224643 0 0 0 30000 6221 0
1651000 0 0 0 0 45000 10000 0
1675000 - - - - 45000 - 3827
446000 0 0 0 0 68000 18000 0
54723090 74853096 13119140 9839355 244000 36338 24975817 244000
53942249 33611939 - 9839355 - 6245966 29250235 -
913958253 14414815784 0 0 0 0 15070138 22954890
7812690 86281277 2952042 37001000 0 0 1790452 35020370
8104841 102540781 0 34000000 24838023 2100000 7196262 0
7014345 107594221 0 34000000 23018218 2933630 808130 0
2582747 5
0 - - - - - 4490030
- - - - - - - -
- - - - - - - -
- 15871769 - - - - - -
0 4906745 0 0 - 58832 0 0
0 6216618 0 0 0 46081 0 0
19705028 85723876 - 29370000 - 111677 - 15000000
- 93201479 - - - - - -
- 18448416 - 3800000 - - - 13114670
226596 0 0 0 0 11276 0 -
123200 0 0 0 0 34855 0 -
27677576 5
0 0 0 0 47147 0 272289
AFRICAN
2013 9450471 0 0 3259541
Gambia 2014 4139913 0 0 3571824
2015 3570386 0 0 4636670
2013 68982118 29043718 1950363 159531
Ghana 2014 14858744 28033600 -193385 13571490
2015 48569128 28000000 -193617 17617474
2013 4683637 12586255 0 0
Guinea 2014 9155326 12515000 0 0
2015 11116893 12500000 0 0
2013 7447874 0 0 0
Guinea-Bissau 2014 2343620 0 0 0
2015 2442286 0 0 0
2013 33890896 34852054 0 24424951
Kenya 2014 49600626 35042000 0 10299449
2015 4178019 35000000 0 13369959
2013 5985313 12585238 0 0
Liberia 2014 10417780 12014400 0 0
2015 7326968 12000000 0 0
2013 23041363 26478852 0 0
Madagascar 2014 499916 26031200 0 0
2015 23405037 26000000 0 0
2013 9242261 24493905 0 0
Malawi 2014 7137815 22026400 0 0
2015 29090137 22000000 0 0
2013 14086732 25442122 0 0
Mali 2014 10815983 25030000 0 265099
2015 7156264 25000000 0 344131
2013 0 0 0 289208
Mauritania 2014 0 0 0 194250
2015 -186844 0 0 252160
2013 0 0 0 0
Mayotte 2014 0 0 0 0
2015 0 0 0 0
2013 12846315 29528000 2081542 8459472
Mozambique 2014 34683850 29034800 1051656 0
2015 18387135 29000000 1052918 0
2013 3671321 0 0 0
Namibia 2014 557477 0 0 0
2015 -428418 0 0 0
2013 9467744 0 0 0
Niger 2014 24038455 0 0 0
2015 7579029 0 0 0
2013 46154643 74546933 28656321 33723741
Nigeria 2014 145100000 75090000 60004274 25486088
2015 83002031 75000000 60076279 33084096
2013 23279708 18316252 0 0
Rwanda 2014 15445694 17521000 0 0
2015 10893839 18000000 0 0
2013 3763889 0 9689 0
Sao Tome and Principe 2014 3310033 0 0 156962
2015 1088458 0 0 203756
2013 3725853 24543758 0 0
Senegal 2014 21700475 24028800 0 107327
2015 15858305 24000000 0 139323
Government Global Fund The World Bank PMI/USAID Other WHO UNICEF Other
(NMCP) bilaterals contributions6
AFRICAN
2013 6322646 0 0 6665038
Sierra Leone 2014 13804625 0 1818657 1749926
2015 6177403 0 1820839 2271620
2013 0 0 0 0
South Africa 2014 0 0 0 89809
2015 0 0 0 116584
2013 8868037 7067878 0 9789412
South Sudan7 2014 14270616 6007200 0 11110486
2015 28351902 6000000 0 14422786
2013 1359333 0 0 0
Swaziland 2014 1656196 0 0 0
2015 -9242 0 0 0
2013 20867709 0 0 0
Togo 2014 7422179 0 0 0
2015 574092 0 0 0
2013 19851005 34369807 0 744053
Uganda 2014 14240284 34040800 0 23540773
2015 19156953 34000000 0 30558836
2013 53130202 46857374 0 8038848
United Republic of Tanzania8 2014 28978524 46055200 0 11797783
2015 56565404 46000000 0 15314982
2013 48951490 0 0 0
Mainland 2014 28978524 0 0 0
2015 56656620 0 0 0
2013 4178713 0 0 0
Zanzibar 2014 0 0 0 0
2015 -91216 0 0 0
2013 29845578 24446087 5025296 21025870
Zambia 2014 0 24028800 -79393 9560356
2015 9533481 24000000 -79489 12410525
2013 10159204 15296609 0 0
Zimbabwe 2014 10708651 15018000 0 0
2015 24281811 15000000 0 0
AMERICAS
2013 0 0 0 0
Belize 2014 0 0 0 0
2015 0 0 0 0
2013 2149471 0 0 0
Bolivia (Plurinational State of) 2014 1319756 0 0 0
2015 1164955 0 0 0
2013 -232760 0 0 0
Brazil 2014 0 0 0 0
2015 0 0 0 0
2013 6855077 0 0 0
Colombia 2014 2897670 0 0 0
2015 -572451 0 0 0
2013 1169538 0 0 0
Dominican Republic 2014 515308 0 0 0
2015 -23672 0 0 0
2013 1129922 0 0 0
Ecuador 2014 1003447 0 0 0
2015 0 0 0 0
Government Global Fund The World Bank PMI/USAID Other WHO UNICEF Other
(NMCP) bilaterals contributions6
261500 0 0 14223 0 0 0 -
270000 10121 0 6761 0 0 0 -
297500 189879 0 12747 0 0 0 0
787966 365193 0 0 0 0 0 0
718391 1631520 0 0 0 0 0 0
531609 1170000 0 0 0 38991 0 0
73291509 5
0 0 18700 0 0 0 0
72248286 5
0 0 47495 0 0 0 0
60803769 5
0 0 129288 0 0 0 0
23100498 4832745 0 142406 0 0 0 0
11493708 3257687 0 96194 0 0 0 0
13059553 0 0 73391 0 0 0 0
1966812 1158508 0 0 0 21930 0 23382
1883503 852947 0 0 0 0 0 106598
2663837 72511 0 0 0 0 0 213094
1852740 735047 0 19719 0 0 0 -
- 983835 0 98057 0 - 0 -
2444718 0 0 - 0 141000 0 -
AMERICAS
2013 0 0 0 0
El Salvador 2014 0 0 0 0
2015 0 0 0 0
2013 0 0 0 0
French Guiana 2014 0 0 0 0
2015 0 0 0 0
2013 -2125749 0 0 0
Guatemala 2014 4393686 0 0 0
2015 4781163 0 0 0
2013 385865 0 0 0
Guyana 2014 0 0 0 0
2015 54389 0 0 0
2013 3970561 0 0 0
Haiti 2014 4537198 0 0 0
2015 4518050 0 0 0
2013 971241 0 0 0
Honduras 2014 968554 0 0 0
2015 3305959 0 0 0
2013 0 0 0 0
Mexico 2014 0 0 0 0
2015 0 0 0 0
2013 2473993 0 0 0
Nicaragua 2014 1011306 0 0 0
2015 555717 0 0 0
2013 0 0 0 0
Panama 2014 0 0 0 0
2015 0 0 0 0
2013 0 0 0 0
Peru 2014 0 0 0 0
2015 0 0 0 0
2013 559024 0 0 0
Suriname 2014 158942 0 0 0
2015 1274513 0 0 0
2013 0 0 0 0
Venezuela (Bolivarian Republic of) 2014 0 0 0 0
2015 0 0 0 0
EASTERN MEDITERRANEAN
2013 17932702 0 3233062 0
Afghanistan 2014 8413448 0 -978746 0
2015 8284767 0 -979921 0
2013 0 0 53289 0
Djibouti 2014 0 0 169381 0
2015 -283944 0 169584 0
2013 3235422 0 0 0
Iran (Islamic Republic of) 2014 2668430 0 0 0
2015 2480335 0 0 0
2013 5951734 0 0 0
Pakistan 2014 9014340 0 0 0
2015 8491910 0 0 0
2013 0 0 0 0
Saudi Arabia 2014 0 0 0 0
2015 0 0 0 0
Government Global Fund The World Bank PMI/USAID Other WHO UNICEF Other
(NMCP) bilaterals contributions6
2854844 0 0 0 0 56948 0 0
0 0 0 0 0 54340 0 0
0 0 0 13376 0 11563 0 0
- 0 0 0 0 0 0 0
- 0 0 0 0 0 0 0
- - - - - - - -
1385919 3498024 0 105373 0 0 0 0
542663 3278171 0 92461 0 0 0 0
2610850 8232108 0 56824 0 0 0 0
883314 809474 0 297569 0 71370 0 0
800439 451597 0 115708 0 140486 0 0
1023795 337939 0 288169 0 47500 0 0
2433241 1248119 0 - 0 169000 0 820000
- 1161379 0 102864 0 24413 0 -
- 1415674 - 62156 470000 - - 250064
971742 1106404 0 99330 6000 0 0 0
543312 792634 0 113187 0 0 0 6046
- - 0 118071 - 18457 0 -
25256768 0 0 0 0 0 0 0
23827054 0 0 0 0 0 0 0
46662926 0 0 0 0 0 0 0
1907755 2075252 0 37630 0 4814 0 0
2174840 1214811 0 51323 0 21868 0 0
2479318 1013568 0 59175 - 28098 - -
7220410 0 0 32136 0 0 0 0
7469311 5
100000 0 77562 0 0 0 0
7964427 10000 0 49079 0 11000 0 -
429285 5
0 0 56703 0 0 0 0
- 0 0 91037 0 0 0 0
- 0 0 98598 0 - 0 0
152805 550000 0 157887 400000 100000 0 400000
1650498 479600 0 30198 400541 77264 0 0
1049230 975757 0 47762 400541 41437 0 0
800000 5
0 0 0 - - - -
1000000 5
0 0 0 - - - -
19600139 0 0 0 - - - -
- 16651753 - - - 109068 - -
- 9083870 - - - 113341 - -
- 4571460 - - - 89167 - -
- - - - - 121616 200563 9200
- - - - - - - -
- - - - - - - -
5000000 0 - - - 60500 - -
6300000 2979260 - - - 34000 - -
2500000 2418943 - - - 5000 - -
- 8057177 - - - - - -
- 10718906 - - - 154000 - -
- 5910215 - - - 89000 - -
29440000 - - - - - - -
30000000 0 - - - 0 - 0
30000000 0 0 0 0 0 0 0
EASTERN MEDITERRANEAN
2013 2306067 0 0 0
Somalia 2014 9683991 0 0 0
2015 10029201 0 0 0
2013 36300938 0 0 0
Sudan 2014 16072617 0 0 0
2015 45537876 0 0 0
2013 6077055 0 0 0
Yemen 2014 2019956 0 0 0
2015 1766950 0 0 0
EUROPEAN
2013 1330867 0 0 0
Tajikistan 2014 1033516 0 0 0
2015 310931 0 0 0
SOUTH-EAST ASIA
2013 16690261 0 0 0
Bangladesh 2014 4400680 0 0 0
2015 6752177 0 0 0
2013 412322 0 0 0
Bhutan 2014 240177 0 0 0
2015 564401 0 0 0
2013 2753419 0 0 0
Democratic People's Republic of Korea 2014 6712651 0 0 0
2015 3430639 0 0 0
2013 7298886 0 5510326 0
India 2014 4487320 0 336371 0
2015 32762209 0 336774 0
2013 31585463 0 0 325066
Indonesia 2014 11501914 0 0 309236
2015 12520343 0 0 401426
2013 15294281 6680248 0 12333480
Myanmar 2014 30390265 8009600 0 7795850
2015 26232472 9000000 0 10119978
2013 5007753 0 0 0
Nepal 2014 1815285 0 0 0
2015 1718309 0 0 0
2013 11522593 0 0 0
Thailand 2014 20562762 0 0 0
2015 7192438 0 0 0
2013 2649725 0 0 0
Timor-Leste 2014 1529674 0 0 0
2015 2515337 0 0 0
WESTERN PACIFIC
2013 12322502 4066548 0 0
Cambodia 2014 24223323 4505400 0 0
2015 8913449 4500000 0 0
2013 1888802 0 0 0
China 2014 -1740333 0 0 0
2015 -7270 0 0 0
2013 3312655 0 712658 0
Lao People's Democratic Republic 2014 4209255 0 637564 0
2015 5919559 0 638329 0
Government Global Fund The World Bank PMI/USAID Other WHO UNICEF Other
(NMCP) bilaterals contributions6
WESTERN PACIFIC
2013 0 0 0 376047
Malaysia 2014 0 0 0 5208116
2015 0 0 0 6760779
2013 23369832 0 0 0
Papua New Guinea 2014 10983626 0 0 122670
2015 7733450 0 0 159240
2013 4890556 0 0 0
Philippines 2014 6940774 0 0 0
2015 4271374 0 0 0
2013 0 0 0 0
Republic of Korea 2014 0 0 0 0
2015 0 0 0 0
2013 0 0 0 0
Solomon Islands 2014 0 0 0 0
2015 682023 0 0 0
2013 2961459 0 0 0
Vanuatu 2014 1487520 0 0 0
2015 763342 0 0 0
2013 4323107 0 0 0
Viet Nam 2014 13050120 0 0 0
2015 7904820 0 0 0
NMCP, National Malaria Control Programme; PMI, United States Presidents Malaria Initiative; UK, Funding from the United Kingdom of Great Britain and Northern Ireland
government; UNICEF, United Nations Childrens Fund; USAID, United States Agency for International Development
1 Source: The Global Fund
2 Source: www.foreignassistance.gov
3 Source: OECD Database
4 Source: OECD Database
5 Budget not expenditure
6 Other contributions as reported by countries: NGOs, foundations, etc.
7 South Sudan became an independent State on 9 July 2011 and a Member State of WHO on 27 September 2011. South Sudan and Sudan have distinct epidemiological profiles
comprising high-transmission and low-transmission areas, respectively. For this reason data up to June 2011 from the high-transmission areas of Sudan (10 southern states
which correspond to contemporary South Sudan) and low-transmission areas (15 northern states which correspond to contemporary Sudan) are reported separately.
8 Where national totals for the United Republic of Tanzania are unavailable, refer to the sum of Mainland and Zanzibar.
* Negative disbursements reflect recovery of funds on behalf of the financing organization.
- refers to data not available.
Government Global Fund The World Bank PMI/USAID Other WHO UNICEF Other
(NMCP) bilaterals contributions6
39845997 - - - - 0 - 0
57535038 0 - - - 0 - 0
64881663 - - - - - - -
388000 25311547 0 0 - - 0 -
377000 695052 0 0 0 0 0 0
1637421 11000000 - - - - - -
5235686 8612874 0 0 0 315326 0 22220
5861758 7395343 0 0 0 0 0 0
6165334 6087433 0 0 0 0 0 0
519102 0 - - - 0 - 0
556200 0 - - - 0 - 0
538495 0 0 0 0 0 0 0
270180 1305840 0 0 1987523 852472 0 674896
260505 1362022 0 0 1820735 654985 0 0
281324 2232220 0 0 1017390 464914 0 0
812377 5
1162890 0 0 1692091 287615 0 0
812377 5
1310500 0 0 1064592 287615 0 0
166359 687267 0 0 424136 175894 0 0
4523810 5254143 0 0 0 410000 0 0
2666667 15263816 0 0 0 640700 0 0
2666666 5528000 0 0 0 560000 0 200000
WHO region Year No. of ITN + LLIN No. of people No. of RDTs First-line treatment ACT treatment
Country/area sold or delivered protected by IRS distributed courses delivered courses delivered
(including ACT)
AFRICAN
2013 0 17407 - 603 0
Algeria 2014 0 - - 266 92
2015 - - 0 747 -
2013 1182519 419353 900000 2814900 2814900
Angola 2014 2978937 58370 - - -
2015 2138331 - 2500000 3185160 3185160
2013 584285 694729 - - -
Benin 2014 6203924 789883 1332948 1101154 1101154
2015 - 802597 1486667 1177261 1177261
2013 0 176887 1600 3953 3953
Botswana 2014 - 205831 - - -
2015 50000 143268 1135 1386 1386
2013 9959820 0 5728612 5797938 5797938
Burkina Faso 2014 239559 0 6224055 7494498 7494498
2015 481107 0 8290188 7824634 7824634
2013 731981 0 2857991 3836437 3836437
Burundi 2014 5752583 0 3089202 4772805 4263178
2015 726767 - 5075437 4798379 4798376
2013 0 298475 - 4824 3144
Cabo Verde 2014 0 25780 - 46 41
2015 0 308586 - 26 26
2013 - 0 920382 1048811 497022
Cameroon 2014 - 0 - 1270172 1270172
2015 2751112 - 1573992 826434 826434
2013 150000 0 25000 420000 420000
Central African Republic 2014 555334 - 303582 522270 522270
2015 1170566 - 759245 1043674 1043674
2013 230043 - 994779 814449 814449
Chad 2014 6321676 - 1144686 1038000 1038000
2015 1218640 - 1057033 1326091 1326091
2013 377252 31150 23565 60868 60868
Comoros 2014 13576 22475 5375 4750 4750
2015 16969 20275 14813 577 550
2013 14005 0 39375 0 0
Congo 2014 180595 0 19746 0 0
2015 447 - 0 1304959 1304959
2013 1821267 - 3891695 2358567 2358567
Cte d'Ivoire 2014 12627282 - - - -
2015 3663080 - 5600100 3296991 3296991
2013 7947747 185252 9746694 14941450 7112841
Democratic Republic
2014 13918109 194566 13962862 19008927 19008927
of the Congo
2015 15419488 77643 13574891 9871484 9871484
2013 8397 129000 17630 40911 40911
Equatorial Guinea 2014 10010 165944 9801 14577 -
2015 - - - - -
2013 86597 275857 393780 182911 182911
Eritrea 2014 0 320881 54516 216195 216195
2015 2054194 328915 645 255602 255602
2013 11709780 23150388 18300000 12800000 9164641
Ethiopia 2014 13388552 16709249 7416167 7321471 5321471
2015 17233074 - 13148960 7036620 6049320
2013 21666 0 - - -
Gabon 2014 10000 - - 984423 984423
2015 10730 - - - -
2013 138149 800290 907880 468767 468767
Gambia 2014 1046510 350442 603900 319182 319182
2015 93375 438234 875850 351677 351677
2013 1926300 2936037 3840000 8330784 8330784
Ghana 2014 5190887 2154924 9309200 14267045 14267045
2015 9085339 1325507 4000000 2715640 4007385
2013 5268245 - 2436825 370771 1402400
Guinea 2014 73145 - 2870250 1312802 644829
2015 741450 - 2412597 1645493 -
AFRICAN
2013 116268 - - - -
Guinea-Bissau 2014 1109568 - 917200 171540 171540
2015 - - - - -
2013 1641982 0 5000000 8300000 7000000
Kenya 2014 5450064 0 5500000 10839611 10614717
2015 11637493 0 4319000 11052564 10321221
2013 95775 - 610225 1332055 443900
Liberia 2014 236996 0 58248 100535 96787
2015 - 0 - - -
2013 6458693 1579521 1640095 2172536 2172536
Madagascar 2014 105442 1307384 2839325 1648093 1648093
2015 11249042 1327326 4962600 2040289 2040289
2013 636318 - - 7601460 7601460
Malawi 2014 1423507 - 8197250 8735160 8735160
2015 1100000 - 8462325 6240060 6240060
2013 636465 826386 4101525 3080130 3080130
Mali 2014 3790403 836568 2563993 2211118 2211118
2015 6080030 494163 4381050 3761319 3761319
2013 105000 - 225680 56015 56015
Mauritania 2014 178922 - 269941 176192 176192
2015 240000 - 360000 - 109000
2013 39400 381 - - -
Mayotte 2014 5252 450 - - -
2015 - - - - -
2013 3315727 9647202 10547052 13477650 13477650
Mozambique 2014 6112245 5597770 17374342 15976059 15976059
2015 5126340 3659845 17219225 13653685 13653685
2013 104249 598901 185025 90377 87520
Namibia 2014 163526 467930 - - -
2015 - 386759 30120 79215 -
2013 409400 0 2561900 6556070 6556070
Niger 2014 2048430 0 4197381 5731036 5731036
2015 6253448 0 3039594 3698674 3698674
2013 8559372 132211 13200766 32568349 32568349
Nigeria 2014 23328225 316255 10679235 22145889 22145889
2015 27628073 - - - -
2013 5249761 1562411 604565 1204913 1204913
Rwanda 2014 1373582 1243704 444729 1917021 1917021
2015 2066915 - 2015100 4392006 4392006
2013 14596 153514 30909 8752 8752
Sao Tome and Principe 2014 11385 124692 58005 1456 1456
2015 113221 143571 72407 1704 1704
2013 3902145 690090 1453000 976840 976840
Senegal 2014 3785595 708999 1193075 703712 703712
2015 556135 514833 2570500 958492 958492
2013 441859 0 2522058 2201370 2201370
Sierra Leone 2014 3846204 0 2057306 1391273 1391273
2015 395061 - 2494935 1687031 1687031
2013 0 2318129 242123 8272 5444
South Africa 2014 0 5650177 499086 14036 14036
2015 0 1178719 16007 0 0
2013 3144818 332968 764670 3125448 3125448
South Sudan1 2014 - - - - -
2015 - - - - -
2013 0 0 21575 356 307
Swaziland 2014 5399 3971 - 588 558
2015 3808 - 58700 491 396
2013 468575 0 989436 964927 802904
Togo 2014 4042425 0 1633891 1134604 1208529
2015 8600 - 1633891 1508016 1208529
2013 13219306 2581839 19048750 24375450 24375450
Uganda 2014 10615631 3219122 17157725 21698700 21698700
2015 1442500 3895232 27110800 30166620 30166620
WHO region Year No. of ITN + LLIN No. of people No. of RDTs First-line treatment ACT treatment
Country/area sold or delivered protected by IRS distributed courses delivered courses delivered
(including ACT)
AFRICAN
2013 2547391 3793027 21785950 20382485 20382485
United Republic of Tanzania 2014 619189 2224900 24126300 19937820 19937820
2015 21141998 14684925 17031950 10164660 10164660
2013 2489536 3537097 21491950 20377410 20377410
Mainland 2014 510000 2000000 24126300 19937820 19937820
2015 20794000 14386280 16416675 10160910 10160910
2013 57855 255930 294000 5075 5075
Zanzibar 2014 109189 224900 - - -
2015 347998 298645 615275 3750 3750
2013 3362588 1063460 9221210 15926301 15926301
Zambia 2014 6368026 5538574 7500000 13000845 13000845
2015 - 5930141 11310350 14365969 14365969
2013 2010000 3106659 1671832 815260 815260
Zimbabwe 2014 1743542 3460871 2446996 960455 960455
2015 84087 3548246 1981613 847333 847333
AMERICAS
2013 2324 21413 0 26 0
Belize 2014 2452 21413 0 19 0
2015 4152 36796 0 13 0
2013 20965 30280 15000 7342 959
Bolivia
2014 23580 16573 - 7401 325
(Plurinational State of)
2015 17514 11138 - 6907 6907
2013 147736 324477 100050 452990 122290
Brazil 2014 229947 287150 46950 334740 59690
2015 - 276278 101700 290580 94380
2013 146196 154000 43600 68879 48285
Colombia 2014 169500 519333 2960 86228 32489
2015 25100 252500 0 108469 55469
2013 54139 49510 71000 579 4
Dominican Republic 2014 6733 6066 54425 496 7
2015 105906 100090 50220 661 3
2013 20337 94321 - 378 161
Ecuador 2014 - - - - -
2015 120532 - - 686 227
2013 10000 15076 0 10865 0
El Salvador 2014 0 6424 0 8 0
2015 0 37500 0 9 0
2013 2920 16932 - - -
French Guiana 2014 2990 - - - -
2015 - - - - -
2013 282788 37450 139525 - -
Guatemala 2014 49905 1700 50459 - -
2015 600049 - 108900 0 0
2013 27921 41000 0 31479 13655
Guyana 2014 152996 25592 0 12354 12354
2015 24201 146 0 9984 3219
2013 0 0 0 109625 0
Haiti 2014 0 0 - 2030300 -
2015 - - - - -
2013 66920 121121 8000 37248 2
Honduras 2014 25118 116490 4275 54466 8
2015 36149 125975 9750 - 8
2013 4500 49401 - 2974 4
Mexico 2014 7500 47775 - 4592 6
2015 15000 214032 0 3133 6
2013 17100 127601 19029 1162 0
Nicaragua 2014 83279 56675 15620 1142 0
2015 0 59282 12527 2307 -
2013 0 17055 0 705 0
Panama 2014 0 11422 0 874 0
2015 0 11581 0 562 0
2013 4600 43617 - 42670 6504
Peru 2014 45000 69155 - 65252 10416
2015 64687 142253 - 66609 13618
AMERICAS
2013 4892 0 - 800 300
Suriname 2014 3000 0 24425 401 144
2015 0 - 17625 - -
2013 467 4369755 - - 27659
Venezuela (Bolivarian
2014 2666 4189850 0 120979 32005
Republic of)
2015 1041 2739290 - 136389 35509
EASTERN MEDITERRANEAN
2013 359622 0 188370 11135 11135
Afghanistan 2014 4325552 0 355160 21625 21625
2015 58830 - 98065 - 200
2013 25700 0 20800 8920 8920
Djibouti 2014 25000 36630 - - -
2015 0 - 40761 - -
2013 169084 281203 - 6230 3400
Iran (Islamic Republic of) 2014 70360 289249 - 8830 8830
2015 91845 217773 114450 37971 2042
2013 2238300 1161825 1170000 2150000 590840
Pakistan 2014 1519947 1103480 857690 907200 162880
2015 1822015 1685264 770074 890500 80000
2013 750000 1736400 - 974 974
Saudi Arabia 2014 1450000 752851 - 1155 1155
2015 125000 131661 - 1444 1444
2013 525000 90060 809520 292000 292000
Somalia 2014 413000 61362 617640 155450 155450
2015 291085 15645 424140 386200 386200
2013 5803319 3902712 1800000 2630400 2077204
Sudan 2014 4432714 3942110 2200000 3823175 3823175
2015 2729334 2460816 4344150 2551310 2551310
2013 1405837 2204429 233311 303847 303847
Yemen 2014 375899 2188436 412350 215486 215486
2015 847946 798707 334525 153682 153682
EUROPEAN
2013 100000 437436 - 1 1
Tajikistan 2014 50000 387010 - 0 0
2015 - - - - -
SOUTH-EAST ASIA
2013 612000 0 186700 42390 42390
Bangladesh 2014 728773 0 - 75479 58770
2015 2380759 - 259171 40742 35708
2013 93726 32824 - 518 518
Bhutan 2014 10609 144669 - 118 118
2015 26000 70926 16875 416 416
2013 0 2651612 0 15673 0
Democratic People's
2014 0 2617120 0 11212 0
Republic of Korea
2015 864750 1146750 253320 29272 0
2013 0 45854424 16200000 147000 147000
India 2014 0 45150612 15562000 211500 211500
2015 7241418 41849017 21182000 2123760 2123760
2013 913135 253815 1047504 300008 300008
Indonesia 2014 6416947 103285 879650 212346 212165
2015 56337 53497 300000 406614 406614
2013 1508557 - 1497545 371663 371663
Myanmar 2014 904613 48626 3048440 281103 281103
2015 3398941 129545 1309300 243515 243515
2013 1395865 345000 65500 38113 325
Nepal 2014 1064518 372000 60000 24500 195
2015 304437 235000 56000 3350 300
2013 670000 106374 160000 15069 15069
Thailand 2014 528850 362469 258823 19314 19314
2015 251500 348713 15400 8125 8125
2013 253037 51627 121991 1042 513
Timor-Leste 2014 99572 110707 86592 347 105
2015 24607 93019 90818 80 56
WHO region Year No. of ITN + LLIN No. of people No. of RDTs First-line treatment ACT treatment
Country/area sold or delivered protected by IRS distributed courses delivered courses delivered
(including ACT)
WESTERN PACIFIC
2013 5418 0 1085325 117547 117547
Cambodia 2014 70411 0 538500 118483 114159
2015 1517074 - 483600 128004 122013
2013 0 447639 821000 4127 3919
China 2014 19899 504936 - 43150 9350
2015 29611 1697188 - 67555 20710
2013 439677 13113 160000 58470 58470
Lao People's Democratic
2014 276655 4691 312075 50092 50092
Republic
2015 152791 - 324225 86456 86456
2013 317943 682288 - 3850 2873
Malaysia 2014 622673 615384 - 3923 3182
2015 285946 489030 - 2311 1616
2013 1625831 0 1032600 915330 915330
Papua New Guinea 2014 1613140 - 963900 802080 802080
2015 991440 - 1000000 728310 728310
2013 715125 1108220 70550 24771 24771
Philippines 2014 996180 1175136 201775 30095 30095
2015 932736 847845 79300 16989 16989
2013 0 - - 443 -
Republic of Korea 2014 5250 - - 638 -
2015 5250 - 4900 699 -
2013 371124 98971 1677 146439 146439
Solomon Islands 2014 47258 128673 47450 147430 147430
2015 10721 175683 107425 242456 242456
2013 94232 3033 35000 24000 24000
Vanuatu 2014 42916 0 50000 24000 24000
2015 38211 - 53400 20256 20256
2013 0 1310820 412530 218389 141570
Viet Nam 2014 526366 616670 434160 194397 106100
2015 658450 620093 459332 97570 45000
ACT, artemisinin-based combination therapy; IRS, indoor residual spraying; ITN, insecticide-treated mosquito net; LLIN, long-lasting insecticidal net; RDT, rapid diagnostic test
1 In May 2013, South Sudan was reassigned to the WHO African Region (WHA resolution 66.21, http://apps.who.int/gb/ebwha/pdf_files/WHA66/A66_R21-en.pdf)
AFRICAN
Burkina Faso MIS 2014 - 47 71 85 66 - 76 1 47 - - 46 64 28 31
Burundi DHS 2013 - 23 46 83 47 - 55 6 - - - - - 69 48
Chad DHS 2015 - 27 40 47 21 - 22 1 41 8 - - 43 10 13
Democratic Republic DHS 2013 - 24 47 85 49 - 59 - - - 8 - - 19 19
of the Congo DHS 2014 - 24 47 85 49 - 59 - - 6 8 23 59 18 19
Gambia DHS 2013 - 19 45 77 36 46 46 32 43 6 12 1 66 31 37
Ghana DHS 2014 - 45 59 49 36 47 43 10 50 39 8 27 77 78 34
DHS 2014 - 32 48 79 41 - 50 2 34 10 - - 73 85 35
Kenya
DHS 2015 - 39 53 78 47 57 58 - - 23 - 8 73 92 39
Liberia DHS 2013 - 20 37 71 31 - 36 13 30 18 - - 80 43 42
Madagascar DHS 2013 - 28 48 85 54 - 61 30 - - 4 - - 41 13
Malawi MIS 2014 - 30 52 86 52 67 61 9 37 - 7 33 67 93 49
DHS 2013 - 38 65 90 58 68 73 6 42 13 21 53 49 17 12
Mali
DHS 2015 - 37 70 91 63 71 78 5 40 - - 36 58 29 14
Namibia DHS 2013 - 12 18 23 4 - 4 17 26 3 3 - 66 46 22
DHS 2013 - 22 36 35 13 - 16 2 23 7 - - 78 18 11
Nigeria
Annex 4 E. Household surveys results, 20132015
DHS 2015 - 34 55 60 37 43 49 1 35 22 10 27 68 38 13
DHS 2013 - 41 66 75 60 - 74 12 - - - - - 93 30
Rwanda
DHS 2015 - 41 64 80 60 67 73 - - - 2 1 59 99 36
DHS 2013 - 27 57 66 39 - 43 13 - - 10 - - 18 -
Senegal DHS 2014 - 34 58 63 39 42 38 10 41 3 5 1 59 10 11
DHS 2015 - 39 66 71 50 55 51 5 42 8 8 0 51 14 18
Sierra Leone DHS 2013 - 14 38 93 41 - 52 5 - - 17 - - 77 40
Togo DHS 2014 - 32 49 61 33 42 40 - - 24 9 38 61 48 24
Uganda MIS 2015 - 60 79 77 67 73 75 5 63 28 5 19 83 87 36
Zambia DHS 2014 - 24 47 65 34 - 41 31 48 50 - - 77 90 49
ACT, artemisinin-based combination therapy; ANC, antenatal care; DHS, demographic and health survey; HH, households; IPT, intermittent preventive treatment;
IRS, indoor residual spraying; ITN, insecticide-treated mosquito net; MIS, malaria indicator survey
117
Annex 4 F. Estimated malaria cases and deaths, 20002015
AFRICAN
cases <50 <10
Algeria
deaths <10 <10
cases 3 300 000 4 800 000 6 400 000 4 100 000 5 400 000 6 700 000
Angola
deaths 17 000 22 000 28 000 16 000 22 000 28 000
cases 1 700 000 2 700 000 3 900 000 2 400 000 3 400 000 4 400 000
Benin
deaths 5 600 7 400 9 500 6 600 8 600 11 000
cases 12 000 27 000 77 000 1 000 2 300 5 600
Botswana
deaths 1 70 240 <10
cases 5 500 000 7 200 000 9 000 000 5 700 000 7 400 000 9 100 000
Burkina Faso
deaths 36 000 39 000 55 000 25 000 32 000 49 000
cases 1 900 000 2 800 000 4 000 000 1 500 000 2 200 000 3 000 000
Burundi
deaths 7 300 10 000 12 000 3 600 6 800 7 600
cases 4 600 000 6 300 000 8 200 000 5 900 000 8 000 000 10 000 000
Cameroon
deaths 16 000 20 000 26 000 15 000 21 000 27 000
cases 210 490 1 400 97 220 590
Cabo Verde
deaths <10 <10
cases 1 100 000 1 600 000 2 300 000 1 200 000 1 900 000 2 700 000
Central African Republic
deaths 5 100 6 400 8 200 5 700 7 400 9 400
cases 810 000 1 700 000 2 800 000 870 000 2 200 000 3 900 000
Chad
deaths 4 400 6 200 9 000 3 800 7 400 11 000
cases 65 000 110 000 190 000 66 000 110 000 190 000
Comoros
deaths 9 280 620 9 280 650
cases 750 000 1 100 000 1 500 000 840 000 1 200 000 1 700 000
Congo
deaths 2 100 2 800 3 600 1 100 2 400 3 100
cases 6 500 000 8 700 000 11 000 000 6 800 000 9 600 000 13 000 000
Cte dIvoire
deaths 27 000 33 000 40 000 25 000 32 000 39 000
cases 17 000 000 24 000 000 31 000 000 20 000 000 29 000 000 38 000 000
Democratic Republic of the Congo
deaths 87 000 100 000 140 000 88 000 110 000 150 000
cases 120 000 190 000 270 000 180 000 250 000 310 000
Equatorial Guinea
deaths 540 680 870 570 790 1 000
cases 21 000 70 000 170 000 18 000 28 000 41 000
Eritrea
deaths 3 140 590 <100
cases 1 100 000 21 000 000 34 000 000 1 200 000 4 800 000 12 000 000
Ethiopia
deaths 450 47 000 74 000 280 9 300 29 000
cases 290 000 440 000 630 000 140 000 230 000 340 000
Gabon
deaths 330 460 590 78 310 430
cases 310 000 410 000 540 000 310 000 410 000 530 000
Gambia
deaths 520 740 990 160 570 820
cases 6 800 000 9 200 000 12 000 000 6 500 000 8 300 000 10 000 000
Ghana
deaths 15 000 19 000 25 000 8 400 16 000 20 000
cases 3 200 000 4 200 000 5 200 000 2 800 000 4 100 000 5 700 000
Guinea
deaths 12 000 15 000 20 000 8 800 12 000 16 000
cases 350 000 570 000 790 000 96 000 190 000 290 000
Guinea-Bissau
deaths 1 200 1 600 2 000 240 730 1 000
cases 5 500 000 7 200 000 9 300 000 3 700 000 5 200 000 6 800 000
Kenya
deaths 8 700 14 000 16 000 3 500 12 000 13 000
cases 950 000 1 400 000 2 100 000 980 000 1 500 000 2 000 000
Liberia
deaths 5 400 6 700 8 700 2 800 4 100 5 300
cases 69 000 1 700 000 5 600 000 22 000 1 300 000 3 500 000
Madagascar
deaths 9 4 400 18 000 5 3 300 12 000
cases 3 300 000 4 800 000 6 400 000 3 100 000 4 100 000 5 100 000
Malawi
deaths 12 000 16 000 20 000 4 800 9 700 13 000
cases 3 900 000 5 000 000 6 200 000 4 800 000 6 100 000 7 400 000
Mali
deaths 21 000 27 000 34 000 18 000 23 000 29 000
cases 31 000 250 000 730 000 44 000 310 000 890 000
Mauritania
deaths 510 920 1 200 280 1 000 1 400
cases 7 400 000 9 400 000 12 000 000 7 600 000 9 300 000 11 000 000
Mozambique
deaths 31 000 40 000 51 000 17 000 25 000 32 000
cases 47 000 84 000 150 000 45 000 70 000 110 000
Namibia
deaths 6 210 520 5 180 400
cases 1 900 000 3 700 000 5 700 000 2 400 000 4 600 000 7 000 000
Niger
deaths 11 000 14 000 20 000 9 100 13 000 19 000
<10 0 1
<10 0 1b
1 700 000 2 400 000 3 300 000 1 800 000 3 100 000 4 700 000 2
8 800 14 000 20 000 9 200 14 000 21 000 2
2 300 000 3 200 000 4 200 000 2 300 000 3 200 000 4 100 000 2
5 100 6 800 8 900 4 200 6 000 8 000 2
1 700 3 400 7 500 370 710 1 500 1
<10 <10 1c
7 300 000 9 400 000 11 000 000 4 500 000 7 000 000 10 000 000 2
22 000 29 000 45 000 10 000 15 000 29 000 2
1 100 000 1 900 000 2 800 000 890 000 1 400 000 2 000 000 2
2 000 5 300 5 700 1 500 5 200 5 600 2
4 200 000 5 700 000 7 300 000 3 500 000 5 300 000 7 700 000 2
6 500 11 000 15 000 4 900 9 200 13 000 2
66 140 300 <50 1
<10 <10 1a
980 000 1 600 000 2 500 000 770 000 1 400 000 2 300 000 2
3 700 5 000 6 400 2 500 3 600 4 600 2
850 000 1 900 000 3 500 000 720 000 1 900 000 3 400 000 2
3 400 7 400 11 000 3 200 7 500 11 000 2
96 000 140 000 210 000 2 000 2 900 4 500 1
12 350 720 <10 1c
530 000 880 000 1 400 000 490 000 800 000 1 200 000 2
390 1 700 2 300 260 1 600 2 400 2
6 900 000 9 000 000 11 000 000 5 900 000 7 900 000 10 000 000 2
17 000 22 000 28 000 9 800 14 000 17 000 2
21 000 000 28 000 000 35 000 000 14 000 000 19 000 000 24 000 000 2
60 000 82 000 110 000 26 000 42 000 65 000 2
80 000 150 000 220 000 75 000 180 000 310 000 2
180 350 460 160 340 450 2
59 000 93 000 140 000 38 000 65 000 100 000 1
11 180 380 7 130 290 1c
480 000 4 400 000 10 000 000 820 000 2 800 000 5 500 000 1
230 8 100 25 000 240 4 900 13 000 1c
100 000 230 000 420 000 140 000 400 000 710 000 2
69 320 460 100 390 530 2
310 000 410 000 550 000 320 000 420 000 520 000 1
120 570 870 110 630 960 2
7 600 000 9 600 000 12 000 000 4 800 000 7 300 000 10 000 000 2
7 300 16 000 20 000 4 600 13 000 17 000 2
3 400 000 4 500 000 5 900 000 3 600 000 4 600 000 5 700 000 2
8 000 11 000 14 000 6 700 9 900 12 000 2
95 000 170 000 250 000 55 000 160 000 330 000 2
170 670 970 150 680 1 000 2
2 500 000 3 300 000 4 200 000 3 800 000 6 500 000 11 000 000 2
2 100 11 000 11 000 2 500 12 000 12 000 2
1 100 000 1 300 000 1 700 000 670 000 1 100 000 1 600 000 2
1 400 2 400 3 100 970 2 000 2 600 2
380 000 650 000 980 000 1 500 000 2 400 000 4 000 000 1
49 1 700 3 500 180 6 000 13 000 1c
5 100 000 6 200 000 7 300 000 2 400 000 3 300 000 4 200 000 2
4 700 10 000 13 000 1 800 7 200 10 000 2
4 200 000 5 300 000 6 300 000 6 100 000 7 500 000 9 100 000 2
12 000 16 000 20 000 16 000 21 000 25 000 2
32 000 240 000 700 000 50 000 260 000 560 000 1
260 1 100 1 500 250 1 200 1 600 2
7 700 000 9 300 000 11 000 000 6 300 000 8 300 000 11 000 000 2
11 000 18 000 24 000 8 100 15 000 20 000 2
2 200 2 900 3 800 17 000 22 000 27 000 1
<10 <100 2
3 400 000 6 000 000 8 600 000 2 800 000 5 200 000 8 400 000 2
9 700 14 000 20 000 6 600 10 000 16 000 2
AFRICAN
cases 41 000 000 54 000 000 66 000 000 46 000 000 59 000 000 74 000 000
Nigeria
deaths 160 000 200 000 260 000 140 000 190 000 240 000
cases 950 000 3 400 000 8 700 000 550 000 1 600 000 3 500 000
Rwanda
deaths 3 400 5 200 7 200 1 000 3 600 5 200
cases 40 000 47 000 55 000 24 000 30 000 39 000
Sao Tome and Principe
deaths 110 110 110 <100
cases 1 100 000 2 300 000 3 800 000 640 000 1 300 000 2 200 000
Senegal
deaths 4 600 6 500 8 400 1 400 4 600 6 400
cases 1 200 000 2 000 000 2 800 000 1 400 000 2 400 000 3 400 000
Sierra Leone
deaths 10 000 12 000 17 000 9 000 12 000 16 000
cases 23 000 39 000 65 000 13 000 17 000 21 000
South Africa
deaths 530 <100
cases 1 200 000 2 000 000 2 900 000 1 200 000 1 800 000 2 600 000
South Sudan1
deaths 5 600 6 100 9 600 2 500 4 000 7 400
cases 630 1 900 3 900 710 970 1 300
Swaziland
deaths <10 <10
cases 1 900 000 2 500 000 3 500 000 2 100 000 2 800 000 3 500 000
Togo
deaths 5 500 6 900 8 800 5 200 6 900 8 900
cases 9 300 000 12 000 000 16 000 000 10 000 000 13 000 000 17 000 000
Uganda
deaths 39 000 49 000 63 000 24 000 35 000 45 000
United Republic of Tanzania cases 8 400 000 12 000 000 15 000 000 7 400 000 9 700 000 12 000 000
deaths 22 000 30 000 38 000 7 800 20 000 26 000
cases 3 000 000 4 000 000 5 200 000 2 200 000 2 900 000 3 700 000
Zambia
deaths 11 000 14 000 18 000 3 400 7 900 10 000
cases 78 000 960 000 2 700 000 85 000 990 000 3 000 000
Zimbabwe
deaths 23 2 500 9 100 25 2 500 9 200
AMERICAS
cases 1 600 1 700 1 900 1 600 1 800 2 000
Belize
deaths 0 0
Bolivia (Plurinational State of) cases 33 000 49 000 110 000 21 000 30 000 62 000
deaths <50 <50
cases 950 000 1 200 000 1 600 000 710 000 820 000 930 000
Brazil
deaths 370 370 370 180 180 180
cases 200 000 320 000 470 000 140 000 190 000 240 000
Colombia
deaths <50 <50
cases 1 300 1 600 2 300 4 200 5 300 6 500
Dominican Republic
deaths <10 <50
cases 110 000 110 000 130 000 17 000 19 000 21 000
Ecuador
deaths 0 0
cases 770 820 920 68 73 82
El Salvador
deaths 0 0
cases 4 200 7 400 24 000 3 700 6 000 16 000
French Guiana
deaths <50 <10
cases 56 000 98 000 340 000 43 000 68 000 190 000
Guatemala
deaths <50 <50
cases 35 000 52 000 83 000 59 000 89 000 140 000
Guyana
deaths 7 78 160 12 120 240
cases 72 000 130 000 210 000 78 000 140 000 220 000
Haiti
deaths 9 330 740 10 370 780
cases 56 000 81 000 110 000 26 000 37 000 52 000
Honduras
deaths <50 <50
cases 7 500 8 100 9 100 3 000 3 200 3 600
Mexico
deaths 0 0
cases 38 000 49 000 62 000 10 000 13 000 17 000
Nicaragua
deaths <50 <10
cases 1 100 1 200 1 300 3 900 4 300 4 600
Panama
deaths <10 <10
cases 99 000 140 000 180 000 130 000 160 000 200 000
Peru
deaths <50 <10
47 000 000 59 000 000 71 000 000 42 000 000 61 000 000 82 000 000 2
94 000 130 000 170 000 78 000 110 000 150 000 2
730 000 1 100 000 1 500 000 2 800 000 3 500 000 4 600 000 1
530 3 000 4 600 320 3 000 4 600 1c
3 600 4 900 6 700 2 600 3 400 4 500 1
<100 <100 1a
1 100 000 1 800 000 2 700 000 950 000 1 400 000 2 100 000 1
800 4 100 6 000 640 4 400 6 500 2
2 000 000 2 800 000 3 700 000 1 200 000 2 000 000 2 800 000 2
8 300 11 000 15 000 4 000 5 800 8 900 2
14 000 17 000 22 000 9 000 12 000 15 000 1
<100 160 1a
970 000 1 800 000 2 800 000 970 000 1 900 000 3 200 000 2
1 800 3 200 7 100 1 400 2 800 7 400 2
370 530 790 190 260 380 1
<10 <10 1c
2 200 000 2 900 000 3 800 000 2 000 000 2 500 000 3 000 000 2
4 500 6 300 7 900 2 700 4 200 5 300 2
12 000 000 14 000 000 17 000 000 4 500 000 8 500 000 13 000 000 2
12 000 20 000 25 000 4 300 12 000 17 000 2
5 300 000 6 900 000 8 700 000 3 900 000 5 300 000 6 900 000 2
3 800 16 000 22 000 3 100 17 000 24 000 2
1 700 000 2 200 000 2 600 000 2 200 000 2 800 000 3 600 000 2
1 700 6 300 8 800 1 900 7 100 9 900 2
450 000 970 000 1 800 000 610 000 960 000 1 500 000 1
58 2 500 6 000 69 2 400 5 200 1c
AMERICAS
cases 12 000 18 000 41 000 9 800 13 000 28 000
Suriname
deaths <50 <10
cases 40 000 78 000 230 000 49 000 78 000 210 000
Venezuela (Bolivarian Republic of)
deaths 11 60 180 12 52 140
EASTERN MEDITERRANEAN
cases 580 000 1 100 000 1 800 000 380 000 580 000 890 000
Afghanistan
deaths 170 540 1 100 86 280 540
cases 2 000 10 000 28 000 2 200 7 900 14 000
Djibouti
deaths <50 <50
cases 12 000 13 000 15 000 15 000 16 000 18 000
Iran (Islamic Republic of)
deaths <10 <10
cases 1 900 000 3 900 000 14 000 000 1 900 000 3 900 000 13 000 000
Pakistan
deaths 410 4 000 15 000 400 4 400 16 000
cases 4 800 5 200 5 800 210 220 250
Saudi Arabia
deaths 0 0
cases 330 000 610 000 1 100 000 740 000 1 100 000 1 400 000
Somalia
deaths 50 1 800 3 900 98 2 800 5 300
cases 1 600 000 2 400 000 3 500 000 1 600 000 2 200 000 2 900 000
Sudan
deaths 210 6 300 12 000 190 5 500 11 000
cases 290 000 730 000 1 900 000 260 000 600 000 2 100 000
Yemen
deaths 44 1 800 6 400 35 1 500 5 400
EUROPE
cases 19 000 21 000 23 000 2 400 2 500 2 800
Tajikistan
deaths 0 0
SOUTH-EAST ASIA
cases 71 000 110 000 150 000 76 000 120 000 170 000
Bangladesh
deaths 13 210 430 11 250 520
cases 6 000 6 500 7 300 1 900 2 000 2 200
Bhutan
deaths <50 <10
250 000 340 000 480 000 300 000 390 000 510 000 1
58 200 340 66 190 330 1c
690 1 600 3 100 1 100 5 600 18 000 1
<10 <50 1c
1 900 2 000 2 300 170 180 200 1
<10 <10 1b
1 100 000 1 500 000 2 100 000 730 000 1 000 000 1 500 000 1
250 1 700 3 200 170 740 1 300 1c
<50 84 91 100 1
0 0 1b
190 000 280 000 390 000 310 000 700 000 1 300 000 1
26 740 1 400 52 2 100 4 800 1c
880 000 1 200 000 1 600 000 970 000 1 400 000 1 900 000 1
110 3 000 5 700 130 3 500 6 800 1c
320 000 510 000 810 000 200 000 310 000 460 000 1
42 1 300 2 800 24 770 1 600 1c
140 000 180 000 220 000 95 000 120 000 150 000 1
22 320 560 17 120 200 1c
5 200 5 900 6 300 <50 1
<10 0 1b
48 000 69 000 97 000 68 000 88 000 110 000 1
6 170 350 <50 1c
5 900 6 400 7 100 1 900 2 000 2 300 1
<50 <10 1b
890 000 1 200 000 1 600 000 650 000 900 000 1 200 000 1
130 2 600 5 100 140 1 200 2 300 1c
35 000 53 000 75 000 9 200 13 000 17 000 1
5 110 240 <50 1c
WESTERN PACIFIC
cases 4 200 4 500 5 100 1 300 1 400 1 600
Republic of Korea
deaths 0 0
cases 160 000 190 000 230 000 180 000 220 000 260 000
Solomon Islands
deaths 25 370 650 28 420 730
cases 17 000 23 000 31 000 19 000 26 000 34 000
Vanuatu
deaths <50 <50
cases 160 000 210 000 250 000 32 000 39 000 47 000
Viet Nam
deaths 24 430 780 5 79 140
REGIONAL SUMMARY
cases 146 716 840 225 899 390 308 872 300 154 924 807 216 738 490 290 668 490
African
deaths 588 411 787 840 1 064 830 458 152 667 360 903 200
cases 1 717 470 2 345 820 3 605 520 1 309 268 1 677 673 2 342 782
Americas
deaths 397 838 1 450 214 722 1 340
cases 4 718 800 8 768 200 22 348 800 4 897 410 8 404 120 20 322 250
Eastern Mediterranean
deaths 884 14 440 38 400 809 14 480 38 240
cases 19 000 21 000 23 000 2 400 2 500 2 800
European
deaths 0 0
cases 21 533 000 30 246 500 41 817 300 23 957 700 36 201 400 46 580 400
South-East Asia
deaths 4 705 45 250 83 350 4 587 52 352 85 140
cases 2 585 200 3 739 500 5 287 100 1 658 600 2 295 000 2 984 900
Western Pacific
deaths 363 8 360 16 190 260 4 429 8 410
cases 177 290 310 271 020 410 381 954 020 186 750 185 265 319 183 362 901 622
Total
deaths 594 760 856 728 1 204 220 464 022 739 343 1 036 330
1 South Sudan became an independent State on 9 July 2011 and a Member State of WHO on 27 September 2011. South Sudan and Sudan have distinct epidemiological profiles
comprising high-transmission and low-transmission areas respectively. For this reason, data up to June 2011 from the high-transmission areas of Sudan (10 southern states,
which correspond to contemporary South Sudan) and low-transmission areas (15 northern states which correspond to contemporary Sudan) are reported separately.
Cases: (1) Estimated from reported confirmed cases, (2) Estimated from parasite prevalence surveys
Deaths: (1a) Reported deaths adjusted for completeness of death reporting, (1b) Reported deaths adjusted for case reporting completeness (1c) Estimated by applying case
fatality rate to estimated cases, (2) Modelled from verbal autopsy data
156 963 936 209 461 870 268 111 090 129 499 160 191 386 270 265 182 880
313 679 498 340 683 660 216 456 391 330 560 830
798 400 1 032 070 1 465 720 570 730 764 350 1 173 370
126 653 1 338 32 400 870
2 742 590 3 833 600 5 385 400 2 511 354 3 805 871 5 688 300
486 6 940 13 440 442 7 300 14 830
110 120 140 0
0 0
21 935 440 28 868 480 41 596 530 11 107 397 14 632 220 20 143 760
3 932 45 420 86 980 1 687 26 390 51 580
1 218 400 1 628 700 2 144 000 869 010 1 177 220 1 541 000
176 3 380 6 568 163 1 371 2 588
183 658 876 244 824 840 318 702 880 144 557 651 211 765 931 293 729 310
318 399 554 733 791 986 218 780 426 791 630 698
AFRICAN
Algeria 39 666 519 - - -
Angola 25 021 974 25 021 974 25 021 974 -
Benin 10 879 829 10 879 829 10 879 829 -
Botswana 2 262 485 1 499 989 95 305 -
Burkina Faso 18 105 570 18 105 570 18 105 570 -
Burundi 11 178 921 11 178 921 11 178 921 -
Cabo Verde 520 502 - - 308 626
Cameroon 23 344 179 23 344 179 16 574 367 -
Central African Republic 4 900 274 4 900 274 4 900 274 -
Chad 14 037 472 13 883 825 9 454 923 -
Comoros 788 474 788 474 375 159 -
Congo 4 620 330 4 620 330 4 620 330 -
Cte d'Ivoire 22 701 556 22 701 556 22 701 556 -
Democratic Republic of the Congo 77 266 814 77 266 814 74 948 810 -
Equatorial Guinea 845 060 845 060 845 060 -
Eritrea 5 227 791 5 227 791 3 711 732 -
Ethiopia 99 390 750 67 585 709 27 034 284 -
Gabon 1 725 292 1 725 292 1 725 292 -
Gambia 1 990 924 1 990 924 1 990 924 -
Ghana 27 409 893 27 409 893 27 409 893 -
Guinea 12 608 590 12 608 590 12 608 590 -
Guinea-Bissau 1 844 325 1 844 325 1 844 325 -
Kenya 46 050 302 46 050 302 32 324 967 -
Liberia 4 503 438 4 503 438 4 503 438 -
Madagascar 24 235 390 24 235 390 21 271 015 -
Malawi 17 215 232 17 215 232 17 215 232 -
Mali 17 599 694 17 599 694 15 839 725 -
Mauritania 4 067 564 4 067 564 2 847 295 -
Mayotte 233 993 - - -
Mozambique 27 977 863 27 977 863 27 977 863 -
Namibia 2 458 830 1 951 686 1 135 022 -
Niger 19 899 120 18 705 173 10 546 534 -
Nigeria 182 201 962 182 201 962 139 161 989 -
Rwanda 11 609 666 11 609 666 11 609 666 -
Sao Tome and Principe 190 344 190 344 190 344 -
Senegal 15 129 273 15 129 273 14 524 102 -
Sierra Leone 6 453 184 6 453 184 6 453 184 -
South Africa 54 490 406 5 449 041 2 179 616 -
South Sudan1 12 339 812 12 339 812 12 339 812 -
Swaziland 1 286 970 360 352 0 -
Togo 7 304 578 7 304 578 7 304 578 -
Uganda 39 032 383 39 032 383 39 032 383 -
United Republic of Tanzania 53 470 420 53 470 420 52 884 689 -
Mainland 51 957 514 51 957 514 51 957 514 -
Zanzibar 1 512 906 1 512 906 927 175 -
Zambia 16 211 767 16 211 767 16 211 767 -
Zimbabwe 15 602 751 12 286 025 4 464 890 -
AMERICAS
Belize 359 287 - - 23 917
Bolivia (Plurinational State of) 10 724 705 4 865 489 267 944 -
Brazil 207 847 528 26 360 703 6 470 279 -
Colombia 48 228 704 10 182 444 4 875 710 -
Dominican Republic 10 528 391 5 072 515 97 337 -
Ecuador 16 144 363 - - 251 369
El Salvador 6 126 583 - - 22 000
French Guiana 268 606 268 606 229 658 -
Guatemala 16 342 897 12 539 759 4 069 177 -
P C P C P C
0 747 - - - -
484 965 2 769 305 - - - -
227 028 1 268 347 - - 94 030 256 392
14 326 0 6 - -
1 271 007 7 015 446 - - - -
83 704 5 159 706 - - 0 269 004
- 28 - - - -
1 159 149 1 162 784 - - 29 162 30 497
354 702 598 833 - - - -
703 510 787 046 - - - -
217 1 300 15 848 584 - -
213 045 51 529 - - - -
230 821 3 375 904 0 73 800 0 94 078
- 11 627 473 - - 0 911 332
- 15 142 - - - -
4 938 19 372 - - 0 8 664
307 648 1 867 059 - - - -
193 420 23 867 - - - -
9 055 240 382 3 966 913 0 5 053
5 866 591 4 319 919 2 145 778 1 337 177 154 619 0
84 037 810 979 39 254 23 898 40 118 80 196
- - - - - -
6 177 953 1 499 027 208 556 460 109 0 82 141
850 006 931 086 - - 43 521 10 625
8 073 744 103 16 084 2 416 418 475 193 138
1 272 178 3 661 238 - - 1 165 029 197 354
1 021 390 2 295 611 - - 67 678 158 897
158 931 22 631 - - - -
- - - - - -
- 7 718 782 - - 84 172 504 032
0 12 050 - - - -
1 545 634 2 272 000 - - 0 120 108
7 881 839 6 850 782 494 445 968 551 - -
0 2 505 794 - - 259 188 772
0 2 058 - - - -
9 831 492 253 - - 93 231 74 580
86 230 1 483 376 3 338 10 541 467 748 0
4 619 4 357 - - 110 602
- - - - - -
456 195 0 300 - -
1 1 113 927 - - 0 394 088
6 284 142 7 137 662 161 371 275 085 - -
3 503 526 4 242 732 83 613 659 921 - -
3 502 326 4 239 490 83 613 658 721 - -
1 200 3 242 - 1 200 - -
909 462 4 184 661 - - - -
0 391 651 - - 0 90 728
0 13 5 0 - -
0 6 907 - - - -
113 143 049 - - - -
4 272 51 594 - - - -
0 661 0 129 277 0
0 686 - - - -
0 9 - - - -
0 434 - - - -
- 6 836 - - - -
AMERICAS
Guyana 767 085 713 389 268 480 -
Haiti 10 711 067 10 711 067 5 676 866 -
Honduras 8 075 060 5 117 453 376 477 -
Mexico 127 017 224 - - 4 466 571
Nicaragua 6 082 032 3 428 487 270 047 -
Panama 3 929 141 184 172 172 882 -
Peru 31 376 670 4 437 249 3 414 952 -
Suriname 542 975 85 247 85 247 -
Venezuela (Bolivarian Republic of) 31 108 083 6 193 641 4 977 960 -
EASTERN MEDITERRANEAN
Afghanistan 32 526 562 24 582 076 8 753 666 -
Djibouti 887 861 443 931 0 -
Iran (Islamic Republic of) 79 109 272 - - 692 020
Pakistan 188 924 874 185 733 706 54 631 264 -
Saudi Arabia 31 540 372 - - 42 995
Somalia 10 787 104 10 787 104 5 490 347 -
Sudan 40 234 882 40 234 882 34 964 112 -
Yemen 26 832 215 20 899 635 6 724 424 -
EUROPEAN
Tajikistan 8 481 855 - - -
SOUTH-EAST ASIA
Bangladesh 160 995 642 16 679 149 4 282 484 -
Bhutan 774 830 - - 36 042
Democratic People's Republic of Korea 25 155 317 - - -
India 1 311 050 527 1 193 055 980 183 547 074 -
Indonesia 257 563 815 67 296 487 30 311 412 -
Myanmar 53 897 154 32 078 320 8 521 440 -
Nepal 28 513 700 13 672 319 1 035 047 -
Thailand 67 959 359 33 979 680 5 436 749 -
Timor-Leste 1 184 765 1 062 868 398 960 -
WESTERN PACIFIC
Cambodia 15 577 899 11 016 604 7 497 002 -
China 1 383 924 532 - - 33 340
Lao People's Democratic Republic 6 802 023 6 299 338 2 125 078 -
Malaysia 30 331 007 - - -
Papua New Guinea 7 619 321 7 619 321 7 162 162 -
Philippines 100 699 395 61 409 115 6 637 429 -
Republic of Korea 50 293 439 - - -
Solomon Islands 583 591 577 755 577 755 -
Vanuatu 264 652 264 652 230 048 -
Viet Nam 93 447 601 68 869 834 6 352 108 -
REGIONAL SUMMARY
African 985 902 466 857 774 467 716 045 227 308 626
Americas 536 180 401 90 160 221 31 253 017 4 763 857
Eastern Mediterranean 410 843 142 282 681 334 110 563 812 735 015
European 8 481 855 0 0 0
South-East Asia 1 907 095 109 1 357 824 801 233 533 166 36 042
Western Pacific 1 689 543 460 156 056 619 30 581 582 33 340
Total 5 538 046 433 2 744 497 442 1 121 976 804 5 876 880
C = Confirmed
P = Presumed
1 In May 2013, South Sudan was reassigned to the WHO African Region (WHA resolution 66.21, http://apps.who.int/gb/ebwha/pdf_files/WHA66/A66_R21-en.pdf)
P C P C P C
0 9 984 - - - -
0 17 583 - - 0 343
0 3 564 0 58 - -
0 551 0 7 - -
0 2 307 - - - -
0 562 0 3 - -
0 66 609 0 463 - -
0 376 - - - -
0 136 402 - - - -
- 5 - - - -
40 908 122 88 681 470 3 172 253 3 813 301 2 658 152 3 670 281
4 385 448 127 5 660 277 343
4 397 260 969 089 0 0 0 16 482
0 5 0 0 0 0
20 516 1 493 189 0 140 0 148 068
292 470 412 745 22 24 796 19 038 76 697
45 622 753 92 004 625 3 172 280 3 838 897 2 677 467 3 911 871
WHO region 2000 2005 2010 2011 2012 2013 2014 2015
Country/area
AFRICAN
Presumed and confirmed 541 299 408 191 887 603 266 747
Microscopy examined 27733 18392 12224 11974 15790 12762 8690 8000
Confirmed with microscopy 541 299 408 191 887 603 266 747
Algeria
RDT examined - - - - - - - 0
Confirmed with RDT - - - - - - - 0
Imported cases 506 297 396 187 828 587 260 729
Presumed and confirmed 2080348 2329316 3687574 3501953 3031546 3144100 3180021 3254270
Microscopy examined - - 1947349 1765933 2245223 3025258 3398029 3345693
Confirmed with microscopy - 889572 1324264 1147473 1056563 1462941 1431313 1396773
Angola
RDT examined - - 639476 833753 1069483 1103815 1855400 3009305
Confirmed with RDT - - 358606 484809 440271 536927 867666 1372532
Imported cases - - - - - - - -
Presumed and confirmed - 803462 1432095 1424335 1513212 1670273 1509221 1495375
Microscopy examined - - - 88134 243008 291479 155205 296264
Confirmed with microscopy - - - 68745 - 99368 108714 108061
Benin
RDT examined - - - 475986 825005 1158526 1335582 1486667
Confirmed with RDT - - - 354223 705839 979466 935521 1160286
Imported cases - - - - - - - -
Presumed and confirmed 71555 11242 12196 1141 308 506 1485 340
Microscopy examined - - - - - - - -
Confirmed with microscopy - - 1046 432 - - - -
Botswana
RDT examined - - - - - - - 1284
Confirmed with RDT - - - - 193 456 1346 326
Imported cases - - - - - - - 48
Presumed and confirmed - 1615695 5723481 5024697 6970700 7146026 8278408 8286453
Microscopy examined - 73262 177879 400005 223372 183971 198947 222190
Confirmed with microscopy - 21335 88540 83857 90089 82875 83259 92589
Burkina Faso
RDT examined - - 940985 450281 4516273 4296350 6224055 8290188
Confirmed with RDT - - 715999 344256 3767957 3686176 5345396 6922857
Imported cases - - - - - - - -
Presumed and confirmed 3252692 2334067 4255301 3298979 2570754 4469007 4831758 5243410
Microscopy examined 484249 903942 2825558 2859720 2659372 4123012 4471998 3254670
Confirmed with microscopy 308095 327464 1599908 1485332 1484676 2366134 2718391 1964862
Burundi
RDT examined - - 273324 181489 1148965 2933869 2903679 5076107
Confirmed with RDT - - 163539 86542 666400 1775253 1866882 3194844
Imported cases - - - - - - - -
Presumed and confirmed 144 68 47 36 36 46 46 28
Microscopy examined 6843 7902 - - 8715 10621 6894 3117
Confirmed with microscopy 144 68 47 - 36 46 46 28
Cabo Verde
RDT examined - - - 26508 - - - -
Confirmed with RDT - - - 36 - - - -
Imported cases - - - 29 35 24 20 21
Presumed and confirmed - 277413 1845691 1829266 1589317 1824633 1369518 2321933
Microscopy examined - - - 1110308 1182610 1236306 1086095 1024306
Confirmed with microscopy - - - - - - - 592351
Cameroon
RDT examined - - - 120466 93392 591670 1254293 1128818
Confirmed with RDT - - - - - - - 570433
Imported cases - - - - - - - -
Presumed and confirmed 89614 131856 66484 221980 459999 407131 495238 953535
Microscopy examined - - - - - 63695 55943 139241
Central African Confirmed with microscopy - - - - - 36943 41436 106524
Republic RDT examined - - - - 55746 136548 369208 724303
Confirmed with RDT - - - - 46759 79357 253652 492309
Imported cases - - - - - - - -
Presumed and confirmed 437041 501846 544243 528454 660575 1272841 1513772 1490556
Microscopy examined 45283 37439 89749 - 69789 - - -
Confirmed with microscopy 40078 31668 75342 86348 - 206082 160260 149574
Chad
RDT examined - - 309927 114122 - 621469 1137455 937775
Confirmed with RDT - - 125106 94778 - 548483 753772 637472
Imported cases - - - - - - - -
AFRICAN
Presumed and confirmed 801784 29554 103670 76661 65139 62565 2465 1517
Microscopy examined - - 87595 63217 125030 154824 93444 89634
Confirmed with microscopy - 6086 35199 22278 45507 46130 1987 963
Comoros
RDT examined - - 5249 20226 27714 21546 9839 11479
Confirmed with RDT - - 1339 2578 4333 7026 216 337
Imported cases - - - - - - - -
Presumed and confirmed 15751 67 446656 277263 120319 183026 248159 264574
Microscopy examined - - - - - 69375 88764 87547
Confirmed with microscopy - - - 37744 120319 43232 54523 51529
Congo
RDT examined - - - - - 0 19746 0
Confirmed with RDT - - - - - 0 11800 0
Imported cases - - - - - - - -
Presumed and confirmed - 1280914 1721461 2588004 2795919 4708425 4658774 3606725
Microscopy examined - - - 49828 195546 395914 568562 811426
Confirmed with microscopy - - 62726 29976 107563 215104 306926 478870
Cte d'Ivoire
RDT examined - - - - 1572785 3384765 4904066 4174097
Confirmed with RDT - - - - 1033064 2291849 3405905 2897034
Imported cases - - - - - - - -
Presumed and confirmed 964623 6334608 9252959 9442144 9128398 11363817 9968983 11627473
Microscopy examined 3758 5531 3678849 4226533 4329318 4126129 3533165 2877585
Democratic Confirmed with microscopy 897 2971 2374930 2700818 2656864 2611478 2126554 1902640
Republic of the
Congo RDT examined - - 54728 2912088 3327071 6096993 11114215 13574891
Confirmed with RDT - - 42850 1861163 2134734 4103745 7842429 9724833
Imported cases - - - - - - - -
Presumed and confirmed - - 78095 37267 20890 25162 20417 15142
Microscopy examined - - 42585 23004 33245 27039 47322 21831
Equatorial Confirmed with microscopy - - 39636 20601 13196 11235 17685 8564
Guinea RDT examined - - 16772 2899 6826 5489 9807 46227
Confirmed with RDT - - 14177 1865 1973 1894 2732 6578
Imported cases - - - - - - - -
Presumed and confirmed - 24192 53750 39567 42178 34678 35725 24310
Microscopy examined - 48937 79024 67190 84861 81541 63766 59268
Confirmed with microscopy - 9073 13894 15308 11557 10890 10993 8332
Eritrea
RDT examined - - - 25570 33758 39281 53032 47744
Confirmed with RDT - - 22088 19540 10258 10427 19775 11040
Imported cases - - - - - - - -
Presumed and confirmed - 3901957 4068764 3549559 3876745 3316013 2513863 2174707
Microscopy examined - 1364194 2509543 3418719 3778479 8573335 7062717 5679932
Confirmed with microscopy - 538942 1158197 1480306 1692578 2645454 2118815 1867059
Ethiopia
RDT examined - - - - - - - -
Confirmed with RDT - - - - - - - -
Imported cases - - - - - - - -
Presumed and confirmed 127024 235479 185105 178822 188089 185196 185996 217287
Microscopy examined - 129513 54714 - 66018 90185 90275 79308
Confirmed with microscopy 50810 70644 12816 - 18694 26432 27687 20390
Gabon
RDT examined - - 7887 - 4129 10132 11812 12761
Confirmed with RDT - - 1120 - 1059 2550 4213 3477
Imported cases - - - - - - - -
Presumed and confirmed - 329426 194009 261967 300363 279829 166229 249437
Microscopy examined - - 290842 172241 156580 236329 286111 272604
Confirmed with microscopy - - 52245 71588 29325 65666 66253 49649
Gambia
RDT examined - - 123564 - 705862 614128 317313 609852
Confirmed with RDT - - 64108 190379 271038 175126 99976 190733
Imported cases - - - - - - - -
Presumed and confirmed 3349528 3452969 3849536 4154261 10676731 7200797 8453557 10186510
Microscopy examined - - 2031674 1172838 4219097 1394249 1987959 2023581
Confirmed with microscopy - 655093 1029384 624756 2971699 721898 970448 934304
Ghana
RDT examined - - 247278 781892 1438284 1488822 3610453 5478585
Confirmed with RDT - 0 42253 416504 783467 917553 2445464 3385615
Imported cases - - - - - - - -
WHO region 2000 2005 2010 2011 2012 2013 2014 2015
Country/area
AFRICAN
Presumed and confirmed 816539 850309 1092554 1189016 1220574 775341 1595828 895016
Microscopy examined - - - 43549 - - 116767 78377
Confirmed with microscopy 4800 50452 20936 5450 191421 63353 82818 52211
Guinea
RDT examined - - - 139066 - - - 1092523
Confirmed with RDT - - - 90124 125779 147904 577389 758768
Imported cases - - - - - - - -
Presumed and confirmed 246316 185493 140143 174986 129684 132176 98952 -
Microscopy examined - 33721 48799 57698 61048 58909 106882 -
Confirmed with microscopy - 14659 30239 21320 23547 17733 35546 -
Guinea-Bissau
RDT examined - - 56455 139531 97047 102079 197536 -
Confirmed with RDT - - 20152 50662 26834 36851 57885 -
Imported cases - - - - - - - -
Presumed and confirmed 4216531 9181224 6071583 11120812 9335951 9750953 9655905 7676980
Microscopy examined - - 2384402 3009051 4836617 6606885 7444865 7772329
Confirmed with microscopy - - 898531 1002805 1426719 2060608 2415950 1025508
Kenya
RDT examined - - - - 164424 655285 850884 1965661
Confirmed with RDT - - - - 26752 274678 392981 473519
Imported cases - - - - - - - -
Presumed and confirmed - 44875 2675816 2480748 1800372 1483676 1066107 1781092
Microscopy examined - 8718 335973 728443 772362 818352 1318801 509062
Confirmed with microscopy - 5025 212927 577641 507967 496269 302708 305981
Liberia
RDT examined - 57325 998043 1593676 1276521 1144405 912382 947048
Confirmed with RDT - 39850 709246 1338121 899488 747951 561496 625105
Imported cases - - - - - - - -
Presumed and confirmed 1392483 1229385 293910 255814 395149 387045 433101 752176
Microscopy examined 31575 37943 24393 34813 38453 42573 37362 39604
Confirmed with microscopy 6946 6753 2173 3447 3667 4947 3853 4748
Madagascar
RDT examined - - 604114 739572 906080 1026110 926998 1488667
Confirmed with RDT - - 200277 221051 355753 380651 374110 739355
Imported cases - - - - - - - 1167
Presumed and confirmed 3646212 3688389 6851108 5338701 4922596 3906838 5065703 4933416
Microscopy examined - - - 119996 406907 132475 198534 216643
Confirmed with microscopy - - - 50526 283138 44501 77635 75923
Malawi
RDT examined - - - 580708 2763986 3029020 5344724 7030084
Confirmed with RDT - - - 253973 1281846 1236391 2827675 3585315
Imported cases - - - - - - - -
Presumed and confirmed 546634 962706 2171542 1961070 2171739 2327385 2590643 3317001
Microscopy examined - - - - - - - -
Confirmed with microscopy - - - - 97995 190337 219637 243151
Mali
RDT examined - - 1380178 974558 - 1889286 - 3389449
Confirmed with RDT - - 227482 307035 788487 1176881 1820216 2052460
Imported cases - - - - - - - -
Presumed and confirmed - 223472 244319 154003 169104 128486 172326 181562
Microscopy examined - - 5449 3752 1865 5510 - -
Confirmed with microscopy - - 909 1130 255 957 - -
Mauritania
RDT examined - - 2299 7991 3293 3576 47500 60253
Confirmed with RDT - - 1085 1796 1633 630 15835 22631
Imported cases - - - - - - - -
Presumed and confirmed - 500 396 92 72 82 15 -
Microscopy examined - - 2023 1214 1463 - - -
Confirmed with microscopy - 500 396 92 72 82 15 -
Mayotte
RDT examined - - - - - - - -
Confirmed with RDT - - - - - - - -
Imported cases - - 236 51 47 71 14 -
Presumed and confirmed - - 3381371 3344413 3203338 3924832 7117648 7718782
Microscopy examined - - 1950933 2504720 2546213 2058998 2295823 2313129
Confirmed with microscopy - - 644568 1093742 886143 774891 1009496 735750
Mozambique
RDT examined - - 2287536 2966853 2234994 5215893 9944222 11928263
Confirmed with RDT - - 878009 663132 927841 2223983 6108152 6983032
Imported cases - - - - - - - -
AFRICAN
Presumed and confirmed - 339204 25889 14406 3163 4911 15914 12050
Microscopy examined - - 14522 13262 7875 1507 1894 -
Confirmed with microscopy - 23339 556 335 194 136 222 -
Namibia
RDT examined - - - 48599 - 32495 185078 207612
Confirmed with RDT - - - 1525 - 4775 15692 12050
Imported cases - - - - - - - 2888
Presumed and confirmed - 817707 3643803 3157482 4592519 4288425 3222613 3817634
Microscopy examined - 107092 165514 130658 1781505 1799299 2872710 295229
Confirmed with microscopy - 46170 49285 68529 1119929 1176711 0 206660
Niger
RDT examined - 21230 7426774 1130514 1781505 1799299 2872710 2657057
Confirmed with RDT - 9873 570773 712347 1119929 1176711 1953309 2065340
Imported cases - - - - - - - -
Presumed and confirmed 2476608 3532108 3873463 4306945 6938519 12830911 16512127 14732621
Microscopy examined - - - 672185 1953399 1633960 1681469 851183
Confirmed with microscopy - - 523513 - - - 1233654 569036
Nigeria
RDT examined - - 45924 242526 2898052 7194960 9188933 8655024
Confirmed with RDT - - 27674 - - - 6593300 6281746
Imported cases - - - - - - - -
Presumed and confirmed - 1654246 638669 208858 483470 962618 1610812 2505794
Microscopy examined - 1438603 2708973 1602271 2904793 2862877 4010202 5811267
Confirmed with microscopy - 683769 638669 208858 422224 879316 1528825 2354400
Rwanda
RDT examined - - - - 190593 201708 168004 281847
Confirmed with RDT - - - - 61246 83302 81987 151394
Imported cases - - - - - - - -
Presumed and confirmed 32149 22370 3346 8442 12550 9243 1754 2058
Microscopy examined 66076 68819 48366 83355 103773 73866 33355 11941
Sao Tome and Confirmed with microscopy 31975 18139 2233 6373 10706 6352 569 140
Principe RDT examined - - 9989 33924 23124 34768 58090 72407
Confirmed with RDT - - 507 2069 1844 2891 1185 1918
Imported cases - - - - - - - 2
Presumed and confirmed 1123377 1346158 707772 604290 634106 772222 628642 502084
Microscopy examined 56169 105093 27793 18325 19946 24205 19343 26556
Confirmed with microscopy 44959 33160 17750 14142 15612 20801 12636 17846
Senegal
RDT examined - - 651737 555614 524971 668562 697175 1384834
Confirmed with RDT - - 325920 263184 265468 325088 252988 474407
Imported cases - - - - - - - 352
Presumed and confirmed 460881 233833 934028 856332 1945859 1715851 1898852 1569606
Microscopy examined - 10605 718473 46280 194787 185403 66277 75025
Confirmed with microscopy - 3702 218473 25511 104533 76077 39414 37820
Sierra Leone
RDT examined - 3452 1609455 886994 1975972 2377254 2056722 2176042
Confirmed with RDT - 1106 715555 613348 1432789 1625881 1335062 1445556
Imported cases - - - - - - - -
Presumed and confirmed 64624 7755 8060 9866 6846 8851 13988 8976
Microscopy examined - - - 178387 121291 364021 300291 13917
Confirmed with microscopy - 7755 3787 5986 1632 2572 4101 785
South Africa
RDT examined - - 276669 204047 30053 239705 240622 17446
Confirmed with RDT - - 4273 3880 3997 6073 7604 3572
Imported cases - - - - - - - 3568
Presumed and confirmed - 337582 900283 795784 1125039 1855501 - -
Microscopy examined - - - - - - - -
Confirmed with microscopy - - 900283 112024 225371 262520 - -
South Sudan1
RDT examined - - - - - - - -
Confirmed with RDT - - - - - - - -
Imported cases - - - - - - - -
Presumed and confirmed 29374 6066 1722 797 626 962 711 651
Microscopy examined - 4587 - - - - - -
Confirmed with microscopy - 279 87 130 345 488 711 43
Swaziland
RDT examined - - - - - - - -
Confirmed with RDT - - 181 419 217 474 - 152
Imported cases - - - 170 153 234 322 282
WHO region 2000 2005 2010 2011 2012 2013 2014 2015
Country/area
AFRICAN
Presumed and confirmed - 437662 983430 519450 768287 882430 1130251 1113928
Microscopy examined - - 478354 502977 579507 560096 621119 621119
Confirmed with microscopy - - 224087 237305 260535 272855 310207 305727
Togo
RDT examined - - 575245 390611 660627 882475 1135581 1135581
Confirmed with RDT - - 393014 282145 436839 609575 820044 808200
Imported cases - - - - - - - -
Presumed and confirmed 3552859 9867174 13208169 12173358 13591932 16541563 13724345 13421804
Microscopy examined - 2107011 3705284 385928 3466571 3718588 2048185 3684722
Confirmed with microscopy - 1104310 1581160 134726 1413149 1502362 578289 1248576
Uganda
RDT examined - - - 194819 2449526 7387826 7060545 12126996
Confirmed with RDT - - - 97147 1249109 - 3053650 5889086
Imported cases - - - - - - - -
Presumed and confirmed 45643 11466713 12893535 10164967 8477435 8585482 7403562 7746258
Microscopy examined 53533 8037619 3637659 5656907 6931025 6804085 727130 673223
United Republic Confirmed with microscopy 17734 2764049 1277024 1813179 1772062 1481275 572289 412702
of Tanzania RDT examined - - 136123 1628092 1091615 813103 17740207 16620299
Confirmed with RDT - - 1974 337582 214893 71169 107728 3830030
Imported cases - - - - - - - 2550
Presumed and confirmed - 11441681 12819192 10160478 8474278 8582934 7399316 7741816
Microscopy examined - 7993977 3573710 5513619 6784639 6720141 592320 532118
Confirmed with microscopy - 2756421 1276660 1812704 1771388 1480791 571598 411741
Mainland
RDT examined - - - 1315662 701477 369444 17566750 16416675
Confirmed with RDT - - - 333568 212636 69459 106609 3827749
Imported cases - - - - - - - -
Presumed and confirmed 45643 25032 74343 4489 3157 2548 4246 4442
Microscopy examined 53533 43642 63949 143288 146386 83944 134810 141105
Confirmed with microscopy 17734 7628 364 475 674 484 691 961
Zanzibar
RDT examined - - 136123 312430 390138 443659 173457 203624
Confirmed with RDT - - 1974 4014 2257 1710 1119 2281
Imported cases - - - - - - - 2550
Presumed and confirmed 3337796 4121356 4229839 4607908 4695400 5465122 5972933 5094123
Microscopy examined - - - - - - - -
Confirmed with microscopy - - - - - - - -
Zambia
RDT examined - - - - - - 5964354 7207500
Confirmed with RDT - - - - - - 4077547 4184661
Imported cases - - - - - - - -
Presumed and confirmed - 1494518 648965 - - - 535983 391651
Microscopy examined - - - 10004 - - - -
Confirmed with microscopy - - - - - - - -
Zimbabwe
RDT examined - - 513032 470007 727174 1115005 1420894 1384893
Confirmed with RDT - - 249379 319935 276963 422633 535931 391651
Imported cases - - - - - - - 180
AMERICAS
Presumed and confirmed 1486 1549 150 79 37 26 19 13
Microscopy examined 18559 25119 27366 22996 20789 25351 24122 26367
Confirmed with microscopy 1486 1549 150 79 37 26 19 13
Belize
RDT examined - - - - - - - -
Confirmed with RDT - - - - - - - -
Imported cases - - - 7 4 4 0 4
Presumed and confirmed 31469 21442 13769 7143 7415 7342 7401 6907
Microscopy examined 143990 202021 133463 143272 121944 133260 124900 159167
Bolivia Confirmed with microscopy 31469 20142 12252 6108 6293 6272 7401 6907
(Plurinational
State of) RDT examined - 6000 7394 7390 10960 10789 - -
Confirmed with RDT - 1300 1517 1035 1122 1070 - -
Imported cases - - - - - - - -
Presumed and confirmed 613241 606067 334668 267146 242758 178546 143415 143162
Microscopy examined 2562576 2660539 2711432 2476335 2325775 1873518 1658976 1488072
Confirmed with microscopy 613241 606067 334667 266713 237978 174048 142031 139844
Brazil
RDT examined - - - 1486 23566 19500 11043 14655
Confirmed with RDT - - - 433 4780 3719 1384 3205
Imported cases - - - - - - - 4949
AMERICAS
Presumed and confirmed 144432 121629 117650 64436 60179 51722 40768 55866
Microscopy examined 478820 493562 521342 396861 346599 284332 325713 316451
Confirmed with microscopy 144432 121629 117637 60121 50938 44293 36166 48059
Colombia
RDT examined - - - 21171 70168 42723 77819 11983
Confirmed with RDT - - 13 4188 9241 7403 4602 3535
Imported cases - - - - - - - 532
Presumed and confirmed 1233 3837 3414 1616 952 579 496 661
Microscopy examined 427297 397108 469052 421405 415808 431683 362304 316947
Dominican Confirmed with microscopy 1233 3837 2482 1616 952 579 496 661
Republic RDT examined - - 26585 56150 90775 71000 54425 50220
Confirmed with RDT - - 932 - - - - -
Imported cases - - - - - - - 30
Presumed and confirmed 104528 17050 1888 1233 558 378 241 686
Microscopy examined 544646 358361 481030 460785 459157 397628 370825 261824
Confirmed with microscopy 104528 17050 1888 1233 558 378 241 686
Ecuador
RDT examined - - 7800 - - - - -
Confirmed with RDT - - - - - - - -
Imported cases - - - 14 14 10 - 68
Presumed and confirmed 753 67 24 16 19 7 8 9
Microscopy examined 279072 102479 115256 100883 124885 103748 106915 89267
Confirmed with microscopy 753 67 24 15 19 7 8 9
El Salvador
RDT examined - - - 1 - - - 0
Confirmed with RDT - - - 1 - - - 0
Imported cases - - 7 6 6 1 2 6
Presumed and confirmed 3708 3414 1632 1209 900 875 448 434
Microscopy examined 48162 32402 14373 14429 13638 22327 14651 11558
Confirmed with microscopy 3708 3414 688 505 401 324 187 272
French Guiana
RDT examined - - - - - - - -
Confirmed with RDT - - 944 704 499 551 261 162
Imported cases - - - - - - - -
Presumed and confirmed 53311 39571 7384 6817 5346 6214 4931 6836
Microscopy examined 246642 178726 235075 195080 186645 153731 264269 295246
Confirmed with microscopy 53311 39571 7384 6817 5346 6214 4931 5538
Guatemala
RDT examined - - 2000 - 0 0 50025 6500
Confirmed with RDT - - 0 - 0 0 754 1298
Imported cases - - - - - - - 2
Presumed and confirmed 24018 38984 22935 29506 31656 31479 12354 9984
Microscopy examined 209197 210429 212863 201693 196622 205903 142843 132941
Confirmed with microscopy 24018 38984 22935 29471 31601 31479 12354 9984
Guyana
RDT examined - - - 0 - 0 0 0
Confirmed with RDT - - - 35 55 0 0 0
Imported cases - - - - - - - -
Presumed and confirmed 16897 21778 84153 32969 25423 26543 17696 17583
Microscopy examined 21190 3541506 270427 184934 167726 165823 134766 69659
Confirmed with microscopy 16897 21778 84153 32969 25423 20957 10893 5224
Haiti
RDT examined - - - - 46 5586 126637 233081
Confirmed with RDT - - - - - - 6803 12359
Imported cases - - - - - - - -
Presumed and confirmed 35125 15943 9685 7618 6439 5428 3380 3564
Microscopy examined 175577 153474 152961 152451 155165 144436 151420 150854
Confirmed with microscopy 35125 15943 9685 7465 6439 5364 3380 3555
Honduras
RDT examined - 2500 4000 4000 4000 237 1427 3052
Confirmed with RDT - - - 45 10 64 102 20
Imported cases - - - - - - - 0
Presumed and confirmed 7390 2967 1226 1130 842 499 664 551
Microscopy examined 2003569 1559076 1192081 1035424 1025659 1017508 900578 867853
Confirmed with microscopy 7390 2967 1226 1130 842 499 664 551
Mexico
RDT examined - - - - - 0 0 0
Confirmed with RDT - - - - - 0 0 0
Imported cases - - 7 6 9 4 8 34
WHO region 2000 2005 2010 2011 2012 2013 2014 2015
Country/area
AMERICAS
Presumed and confirmed 23878 6642 692 925 1235 1194 1163 2307
Microscopy examined 509443 516313 535914 521904 536278 519993 605357 604418
Confirmed with microscopy 23878 6642 692 925 1235 1196 1163 2307
Nicaragua
RDT examined - - 18500 14201 16444 19029 15620 -
Confirmed with RDT - - 0 - 0 - 0 -
Imported cases - - - - - - - 29
Presumed and confirmed 1036 3667 418 354 844 705 874 562
Microscopy examined 149702 208582 141038 116588 107711 93624 80701 64511
Confirmed with microscopy 1036 3667 418 354 844 705 874 562
Panama
RDT examined - - - 0 0 0 0 0
Confirmed with RDT - - - 0 0 0 0 0
Imported cases - - - - - - - 16
Presumed and confirmed 68321 87699 31546 25039 31570 43139 65252 66609
Microscopy examined 1483816 1438925 744627 702894 758723 863790 864413 865980
Confirmed with microscopy 68321 87699 31545 25005 31436 48719 65252 66609
Peru
RDT examined - - 23 58 562 858 1634 0
Confirmed with RDT - - 1 34 - - - -
Imported cases - - - - - - - -
Presumed and confirmed 11361 9131 1771 795 569 729 400 376
Microscopy examined 63377 59855 16533 15135 17464 13693 17608 15083
Confirmed with microscopy 11361 9131 1574 751 306 530 98 345
Suriname
RDT examined - - 541 1025 4008 6043 15489 153
Confirmed with RDT - - 138 20 50 199 303 31
Imported cases - - - - - - - 274
Presumed and confirmed 29736 45049 45155 45824 52803 78643 90708 136402
Microscopy examined 261866 420165 400495 382303 410663 476764 522617 625174
Venezuela Confirmed with microscopy 29736 45049 45155 45824 52803 78643 90708 136402
(Bolivarian
Republic of) RDT examined - - - - - - - -
Confirmed with RDT - - - - - - - -
Imported cases - - - - - - - 1594
EASTERN MEDITERRANEAN
Presumed and confirmed 203911 326694 392463 482748 391365 319742 290079 350044
Microscopy examined 257429 338253 524523 531053 511408 507145 1028932 538789
Confirmed with microscopy 94475 116444 69397 77549 54840 39263 122724 86895
Afghanistan
RDT examined - - - 0 0 0 155919 138026
Confirmed with RDT - - - 0 0 0 22558 16482
Imported cases - - - - - - - -
Presumed and confirmed 4667 2469 1010 230 27 1684 9439 -
Microscopy examined - 1913 - 124 1410 7189 39284 -
Confirmed with microscopy - 413 1010 - 22 1684 9439 -
Djibouti
RDT examined - - - - - - - -
Confirmed with RDT - - - - 3 - - -
Imported cases - - - - - - - -
Presumed and confirmed 19716 18966 3031 3239 1629 1373 1243 799
Microscopy examined 1732778 1674895 614817 530470 479655 385172 468513 610337
Iran (Islamic Confirmed with microscopy 19716 18966 3031 3239 1629 1373 1243 799
Republic of) RDT examined - - - - 0 - - 20549
Confirmed with RDT - - - - 0 - - 579
Imported cases 7422 4570 1184 1529 842 853 867 632
Presumed and confirmed 3337054 4022823 4281356 4065802 4285449 3472727 3666257 3776244
Microscopy examined - 4776274 4281346 4168648 4497330 3933321 4343418 4619980
Confirmed with microscopy 82526 127826 220870 287592 250526 196078 193952 137401
Pakistan
RDT examined - - 279724 518709 410949 628504 779815 691245
Confirmed with RDT - - 19721 46997 40255 85677 81197 64612
Imported cases - 290 - - - - - -
Presumed and confirmed 6608 1059 1941 2788 3406 2513 2305 2620
Microscopy examined - 715878 944723 1062827 1186179 1309783 1249752 1306700
Confirmed with microscopy 6608 1059 1941 2788 3406 2513 2305 2620
Saudi Arabia
RDT examined - - - - 0 - - -
Confirmed with RDT - - - - 0 - - -
Imported cases 1872 855 1912 2719 3324 2479 2254 2537
EASTERN MEDITERRANEAN
Microscopy examined - 47882 20593 26351 - - - -
Confirmed with microscopy - 12516 5629 1627 - - - -
RDT examined - - 200105 35236 37273 67464 64480 100792
Somalia
Confirmed with RDT - - 18924 1724 6817 7407 11001 20953
Imported cases - - - - - - - -
Presumed and confirmed 4332827 2515693 1465496 1214004 964698 989946 1207771 1102186
Microscopy examined - - - - - - - -
Confirmed with microscopy 368557 628417 625365 506806 526931 592383 579038 586827
RDT examined - - 1653300 2222380 2000700 1800000 788281 -
Sudan
Confirmed with RDT - - 95192 - - - 489468 -
Imported cases - - - - - - - -
Presumed and confirmed 1394495 200560 198963 142147 165678 149451 97089 95287
Microscopy examined - 472970 645463 645093 685406 723691 643994 529932
Confirmed with microscopy 1394495 44150 78269 60207 68849 63484 51768 38254
RDT examined - - 97289 108110 150218 157457 141519 111787
Yemen
Confirmed with RDT - - 28428 30203 41059 39294 34939 30728
Imported cases - - - - - - - -
Imported cases - - - - - - - -
EUROPEAN
Presumed and confirmed 233785 216197 112 78 33 14 7 5
Microscopy examined 233785 216197 173523 173367 209239 213916 200241 -
Confirmed with microscopy 19064 2309 112 78 33 14 7 5
Tajikistan
RDT examined - - - - - - - -
Confirmed with RDT - - - - - - - -
Imported cases - - 1 13 15 7 5 4
SOUTH-EAST ASIA
Presumed and confirmed 437838 290418 91227 51773 29518 3864 10216 6608
Microscopy examined 360300 220025 308326 270253 253887 74755 78719 69093
Confirmed with microscopy 55599 48121 20519 20232 4016 1866 3249 1612
Bangladesh
RDT examined - - 152936 119849 35675 19171 46482 53713
Confirmed with RDT - - 35354 31541 5885 1998 6967 4996
Imported cases - - - - - - - 129
Presumed and confirmed 5935 1825 487 207 82 45 48 104
Microscopy examined 76445 60152 54709 44481 42512 31632 33586 26149
Confirmed with microscopy 5935 1825 436 194 82 45 48 84
Bhutan
RDT examined - - - - - - - 47938
Confirmed with RDT - - - - - - - 20
Imported cases - - - - 0 23 29 70
Presumed and confirmed 204428 11507 13520 16760 23537 15673 11212 7409
Microscopy examined - - 25147 26513 39238 71453 38201 29272
Democratic Confirmed with microscopy 90582 11315 13520 16760 21850 14407 10535 7010
People's Republic
of Korea RDT examined - - - - 0 0 0 61348
Confirmed with RDT - - - - 0 0 0 12
Imported cases - - - - 0 0 0 205
Presumed and confirmed 2031790 1816569 1599986 1310656 1067824 881730 1102205 1169261
Microscopy examined 86790375 104120792 108679429 108969660 109033790 113109094 124066331 121141970
Confirmed with microscopy 2031790 1816569 1599986 1310656 1067824 881730 1102205 1169261
India
RDT examined - - 10600000 10500384 13125480 14782104 14562000 19699260
Confirmed with RDT - - - - - - - -
Imported cases - - - - - - - -
Presumed and confirmed 256993 315394 465764 422447 417819 1833256 252027 217025
Microscopy examined 1752763 1178457 1335445 962090 1429139 1447980 1300835 1224504
Confirmed with microscopy 245612 315394 465764 422447 417819 343527 252027 217025
Indonesia
RDT examined - - 255734 250709 471586 260181 249461 342946
Confirmed with RDT - - - - - - - -
Imported cases - - - - - - - -
WHO region 2000 2005 2010 2011 2012 2013 2014 2015
Country/area
SOUTH-EAST ASIA
Presumed and confirmed 581560 516041 693124 567452 480586 315509 152195 77842
Microscopy examined 381610 437387 275374 312689 265135 138473 93842 52076
Confirmed with microscopy 120083 165737 103285 91752 75220 25215 11952 6569
Myanmar
RDT examined - - 729878 795618 1158831 1162083 797071 661999
Confirmed with RDT - - 317523 373542 405366 226058 140243 71273
Imported cases - - - - - - - 345
Presumed and confirmed 48686 178056 96383 71752 70272 38113 26526 20621
Microscopy examined 100063 188930 102977 95011 152780 100336 127130 63946
Confirmed with microscopy 7981 5050 3115 1910 1659 1197 1469 1112
Nepal
RDT examined - - 17887 25353 22472 32989 48444 49649
Confirmed with RDT - - 779 1504 433 777 - 725
Imported cases - - - - - - 667 517
Presumed and confirmed 78561 29782 32480 24897 32569 41362 37921 14755
Microscopy examined 4403739 2524788 1695980 1354215 1130757 1830090 1756528 1358953
Confirmed with microscopy 78561 29782 22969 14478 32569 33302 37921 14135
Thailand
RDT examined - - 81997 96670 - - - 10888
Confirmed with RDT - - 9511 10419 - - - 0
Imported cases - - - - - - - 9890
Presumed and confirmed 15212 130679 119072 36064 6148 1042 342 80
Microscopy examined - 97781 109806 82175 64318 56192 30515 30275
Confirmed with microscopy 15212 43093 40250 19739 5211 1025 342 80
Timor-Leste
RDT examined - - 85643 127272 117599 121991 86592 90835
Confirmed with RDT - - 7887 - - - 0 0
Imported cases - - - - - - - -
WESTERN PACIFIC
Presumed and confirmed 203164 67036 49356 57423 45553 24130 26278 33930
Microscopy examined 122555 88991 90175 86526 80212 54716 48591 49357
Confirmed with microscopy 51320 26914 14277 13792 10124 4598 5288 7423
Cambodia
RDT examined 18167 58791 103035 130186 108974 94600 92525 114323
Confirmed with RDT 11122 22522 35079 43631 30352 16711 19864 26507
Imported cases - - - - - - - -
Presumed and confirmed - 100106 7855 4498 2678 4121 2921 3116
Microscopy examined - 3814715 7115784 9189270 6918657 5554960 4403633 4052588
Confirmed with microscopy - 21936 4990 3367 2603 4086 2921 3088
China
RDT examined - - - - - - - -
Confirmed with RDT - - - - - - - -
Imported cases - 2632 - - 2399 4007 2864 3055
Presumed and confirmed 279903 30359 23047 17904 46819 41385 48071 36056
Microscopy examined 256273 156954 150512 213578 223934 202422 133916 110084
Lao People's Confirmed with microscopy 40106 13615 4524 6226 13232 10036 8018 4167
Democratic
Republic RDT examined - - 127790 7743 145425 133337 160626 173919
Confirmed with RDT - - 16276 11609 32970 28095 40053 31889
Imported cases - - - - - - - 0
Presumed and confirmed 874894 573788 6650 5306 4725 3850 3923 2311
Microscopy examined 1832802 1425997 1619074 1600439 1566872 1576012 1443958 1066470
Confirmed with microscopy 12705 5569 6650 5306 4725 3850 3923 2311
Malaysia
RDT examined - - - - - - - -
Confirmed with RDT - - - - - - - -
Imported cases - - 831 1142 924 865 766 435
Presumed and confirmed 1751883 1788318 1379787 1151343 878371 1125808 644688 553103
Microscopy examined 225535 267132 198742 184466 156495 139972 83257 112864
Papua New Confirmed with microscopy 79839 92957 75985 70603 67202 70658 68114 64719
Guinea RDT examined - - 20820 27391 228857 468380 475654 541760
Confirmed with RDT - - 17971 13457 82993 209336 213068 233068
Imported cases - - - - - - - -
Presumed and confirmed 36596 46342 19106 9617 8154 7720 4903 5135
Microscopy examined - 581871 301031 327060 332063 317360 286222 224843
Confirmed with microscopy - - 18560 9552 7133 5826 3618 4988
Philippines
RDT examined - 12125 - - - 1523 28598 35789
Confirmed with RDT - - - - - 688 1285 134
Imported cases - - - - - - - 18
WESTERN PACIFIC
Presumed and confirmed 4183 1369 1772 838 555 443 638 699
Microscopy examined - - - - - - - -
Republic of Confirmed with microscopy - - 1772 838 555 443 638 699
Korea RDT examined - - - - - - - -
Confirmed with RDT - - - - - - - -
Imported cases - - 56 64 47 50 78 65
Presumed and confirmed 368913 393288 95006 80859 57296 53270 51649 50916
Microscopy examined 300806 316898 212329 182847 202620 191137 173900 124376
Confirmed with microscopy 68107 76390 35373 23202 21904 21540 13865 14793
Solomon Islands
RDT examined - - 17300 17457 13987 26216 26658 40750
Confirmed with RDT - - 4331 3455 2479 4069 4539 9205
Imported cases - - - - - - - -
Presumed and confirmed 33779 34912 16831 5764 3435 2381 982 697
Microscopy examined 31668 61092 29180 19183 16981 15219 18135 4870
Confirmed with microscopy 6768 9834 4013 2077 733 767 190 15
Vanuatu
RDT examined - - 10246 12529 16292 13724 17435 9794
Confirmed with RDT - - 4156 2743 2702 1614 792 408
Imported cases - - - - - - - 0
Presumed and confirmed 274910 84473 54297 45588 43717 35406 27868 19252
Microscopy examined 2682862 2728481 2760119 2791917 2897730 2684996 2357536 2204409
Confirmed with microscopy 74316 19496 17515 16612 19638 17128 15752 9331
Viet Nam
RDT examined - - 7017 491373 514725 412530 416483 459332
Confirmed with RDT - - - - - - - -
Imported cases - - - - - - - -
REGIONAL SUMMAR Y
(presumed and confirmed malaria cases)
African 33178671 75645235 103145240 99885087 110636435 124035580 127886819 129589592
Americas 1171923 1046486 678160 493855 469545 434048 390218 452512
Eastern Mediterranean 9309642 7116668 6368813 5952125 5847964 4946571 5300357 5366349
European 233785 216197 112 78 33 14 7 5
South-East Asia 3661003 3290271 3112043 2502008 2128355 3130594 1592692 1513705
Western Pacific 3828225 3119991 1653707 1379140 1091303 1298514 811921 705215
Total 51383249 90434848 114958075 110212293 120173635 133845321 135982014 137627378
WHO region 2000 2005 2010 2011 2012 2013 2014 2015
Country/area
AFRICAN
Suspected 27733 18392 12224 11974 15790 12762 8690 8000
No Pf 261 242 7 4 48 14 0 0
Algeria
No Pv 277 57 4 0 11 2 0 0
No other - - 1 0 - 0 0 0
Suspected 2080348 2329316 4591529 4469357 4849418 5273305 6134471 6839963
No Pf - - - - - - - -
Angola
No Pv - - - - - - - -
No other - - - - - - - -
Suspected - 803462 1432095 1565487 1875386 2041444 1955773 2009959
No Pf - - - 68745 0 - - -
Benin
No Pv - - - 0 0 - - -
No other - - - 0 0 - - -
Suspected 71555 11242 12196 1141 308 506 1485 1298
No Pf - - 1046 432 193 456 1346 326
Botswana
No Pv - - - - - - - -
No other - - - - - - - -
Suspected - 1667622 6037806 5446870 7852299 7146026 8278408 8286453
No Pf - 0 - - - - - -
Burkina Faso
No Pv - - - - - - - -
No other - - - - - - - -
Suspected 3428846 2910545 5590736 4768314 4228015 7384501 7622162 8414481
No Pf - - - - - - - -
Burundi
No Pv - - - - - - - -
No other - - - - - - - -
Suspected 6843 7902 47 26508 8715 10621 6894 3117
No Pf 144 68 47 7 1 22 26 7
Cabo Verde
No Pv 0 0 0 0 0 0 0 0
No other - - 0 0 0 0 0 0
Suspected - 277413 1845691 3060040 2865319 3652609 3709906 3312273
No Pf - - - - - - - 592351
Cameroon
No Pv - - - - - - - -
No other - - - - - - - -
Suspected 89614 131856 66484 221980 468986 491074 625301 1218246
Central African No Pf - - - - - - 295088 598833
Republic No Pv - - - - - - 0 -
No other - - - - - - 0 -
Suspected 442246 507617 743471 528454 730364 1272841 1737195 1641285
No Pf 20977 14770 - - - - - -
Chad
No Pv 19101 16898 - - - - - -
No other - - - - - - - -
Suspected - 29554 159976 135248 168043 185779 103545 101330
No Pf - - 33791 21387 43681 46032 2203 1300
Comoros
No Pv - - 528 334 637 72 0 0
No other - - 880 557 - 0 0 0
Suspected - - 446656 277263 117640 209169 290346 300592
No Pf - - - 37744 120319 43232 66323 51529
Congo
No Pv - - - 0 0 0 0 0
No other - - - - - 0 0 0
Suspected - 1280914 1721461 2607856 3423623 5982151 6418571 5216344
No Pf - - - - - 2506953 3712831 3375904
Cte d'Ivoire
No Pv - - - - - 0 0 0
No other - - - - - 0 0 0
Suspected 967484 6337168 10568756 12018784 11993189 14871716 14647380 16452476
Democratic No Pf 889 2844 - - - - - -
Republic of the
Congo No Pv - 110 - - - - - -
No other - - - - - - - -
Suspected - - 83639 40704 45792 44561 57129 68058
Equatorial No Pf - - 53813 22466 15169 13129 17452 -
Guinea No Pv - - - - - - - -
No other - - - - - - - -
Suspected - 64056 96792 97479 138982 134183 121755 111950
No Pf - 7506 9848 10357 12467 13873 23953 14580
Eritrea
No Pv - 1567 3989 4932 9204 7361 6780 4780
No other - - 57 19 - 83 35 12
AFRICAN
Suspected - 4727209 5420110 5487972 5962646 9243894 7457765 5987580
No Pf - 374335 806577 814547 946595 1687163 1250110 1188627
Ethiopia
No Pv - 158658 390252 665813 745983 958291 868705 678432
No other - - 0 - - - - -
Suspected 127024 294348 233770 178822 238483 256531 256183 285489
No Pf 50810 70644 2212 - - 26432 26117 -
Gabon
No Pv - - 720 - - 0 0 -
No other - - 2015 - - 0 1570 -
Suspected - 329426 492062 261967 862442 889494 603424 891511
No Pf - - 64108 190379 271038 240792 99976 240382
Gambia
No Pv - - - - - - - -
No other - - - - - - - -
Suspected 3349528 3452969 5056851 5067731 12578946 8444417 8453557 10186510
No Pf - - 926447 593518 3755166 1629198 3415912 4319919
Ghana
No Pv - - 0 0 0 0 0 0
No other - - 102937 31238 0 0 0 0
Suspected 816539 850309 1092554 1276057 1220574 775341 1595828 1254937
No Pf 4800 50452 20936 5450 191421 63353 660207 810979
Guinea
No Pv - - - - - 0 - -
No other - - - - - 0 - -
Suspected 246316 204555 195006 300233 237398 238580 309939 -
No Pf - - - - - - - -
Guinea-Bissau
No Pv - - - - - - - -
No other - - - - - - - -
Suspected 4216531 9181224 7557454 13127058 12883521 14677837 15142723 15915943
No Pf - - 898531 1002805 1453471 2335286 2808931 1499027
Kenya
No Pv - - - - - - - -
No other - - - - - - - -
Suspected - 66043 3087659 2887105 2441800 2202213 2433086 2306116
No Pf - 44875 212927 577641 1407455 1244220 864204 931086
Liberia
No Pv - - 0 - - 0 0 0
No other - - 0 - - 0 0 0
Suspected 1417112 1260575 719967 805701 980262 1071310 977228 1536344
No Pf - - - - - - - -
Madagascar
No Pv - - - - - - - -
No other - - - - - - - -
Suspected 3646212 3688389 6851108 5734906 6528505 5787441 7703651 8518905
No Pf - - - - 1564984 1280892 2905310 3585315
Malawi
No Pv - - - - - - - -
No other - - - - - - - -
Suspected 546634 962706 3324238 2628593 2171739 2849453 2590643 4410839
No Pf - - - - - - - -
Mali
No Pv - - - - - - - -
No other - - - - - - - -
Suspected - 223472 250073 162820 172374 135985 203991 219184
No Pf - - - - - - - -
Mauritania
No Pv - - - - - - - -
No other - - - - - - - -
Suspected - 500 2023 1214 1463 82 15 -
No Pf - - 169 38 25 9 1 -
Mayotte
No Pv - - 3 2 2 0 0 -
No other - - 19 0 - - 0 -
Suspected - - 6097263 7059112 6170561 8200849 12240045 14241392
No Pf - - 878009 663132 927841 2998874 7117648 7718782
Mozambique
No Pv - - - - - - - -
No other - - - - - - - -
Suspected - 339204 39855 74407 10844 34002 186972 207612
No Pf - - 556 335 194 136 15914 12050
Namibia
No Pv - - 0 0 0 0 0 0
No other - - 0 0 0 0 0 0
Suspected - 889986 10616033 3637778 5915671 5533601 7014724 4497920
No Pf - 74129 618578 778819 2207459 2352422 3906588 2267867
Niger
No Pv - - 0 0 0 0 0 0
No other - - - - - - - 4133
WHO region 2000 2005 2010 2011 2012 2013 2014 2015
Country/area
AFRICAN
Suspected 2476608 3532108 3873463 5221656 11789970 21659831 19555575 17388046
No Pf - - 523513 - - - - -
Nigeria
No Pv - - - - - - - -
No other - - - - - - - -
Suspected - 2409080 2708973 1602271 3095386 3064585 4178206 6093114
No Pf - - 638669 208858 483470 962618 1623176 -
Rwanda
No Pv - - - - 0 0 0 -
No other - - - - 0 0 0 -
Suspected 66250 73050 58961 117279 126897 108634 91445 84348
Sao Tome and No Pf - - 2219 6363 10700 9242 1754 2057
Principe No Pv - - 14 4 1 1 0 0
No other - - 0 6 - 0 0 1
Suspected 1134587 1418091 1043632 900903 897943 1119100 1079536 1421221
No Pf 44959 38746 343670 277326 281080 345889 265624 492253
Senegal
No Pv - - - - 0 0 0 0
No other - - - - - 0 0 -
Suspected 460881 243082 2327928 1150747 2579296 2576550 2647375 2337297
No Pf - 3702 218473 25511 1537322 1701958 1374476 1483376
Sierra Leone
No Pv - 0 - - - - 0 0
No other - - - - - - 0 0
Suspected 64624 7755 276669 382434 152561 603932 543196 35982
No Pf - - 2193 6906 4565 8645 11563 555
South Africa
No Pv - - 0 14 5 0 0 0
No other - - 5 15 - 0 0 0
Suspected - 337582 900283 795784 1125039 1855501 - -
No Pf - - - 112024 - - - -
South Sudan1
No Pv - - - - - - - -
No other - - - - - - - -
Suspected 29374 10374 1722 797 626 669 711 651
No Pf 0 279 87 130 345 487 710 157
Swaziland
No Pv - 0 0 0 0 0 1 0
No other - - 0 0 0 1 0 0
Suspected - 437662 1419928 893588 1311047 1442571 1756700 1756701
No Pf - - 224080 237282 260526 272855 1130234 1113910
Togo
No Pv - - 0 0 0 0 0 0
No other - - 7 23 - 8 17 17
Suspected 3552859 10869875 15332293 12522232 16845771 26145615 19201136 22095860
No Pf - 1082223 1612783 231873 2662258 1502362 3631939 7137662
Uganda
No Pv - - 15812 0 0 0 0 0
No other - - 0 0 0 0 0 0
Suspected 81442 16740283 15388319 15299205 14513120 7617188 25190092 -
United Republic No Pf 17734 7628 2338 4489 2730 - - -
of Tanzania No Pv 0 0 0 0 0 - - -
No other - - - - 201 - - -
Suspected - 16679237 15116242 14843487 13976370 14122269 24880179 20451119
No Pf - - - - 212636 69459 106609 411741
Mainland
No Pv - - - - - - - -
No other - - - - - - - -
Suspected 81442 61046 272077 455718 536750 527957 310703 345929
No Pf 17734 7628 2338 4489 2931 1725 2390 2049
Zanzibar
No Pv - - 0 0 0 0 0 0
No other - - 0 0 0 0 0 0
Suspected 3337796 4121356 4229839 4607908 4695400 5465122 7859740 8116962
No Pf - - - - - - - -
Zambia
No Pv - - - - - - - -
No other - - - - - - - -
Suspected - 1494518 912618 480011 727174 1115005 1420946 1384893
No Pf - - 249379 319935 276963 422633 535931 391651
Zimbabwe
No Pv - - - - - - - -
No other - - - 0 - - - -
AMERICAS
Suspected 18559 25119 27366 22996 20789 25351 24122 26367
No Pf 20 32 1 0 0 0 0 0
Belize
No Pv 1466 1517 149 72 33 20 18 9
No other - - 0 0 0 0 0 0
AMERICAS
Suspected 143990 208021 140857 150662 132904 144049 124900 159167
Bolivia No Pf 2536 1080 1592 543 396 996 341 96
(Plurinational
No Pv 28932 19062 13694 7635 8141 6346 7060 6811
State of)
No other - - 0 0 0 0 0 0
Suspected 2562576 2660539 2711433 2477821 2349341 1893797 1670019 1502840
No Pf 131616 155169 51048 35706 40159 34685 24654 16793
Brazil
No Pv 478212 450687 283435 231368 203018 143050 118724 126211
No other 932 211 183 143 105 32 37 45
Suspected 478820 493562 521342 418159 416767 327081 403532 332706
No Pf 51730 43472 34334 15404 17778 18340 20634 30870
Colombia
No Pv 92702 78157 83255 44701 51467 33345 20129 20724
No other - - 48 16 9 11 5 0
Suspected 427297 397108 495637 477555 506583 502683 416729 367167
Dominican No Pf 1226 3829 2480 1614 950 576 491 631
Republic No Pv 7 8 2 2 2 3 5 0
No other - - 0 0 0 0 0 0
Suspected 544646 358361 488830 460785 459157 397628 370825 261824
No Pf 48974 2212 258 296 80 161 49 227
Ecuador
No Pv 55624 14836 1630 937 478 217 199 459
No other - - 0 0 0 0 0 0
Suspected 279072 102479 115256 100884 124885 103748 106915 89267
No Pf 9 2 0 3 0 0 0 0
El Salvador
No Pv 744 65 17 12 15 6 6 3
No other - - 0 0 0 0 0 0
Suspected 48162 32402 14373 14429 13638 22327 14651 11558
No Pf 3265 1777 1548 1080 763 744 348 205
French Guiana
No Pv 657 1637 476 339 257 337 98 227
No other 214 71 5 5 2 345 2 0
Suspected 246642 178726 237075 195080 186645 153731 314294 301746
No Pf 1474 1062 35 67 68 152 92 51
Guatemala
No Pv 50171 38641 7163 6707 5278 6062 5593 5487
No other 36 48 - - 0 0 0 0
Suspected 209197 210429 212863 201693 196622 205903 142843 132941
No Pf 12324 16438 14401 20309 20329 17425 5140 3950
Guyana
No Pv 11694 21255 8402 9066 11244 13953 7173 6002
No other - 1291 132 96 83 101 41 32
Suspected 21190 3541506 270427 184934 167772 20586 258817 302740
No Pf 16897 21778 84153 32969 25423 20957 17696 17583
Haiti
No Pv 0 0 0 0 0 0 0 0
No other - - 0 0 0 0 0 0
Suspected 175577 153474 152961 152604 155165 144673 151420 153906
No Pf 1446 998 986 619 584 1159 601 933
Honduras
No Pv 33679 15011 8759 7044 5865 4269 2881 2642
No other - - 0 0 0 0 0 0
Suspected 2003569 1559076 1192081 1035424 1025659 1017508 900578 867853
No Pf 131 22 0 0 0 0 0 0
Mexico
No Pv 7259 2945 1226 1124 833 495 656 517
No other - - 0 0 0 0 0 0
Suspected 509443 516313 554414 536105 552722 536170 620977 604418
No Pf 1369 1114 154 150 236 208 157 342
Nicaragua
No Pv 22645 5498 538 775 999 954 985 1937
No other - - 0 0 0 0 0 0
Suspected 149702 208582 141038 116588 107711 93624 80701 64511
No Pf 45 766 20 1 1 6 8 6
Panama
No Pv 991 2901 398 353 843 699 866 556
No other - - 0 0 0 0 0 0
Suspected 1483816 1438925 744650 702952 759285 864648 866047 865980
No Pf 20631 15058 2374 3018 3501 8103 10684 13682
Peru
No Pv 47690 72611 29169 21984 28030 40829 54819 52919
No other 13 - 3 3 7 11 17 8
Suspected 63377 59855 17133 16184 21685 19736 26964 15236
No Pf 10648 6931 721 331 126 407 323 145
Suriname
No Pv 1673 1611 817 382 167 322 78 231
No other 811 589 36 17 2 0 0 0
WHO region 2000 2005 2010 2011 2012 2013 2014 2015
Country/area
AMERICAS
Suspected 261866 420165 400495 382303 410663 476764 522617 625174
Venezuela No Pf 5491 5725 10915 10633 13302 27659 27843 35509
(Bolivarian
Republic of) No Pv 24829 38985 32710 34651 39478 50938 62850 100880
No other 1 38 60 6 23 46 15 13
EASTERN MEDITERRANEAN
Suspected 366865 548503 847589 936252 847933 787624 743183 801938
No Pf 5115 5917 6142 5581 1231 1877 8983 4004
Afghanistan
No Pv 89240 110527 63255 71968 53609 43369 136299 82891
No other - 0 0 0 0 0 0 -
Suspected - 3969 - 354 1412 - 39276 -
No Pf - 413 1010 - 20 0 - -
Djibouti
No Pv - 0 0 - 0 0 - -
No other - 0 0 - 0 0 - -
Suspected - - - - - - - -
Iran (Islamic No Pf 2546 2219 191 208 44 94 25 9
Republic of) No Pv - 16747 1656 1502 711 426 351 157
No other - 0 0 0 0 0 - 0
Suspected - 8671271 8601835 8418570 8902947 7752797 8514341 8885456
No Pf - 42056 73857 73925 97996 56573 42817 38141
Pakistan
No Pv - 85748 143136 205879 228215 283661 232332 163872
No other - 0 0 0 0 0 0 0
Suspected - - - - - - - -
No Pf - - 29 69 82 34 51 83
Saudi Arabia
No Pv - - 0 0 0 0 0 0
No other - - 0 0 - 0 0 0
Suspected - 63770 220698 99403 70459 85174 79653 119008
No Pf - 12516 5629 - - - - -
Somalia
No Pv - 0 0 - - - - -
No other - 0 0 - - - - -
Suspected - - - - - - - -
No Pf - - - - - - - -
Sudan
No Pv - - - - - - - -
No other - - - - - - - -
Suspected - 629380 835018 804940 891394 927821 725169 668024
No Pf - 42627 77301 59696 109504 102369 86440 68682
Yemen
No Pv - 1442 966 478 398 408 267 300
No other - - 2 33 - 0 0 -
EUROPEAN
Suspected 233785 216197 173523 173367 209239 213916 200241 -
No Pf 831 81 0 0 0 0 0 -
Tajikistan
No Pv 18233 2228 111 65 18 7 2 0
No other 0 0 0 0 0 0 0 -
SOUTH-EAST ASIA
Suspected 742539 462322 496616 390102 309179 93926 125201 122806
No Pf 39475 37679 52049 49194 9464 3602 9727 6120
Bangladesh
No Pv 16124 10442 3824 2579 396 262 489 488
No other - - 0 0 0 0 0 0
Suspected 76445 60152 54760 44494 42512 31632 28716 74087
No Pf 2738 853 175 102 33 14 17 42
Bhutan
No Pv 3197 871 261 92 47 9 31 62
No other - - 0 0 0 - 0 0
Suspected 204428 11507 25147 26513 40925 72719 38878 91007
Democratic No Pf - 0 0 0 0 0 0 0
People's Republic
of Korea No Pv - 6728 13520 16760 21850 14407 10535 7022
No other - - 0 0 0 0 0 0
Suspected 86790375 104120792 119279429 119470044 122159270 127891198 138628331 140841230
No Pf 1047218 805077 834364 665004 524370 463846 722546 778821
India
No Pv 984572 1011492 765622 645652 534129 417884 379659 390440
No other - - - - - - - 0
Suspected 3178212 2113265 2205293 2092187 2051425 1833256 1575907 1599427
No Pf 89289 127594 242041 232197 229255 191200 142807 116420
Indonesia
No Pv 156323 147543 187583 187989 187583 150985 107260 94267
No other - - 2547 2261 981 1342 1960 8
SOUTH-EAST ASIA
Suspected 843087 787691 1277568 1210465 1423966 1364792 890913 714075
No Pf 95499 124644 72995 62624 342593 234986 110324 51519
Myanmar
No Pv 21802 37014 29944 28966 135388 98860 41866 26316
No other - - 346 162 - 25 5 7
Suspected 140768 361936 213353 188702 243432 169464 200631 83455
No Pf 560 1181 766 249 612 295 139 87
Nepal
No Pv 7056 5691 2349 1631 1480 1659 693 504
No other - - 0 0 0 0 - 0
Suspected 4403739 2524788 1777977 1450885 1130757 1838150 1756528 1370461
No Pf 43717 14670 9548 5857 11553 14645 14331 3348
Thailand
No Pv 37975 14921 13401 8608 17506 15573 20513 4655
No other - - 20 13 - 3084 3077 0
Suspected 15212 185367 266384 225772 182854 178200 117107 121110
No Pf - 43093 28818 15981 1962 513 203 56
Timor-Leste
No Pv - 15523 11432 3758 2288 512 139 24
No other - - 0 0 0 0 0 0
WESTERN PACIFIC
Suspected 281444 165382 193210 216712 194263 152137 142242 163680
No Pf 46150 17482 9483 8637 19867 9510 14796 20784
Cambodia
No Pv 4505 9004 4794 5155 19575 11267 10356 13146
No other - - 0 0 - 0 0 -
Suspected - 3892885 7118649 9190401 6918732 5554995 4403633 4052616
No Pf - 3588 1295 1410 1419 3091 6 1
China
No Pv - 18187 3675 1907 179 930 50 26
No other - - 20 50 - 0 1 0
Suspected 496070 173698 280549 221390 369976 339013 294542 284003
Lao People's No Pf 38271 13106 4401 5770 38461 25494 25445 15252
Democratic
Republic No Pv 1689 473 122 442 7634 12537 22625 20804
No other - - 1 14 - 1 1 0
Suspected 2694991 1994216 1619074 1600439 1566872 1576012 1443958 1066470
No Pf 6000 2222 1489 754 651 464 210 132
Malaysia
No Pv 5953 2729 3387 1750 915 385 241 84
No other - - 943 1660 - 2136 2706 1659
Suspected 1897579 1962493 1505393 1279140 1113528 1454166 922417 909940
Papua New No Pf 63591 62926 60824 60317 58747 120748 200215 233609
Guinea No Pv 14721 22833 13171 9654 7108 7579 78846 62228
No other - - 1990 632 - 1279 2125 1950
Suspected 36596 593996 301577 327125 333084 320089 314820 260645
No Pf 25912 20033 12038 7043 4774 5051 3995 4343
Philippines
No Pv - 6482 2885 2380 2189 1357 834 699
No other - - 175 127 - 67 74 80
Suspected 4183 1369 1772 838 555 443 638 699
Republic of No Pf - - 27 20 36 0 0 0
Korea No Pv - - 1691 754 473 383 557 627
No other - - 0 0 0 0 0 0
Suspected 601612 633796 284931 254506 249520 245014 233803 192044
No Pf 46703 54001 23092 14537 14980 13640 10559 11848
Solomon Islands
No Pv 21322 22515 12281 8665 9339 11628 7845 12150
No other - - - 0 - 0 0 0
Suspected 58679 86170 48088 32656 33273 28943 35570 14938
No Pf 3226 3817 1738 851 1727 1039 279 150
Vanuatu
No Pv 2972 4453 2265 1224 1680 1342 703 273
No other - - 10 2 0 0 0 0
Suspected 2883456 2793458 2803918 3312266 3436534 3115804 2786135 2673662
No Pf 58377 14394 12763 10101 11448 9532 8532 4561
Viet Nam
No Pv 15935 5102 4466 5602 7220 6901 7220 4756
No other - - 0 0 0 0 0 14
WHO region 2000 2005 2010 2011 2012 2013 2014 2015
Country/area
AFRICAN
Algeria 2 - 1 0 0 0 0 1
Angola 9510 13768 8114 6909 5736 7300 5714 7832
Benin - 322 964 1753 2261 2288 1869 1416
Botswana - 11 8 8 3 7 22 5
Burkina Faso - 5224 9024 7001 7963 6294 5632 5379
Burundi 691 776 2677 2233 2263 3411 2974 3799
Cabo Verde - 2 1 1 0 0 2 0
Cameroon - 836 4536 3808 3209 4349 4398 3440
Central African Republic 439 668 526 858 1442 1026 635 1763
Chad 712 558 886 1220 1359 1881 1720 1572
Comoros - 92 53 19 17 15 0 1
Congo - - - 892 623 2870 271 435
Cte d'Ivoire - - 1023 1389 1534 3261 4069 2604
Democratic Republic of the Congo 3856 15322 23476 23748 21601 30918 25502 39054
Equatorial Guinea - - 30 52 77 66 - 28
Eritrea - 49 27 12 30 6 15 12
Ethiopia - 1086 1581 936 1621 358 213 662
Gabon 2016 353 182 74 134 273 159 309
Gambia - 426 151 440 289 262 170 167
Ghana 6108 2037 3859 3259 2855 2506 2200 2137
Guinea 626 490 735 743 979 108 1067 846
Guinea-Bissau - 565 296 472 370 418 357 -
Kenya 48767 44328 26017 713 785 360 472 15061
Liberia - 41 1422 - 1725 1191 2288 1379
Madagascar 591 699 427 398 552 641 551 841
Malawi - 5070 8206 6674 5516 3723 4490 3799
Mali 748 1285 3006 2128 1894 1680 2309 1544
Mauritania - - 211 77 106 25 19 39
Mayotte - - 0 0 0 0 0 -
Mozambique - - 3354 3086 2818 2941 3245 2467
Namibia - 1325 63 36 4 21 61 45
Niger 1244 2060 3929 2802 2825 2209 2691 2778
Nigeria - 6494 4238 3353 7734 7878 6082 -
Rwanda - 2581 670 380 459 409 496 516
Sao Tome and Principe 254 85 14 19 7 11 0 0
Senegal 1275 1587 553 472 649 815 500 526
Sierra Leone - 50 8188 3573 3611 4326 2848 1107
South Africa 424 63 83 54 72 105 174 110
South Sudan1 - - 1053 406 1321 1311 - -
Swaziland - 17 8 1 3 4 4 5
Togo - 1024 1507 1314 1197 1361 1205 1205
Uganda - - 8431 5958 6585 7277 5921 6100
United Republic of Tanzania 379 18322 15867 11806 7820 8528 5373 6313
Mainland - 18075 15819 11799 7812 8526 5368 6311
Zanzibar 379 247 48 7 8 2 5 2
Zambia - 7737 4834 4540 3705 3548 3257 2389
Zimbabwe - 1916 255 451 351 352 406 200
AMERICAS
Belize 0 0 0 0 0 0 0 0
Bolivia (Plurinational State of) 11 0 0 0 0 0 1 0
Brazil 245 123 76 70 60 40 36 37
Colombia 124 87 42 23 24 10 17 18
Dominican Republic 6 16 15 10 8 5 4 3
Ecuador 66 22 0 0 0 0 0 0
El Salvador 0 0 0 0 0 0 0 0
French Guiana 0 2 1 2 2 3 0 0
Guatemala 0 4 0 0 0 1 1 1
Guyana 29 33 24 36 35 14 11 12
Haiti 16 29 8 5 6 10 9 15
Honduras 0 1 3 2 1 1 2 0
Mexico 0 0 0 0 0 0 0 0
Nicaragua 4 6 1 1 2 0 0 1
AMERICAS
Panama 1 1 1 0 1 0 0 0
Peru 20 4 0 1 7 4 5 3
Suriname 24 1 1 1 0 1 0 0
Venezuela (Bolivarian Republic of) 24 17 18 16 10 6 5 8
EASTERN MEDITERRANEAN
Afghanistan - 0 22 40 36 24 64 49
Djibouti - - 0 0 0 17 28 -
Iran (Islamic Republic of) 4 1 0 0 0 0 0 1
Pakistan - 52 - 4 260 244 56 34
Saudi Arabia - 0 0 0 0 0 0 0
Somalia - 15 6 5 10 23 14 27
Sudan 2162 1789 1023 612 618 685 823 868
Yemen - - 92 75 72 55 23 12
EUROPEAN
Tajikistan 0 0 0 0 0 0 0 0
SOUTH-EAST ASIA
Bangladesh 484 501 37 36 11 15 45 9
Bhutan 15 5 2 1 1 0 0 0
Democratic People's Republic of
- - 0 0 0 0 0 0
Korea
India 892 963 1018 754 519 440 562 384
Indonesia 833 88 432 388 252 385 217 157
Myanmar 2556 1707 788 581 403 236 92 37
Nepal - 10 6 2 0 0 0 0
Thailand 625 161 80 43 37 47 38 33
Timor-Leste - 71 58 16 3 3 1 0
WESTERN PACIFIC
Cambodia 608 296 151 94 45 12 18 10
China 31 48 19 33 0 0 0 0
Lao People's Democratic Republic 350 77 24 17 44 28 4 2
Malaysia 35 33 13 12 12 10 4 8
Papua New Guinea 617 725 616 523 381 307 203 163
Philippines 536 145 30 12 16 12 10 20
Republic of Korea 0 0 1 2 0 0 0 0
Solomon Islands 38 38 34 19 18 18 23 13
Vanuatu 3 5 1 1 0 0 0 0
Viet Nam 142 18 21 14 8 6 6 3
REGIONAL SUMMARY
African 77642 137269 150486 104068 104105 116333 99381 117886
Americas 570 346 190 167 156 95 91 98
Eastern Mediterranean 2166 1857 1143 736 996 1048 1008 991
European 0 0 0 0 0 0 0 0
South-East Asia 5405 3506 2421 1821 1226 1126 955 620
Western Pacific 2360 1385 910 727 524 393 268 219
Total 88143 144363 155150 107519 107007 118995 101703 119814
Reported malaria can be presumed and confirmed or only confirmed deaths depending on the country
Indigenous malaria deaths are in italics
1 In May 2013, South Sudan was reassigned to the WHO African Region (WHA resolution 66.21, http://apps.who.int/gb/ebwha/pdf_files/WHA66/A66_R21-en.pdf)